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RESUMEN 
Los MicroARNs (miARNs) son pequeñas moléculas de ARN que regulan la expresión 
génica en diversos procesos biológicos incluida la respuesta inmunitaria. Se ha descrito 
que los miARNs pueden transferirse entre células a través de exosomas. La sinapsis 
inmune (SI) es una estructura muy organizada de comunicación entre los linfocitos T y las 
células presentadoras de antígeno (CPA) que se forma durante el reconocimiento de 
antígeno. En esta tesis se ha estudiado en primer lugar la comunicación intercelular entre 
los linfocitos T y las CPAs a través de la SI, mediada por el intercambio de exosomas que 
contienen miARNs. En los siguientes objetivos se analizaron los patrones de expresión de 
los miARNs durante la activación  de los linfocitos T incluyendo el estudio de sus dianas 
de mRNA así como su regulación por modificaciones post-transcripcionales. 
Los datos presentados en esta tesis muestran que los exosomas de las células T, B y células 
dendríticas (CDs) contienen miRNAs específicos que difieren de los de la célula 
productora. Tras la formación de la SI, encontramos una transferencia unidireccional de 
miARNs desde la célula T a la CPA mediada por la transmisión de exosomas. Los 
miARNs transferidos durante la SI son capaces de alterar la expresión génica de la célula 
receptora.  
En el segundo objetivo, analizamos cómo cambia el patrón de miARNs de la célula T 
después de ser activada por distintos tipos de CDs. También estudiamos las dianas de 
mRNA comunes a los miARNs que se modulan durante la activación T y validamos la 
relación entre uno de los miARN que más se inducen, miR-132-3p, y el gen pik3r1 que se 
predijo como diana común de los miARNs aumentados en activación. 
Finalmente, en el tercer objetivo de esta tesis, nos centramos en la regulación de miARNs 
durante la activación de los linfocitos T mediante la adición de nucleótidos no codificados 
en 3’ (3’ANC). Detectamos que tras la activación, la adición de uracilos disminuye 
específicamente, acompañada por una disminución de los niveles de las enzimas uracil 
transferasas TUT4 y TUT7. La adición en 3’ de uracilos, además, promueve la degradación 
de miARNs específicamente durante la activación del linfocito T. 
Los resultados presentados en esta tesis apoyan un nuevo mecanismo de comunicación 
intercelular que consiste en la transferencia de miRNAs mediante exosomas  durante la SI. 
Además se ha analizado el perfil de miARNs durante la activación T y se ha descrito que 
la uridilación modula los niveles de miARNs durante este proceso.  
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SUMMARY 
microRNAs (miRNAs) are small regulatory RNA molecules that control gene expression 
in many biological processes including immune response. Moreover, it has been described 
that miRNAs can be transferred between cells via exosomes. The Immune Synapse (IS) is 
a very well organized structure of communication between T cells and antigen presenting 
cells (APC) formed during antigen recognition. This thesis addresses firstly the 
intercellular communication between T cells and APCs at the IS mediated by the exchange 
of exosomes bearing miRNAs. Our next objectives were to analyze the changes on T cell 
miRNA profile during T cell activation including the mRNA targets and post-
transcriptional modification of the miRNAs.  
Our data showed that exosomes of T, B and dendritic cells (DCs) contain specific miRNAs 
repertories different from those of their cellular counterpart. We found that upon IS 
formation there is a unidirectional transfer of miRNAs from the T cell to the APC, 
mediated by the delivery of exosomes. Moreover, miRNAs transferred during IS were 
able to modulate gene expression in recipient cells.  
In the second objective we analyzed how the miRNA profile of T cells changes after 
activation by different DCs subsets. We also studied the mRNA targets common to 
miRNAs regulated in T cell activation and validated the inhibitory relationship between 
the upregulated miR-132-3p and pik3r1 gene, which is a target for the miRNAs 
upregulated after T cell activation. 
Finally, as a third objective we focused on the regulation of miRNAs during T cell 
activation by 3’ non-templated nucleotide addition (3’NTA). We detected that upon T cell 
activation, uracyl addition is specifically decreased, concomitantly with downregulation 
of TUT4 and TUT7 enzymes. We found that 3’ addition of uridine promotes degradation 
of miRNAs after T cell activation.  
The results presented in this thesis support a novel mechanism of cellular communication 
involving antigen-dependent, unidirectional intercellular transfer of miRNAs by 
exosomes during immune synapsis. Moreover, we have addressed the activation-driven 
changes on T cell miRNAs profile and we uncover post-transcriptional uridylation as a 
mechanism to fine tune miRNA levels during T cell activation. 
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1 INTRODUCTION 
1.1 The T cell Response  
Adaptive immune response is a form of immunity that, in contrast to innate immunity, 
adapts to develop a specific response to a particular antigen. For that reason it can also be 
called specific or acquired immunity. The main components of adaptive immune system 
are lymphocytes and their secreted products. While B lymphocytes are the central 
mediators of humoral immunity (mediated by their secreted antibodies against 
extracellular microbes and their toxins), T cells are the mediators of cellular immunity.  
This type of immunity promotes the elimination of intracellular microbes and either help 
the phagocytes to destroy these microbes or directly kill the infected cells. Thanks to their 
highly evolved T cell Receptors (TCR), T cells recognized only and specifically peptides 
derived from foreign proteins that are bound to host proteins called major 
histocompatibility complex (MHC) molecules, which are expressed on the surface of other 
cells. T lymphocytes consist of functionally distinct populations, cytotoxic (CTLs or CD8+) 
and helper T cells (Th or CD4+). In response to antigenic stimulation, CD4 Th cells secrete 
cytokines that will stimulate the proliferation and differentiation of the T cells themselves 
and activate other cells, including B cells, macrophages and other leukocytes.  
1.1.1 The Immune Synapse 
As mentioned above, T cells need to recognize a specific antigen in the context of MHC 
molecule on the surface of another cell. Professional antigen presenting cells (APC), such 
as dendritic cells, B cells and mononuclear phagocytes,  bear MHC-II molecules and are 
able to engage CD4 T cells; while every cell of the organism bears MHC-I molecules able 
to engage CD8 T cells. Thus, the contact between these cells is required for the 
development and maintenance of the immune response. This highly evolved cognate 
interaction that is named Immunological or Immune Synapse (IS), consists of a long 
lasting and tight spatial reorganization of the surface receptors and cytoplasmic molecules 
at the interface between the two interacting cells (Dustin, 1998; Monks et al., 1998).  The 
TCR and peptide–MHC complexes are clustered together with costimulatory molecules 
(CD4, CD2, and CD28) at the center of the contact zone, the central supramolecular 
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activating complex (cSMAC) (Monks et al., 1998). The intracellular signaling molecules 
associated to the TCR -PKC-θ, lck, Fyn, and ζ-associated proteins of 70 kDa (Zap70)- are  
also localized at the cSMAC in the inner side of the T-cell membrane. This cSMAC is 
surrounded by the peripheral SMAC (pSMAC), a ring of leukocyte function-associated 
antigen 1 (LFA1) that interacts with intercellular adhesion molecule 1 (ICAM1) as well as 
other integrins that are linked to actin cytoskeletal protein Talin and other intracellular 
molecules that regulate integrin function (Barreiro et al., 2007). More recently, an 
additional SMAC has been described as distal SMAC (dSMAC), an actin-rich region 
containing the actin that has been firstly accumulated at cell-cell contact and subsequently 
cleared to this outer ring (Bunnell, 2010).  The microtubule-organizing center (MTOC) 
translocates toward the IS (Martin-Cofreces et al., 2014; Sancho et al., 2002; Stinchcombe et 
 
Figure 1.1 The Immunological Synapse between a T cell and an APC 
(A) Supramolecular activation clusters (SMACs), signaling downstream the TCR and  actin 
polymerization at the immunological synapse. The central SMAC cointains the TCR and 
coestimulatory molecules that interact with MHCII and their counterparts at the APC side. The 
peripheral SMAC is composed among others by LFA1 interacting with ICAM1. The distal SMAC 
finally is enriched in actin microfilaments. (B) Cytoskeletal distribution on a immunological 
synapse. MTOC is reoriented and the Golgi apparatus is relocated with it. Figure modified from 
(Vicente-Manzanares and Sanchez-Madrid, 2004). 
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al., 2006) bringing the secretory compartments, and providing the basis for polarized 
secretion of cytokines (Huse et al., 2006; Kupfer and Dennert, 1984) and the exocytosis of 
lytic granules by cytotoxic T cells (Griffiths et al., 2010). Endocytic trafficking of the TCR 
(Das et al., 2004) and lymphocyte specific tyrosine kinase (lck) (Gorska et al., 2009) to the 
IS has been reported to be essential both to target TCRs and other molecules to the APC 
contact site and for signal downmodulation by controlling TCR endocytosis. Finally, 
lysobisphosphatidic acid, a marker of late endosomes (multivesicular bodies; MVBs), 
localizes very close to the center of the IS of helper T cells (Varma et al., 2006), suggesting 
that MVBs also polarize to the IS. The IS may thus serve as a focus for both exocytosis and 
endocytosis (Alcover and Thoulouze, 2009; Griffiths et al., 2010). 
1.1.2 CD4 T cell activation and polarization 
The initial activation of naïve T cells occurs mainly in secondary lymphoid organs where 
they can encounter antigens presented by APCs with the subsequent formation of the 
above explained immune synapse. As mentioned, antigen will be recognized in a specific 
context of the MHC, and only with additional stimuli coming from the co-stimulatory 
molecules (mainly CD28 and CD40L) and soluble cytokines will be the cell correctly 
activated. Once activated, antigen-specific T lymphocytes secrete cytokines, proliferate 
and differentiate into effector and memory lymphocytes. Memory cells are long-lived cells 
with an enhanced ability to react against antigen that will recirculate through the 
lymphoid organs, tissue and skin and in case of reappearance of their specific antigen will 
respond rapidly and generate new effector cells.  
CD4 T helper cells can differentiate into distinct subsets of effector cells: Th1, Th2, Th17, 
Th9, Th22, follicular helper T cells (TFH) and induced regulatory T (iTreg) cells. Th1 and 
Th2 subsets were initially described in 1986 (Mosmann et al., 1986). Th1 cells mediate 
immune responses against intracellular pathogens but they are also responsible for the 
induction of some autoimmune diseases. Th2 cells are recognized for their role in host 
defense against multi-cellular parasites and their involvement in allergies, asthma and 
atopic illnesses. Th17 cells mediate immune responses against extracellular bacteria and 
fungi but also participate in the induction of many autoimmune diseases. Recently, new 
subsets of CD4 T cells have been described like peripherally derived regulatory T cells, T 
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TFH cells, Th9 and Th22. These new subsets have initiated some reconsideration in the field 
regarding the plasticity of Th cells that used to be thought to be much more static 
(Raphael et al., 2015; Sun and Zhang, 2014). For a scheme of the properties and known 
driven- and secreted factors of the different Th subsets see Figure 1.2.  
 
Figure 1.2 The CD4 T cell differentiation  
The differentiation of naive CD4+ T cells into different T helper cell subsets is dependent on factors 
present in the local environment, mostly cytokines (arrows). Differential transcription factors are 
expressed by each subset (written inside the cells), determining in turn the cytokines produced and 
their function (listed on the right). Figure based on (Sun and Zhang, 2014) 
 
 
1.2 Extracellular Vesicles and Exosomes 
1.2.1 Biogenesis of extracellular vesicles 
There is yet no consensus on the nomenclature of EVs, although the term exosome is 
generally restricted to vesicles derived from endosomal compartments. Figure 1.3 
represents the different origins of EVs. They can thus be classified according to their 
subcellular origin (Thery et al., 2009):  
a) ECTOSOMES: EVs that bud directly from the plasma membrane have been 
termed microparticles, shedding vesicles, ectosomes, or arrestin domain-
containing protein 1-mediated microvesicles (ARMMs) (Cocucci et al., 2009).  
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They are heterogeneous in size and can be bigger than exosomes (up to 1 
micron).  
b) EXOSOMES: The origin of exosomes are intracellular vesicles formed by 
inward budding of the limiting membrane of late endosomes or multivesicular 
bodies (MVB) of the endocytic compartment. These intraluminal vesicles (ILV) 
can be released after fusion of the MVB limiting membrane with the plasma 
membrane so they will start being called exosomes. Lipids play an important 
role in the formation of ILVs, and blockade of ceramide production by 
suppressing neutral sphingomyelinase activity inhibits exosome production 
Figure 1.3 Mechanisms of Extracellular vesicles biogenesis  
Exosomes are generated by the fusion of multivesicular bodies (MVBs) with the plasma membrane 
and the release of their intraluminal vesicles (ILVs) as exosomes. Molecules described to be 
regulating exosome release are highlighted. Neutral sphingomyelinase 2 (nSMase2), ESCRT (endo-
somal sorting complex required for transport), RAB proteins such as RAB11, RAB27 and RAB35. 
Ectosomes are originated by blebbing of the cellular plasma membrane. Apoptotic bodies are 
generated after the breakdown of dying cells. When extracellular vesicles are secreted into the 
extracellular milieu they can be taken up by recipient cells through mechanisms including fusion 
with the plasma membrane, phagocytosis and endocytosis. Figure modified from (Mittelbrunn and 
Sanchez-Madrid, 2012) 
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(Trajkovic et al., 2008) Figure 1.3. Exosome secretion is also promoted by DGK 
kinase and phospholipase D (PLD2) activities (Alonso et al., 2011; Alonso et al., 
2005; Laulagnier et al., 2004a). In addition, depletion of components of the 
ESCRT machinery results in fewer ILVs Figure 1.3. Of the ESCRT complexes, 
TSG101 plays a major role in the biogenesis of MVBs. Alix, a protein that 
interacts with several ESCRT proteins, regulates the biogenesis of exosomes 
through its interaction with syndecan and syntenin (Baietti et al., 2012). 
Moreover, small Rab GTPases such as Rab4, Rab11, Rab27A, Rab27 and Rab35 
regulate various steps of exosome release, being implicated in cargo 
sequestration, ILV budding, and the transport and docking of MVBs at the 
plasma membrane (Hsu et al., 2010; Ostrowski et al., 2010; Savina et al., 2002; 
Vidal and Stahl, 1993) Figure 1.3.  
c) APOPTOTIC BODIES are larger than ectosomes or exosomes (>1μm in 
diameter). These vesicles originate from apoptotic cells, and contain genomic 
DNA Figure 1.3.  
1.2.2 Exosome composition  
Exosome composition comprises some common proteins and lipids independently of 
their cellular origin as well as specific molecules that depend on the nature of the 
producer cell. For example, exosomes from T cells contain T cell receptor (TCR) and 
costimulatory molecules, while those from B cells contain B cell receptor (BCR) and so on.  
The typical composition of a T cell exosome is shown in Figure 1.4. The exosome 
membrane is a lipid bilayer in which integral membrane proteins maintain the same 
orientation as in the donor-cell plasma membrane. Exosomes are enriched in 
sphingomyelin, phosphatidilserine, glycolipid GM3 and phosphatidethanolamines 
(Laulagnier et al., 2004b). Exosomes are specially enriched in Tetraspanins (Yanez-Mo et 
al., 2009) and their associated proteins. They also contain GPI-anchored proteins, 
complement regulators, transmembrane receptors  like class I and II MHC molecules, co-
stimulatory molecules, BCR (B-cell-derived exosomes), TCR (T cells), and FceRI (Mast 
cells) and growth-factor receptors, as well as cytokines and their receptors. Death 
receptors ligands and components of signaling cascades, like Wnt and Ras, can also be 
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found in exosome membranes. Moreover, exosomes carry molecules in their interior, like 
cytoskeletal components (actin, tubulin), cytosolic proteins involved in signal 
transduction, protein translation, metabolic enzymes, as well as proteins related to 
apoptosis. The endosomal origin of exosomes is reflected in the presence of components 
of the ESCRT complex  and intracellular vesicle trafficking. For an extensive review on 
exosomes composition see (Gutierrez-Vazquez et al., 2013).  
Figure 1.4 Molecular 
composition of T-cell exosomes 
Membrane and luminal 
distribution of molecules 
predicted to be found in a typical 
exosome produced by a T 
lymphocyte. TCR: T-cell receptor; 
TGF: transforming growth 
factor beta; ICAMs: intercellular 
adhesion molecule family; 
CXCR4: C-X-C chemokine 
receptor type 4 or CD184; Tsg101: 
tumor susceptibility gene 101; 
TRAIL: TNF-related apoptosis-
inducing ligand; FasL: Fas ligand 
or CD95L; TfR: transferrin 
receptor; Mfge8: milk-fat globule-
EGF factor 8; ALIX: ALG-2-
interacting protein X; GAPDH: 
glyceraldehyde 3-phosphate 
dehydrogenase; ERMs: ezrin, 
radixin and moesin proteins. 
Figure from (Gutierrez-Vazquez 
et al., 2013). 
 
An unexpected finding was that EVs contain DNA and RNA. EVs derived from 
embryonic stem or tumor cells contain messenger RNAs (mRNAs) (Baj-Krzyworzeka et 
al., 2006; Skog et al., 2008). EVs also contain microRNA (Valadi et al., 2007). The mRNAs 
and miRNAs of EVs differ from the miRNA and mRNA repertoire of the parent cell, 
indicating the existence of a mechanism for sorting specific RNAs into EVs  (Figure 1.4). 
An updated repertoire of miRNAs and mRNAs as well as lipids and proteins found in 
exosomes is available at Exocarta (http://exocarta.org/index.html). 
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1.2.3 Exosomes in immune cell communication  
Exosomes have been reported to be involved in important processes such as antigen 
presentation, tumor immunity and the transmission of infectious agents. Moreover, they 
are increasingly recognized as significant vehicles for intercellular communication 
(Simons and Raposo, 2009; Thery et al., 2009). The number of works analyzing their role in 
diverse physiological and pathological settings has increased enormously in the last few 
years. As mentioned, exosomes express cell recognition molecules on their surface that 
facilitate their selective targeting of and uptake by recipient cells. Recent reports indicate 
that exosomes also harbor a variety of mRNAs and microRNAs (Skog et al., 2008; Valadi 
et al., 2007), which can be transferred to recipient cells and modulate their function 
(Deregibus et al., 2007; Pegtel et al., 2010; Ratajczak et al., 2006a; Skog et al., 2008; Valadi et 
al., 2007; Zernecke et al., 2009). These findings have increased the interest in the role of 
exosomes in cell-to-cell communication, and support the notion that exosomes might 
constitute an exquisite mechanism for local and systemic intercellular transfer not only of 
proteins but also of genetic information in the form of RNA (Ratajczak et al., 2006b; 
Simons and Raposo, 2009; Thery et al., 2009) 
 
1.3 microRNAs  
microRNAs (miRNAs) are a large family of small (22-24 nucleotides long), non-coding 
RNAs that down-regulate gene expression by preventing the translation of specific 
mRNAs into proteins (Carthew and Sontheimer, 2009). The emergence of miRNAs as 
potent post-transcriptional regulators of gene expression has broad implications in all 
areas of cell biology, including the immune system (Lodish et al., 2008; O'Connell et al., 
2010; Sonkoly et al., 2008). One miRNA can regulate hundreds of different mRNAs while 
the same mRNA can be regulated by many different miRNAs. 
1.3.1 The awakening of RNA interference and small silencing RNAs 
RNA interference (RNAi) discovery was preceded by observations in the 80’s of 
transcriptional inhibition by antisense RNA expressed in transgenic plants (Ecker and 
Davis, 1986). However it was not until 1998, that Fire and Mello established that double 
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strand RNA (dsRNA) was the key silencing molecule in Caenorhabditis elegans (Fire et al., 
1998). RNAi resulted to be systemic in plants and nematodes, and in the case of C. elegans 
it was also heritable. dsRNA is converted into small interfering RNA (siRNA), which were 
firstly discovered in plants (Hamilton and Baulcombe, 1999). Later their mechanism was 
described in animals being the guides for endonucleolytic cleavage of RNA targets 
(Hammond et al., 2000; Zamore et al., 2000). Nowadays, siRNAs are categorized in many 
different types depending on the organism, the origin, their regulation or the proteins 
involved in their biogenesis. In animals there are three major types of small silencing 
RNAs: microRNAs (miRNAs), siRNAs and PIWI-interacting RNAs (piRNAs). miRNAs 
are generated from short hairpin RNAs and depend on RNAaseIII enzyme Dicer 
processing. siRNAs (~21 nucleotides long) are derived from long double-stranded RNAs 
or long stem–loop structures through Dicer processing. They mediate the post-
transcriptional suppression of transcripts and transposons, and contribute to antiviral 
defense. piRNAs (24–33 nucleotides long) are not dependent on Dicer and are produced 
from single-stranded precursors. The main function of piRNAs is to silence transposable 
elements in germline cells, although there is room for some still enigmatic roles of some 
piRNAs outside the germline. Of the two subclades of Argonaute proteins (AGO and 
PIWI), miRNAs and siRNAs are associated with the AGO proteins, whereas piRNAs bind 
to PIWI proteins (Ghildiyal and Zamore, 2009). 
1.3.2 microRNAs overview 
The first miRNA to be discovered, lin-4, was identified in C. elegans in a screen for 
essential genes in post-embryonic development. The lin-4 locus produced a non-coding 
22-nucleotide RNA that was partially complementary to sequences in the 3’UTR of lin-14 
mRNA and had opposite phenotype to it. Moreover, the negative regulation of lin-14 
required an intact 3’UTR of its mRNA as well as a functional lin-4 gene (Lee et al., 1993; 
Wightman et al., 1993). Seven years later, tens of miRNAs were identified in humans, flies 
and worms establishing miRNAs as a new class of small silencing RNAs (Lagos-Quintana 
et al., 2001; Lau et al., 2001; Lee and Ambros, 2001). At present, miRBase (Release 21: June 
2014; http://www.mirbase.org/) (Griffiths-Jones, 2004) contains 28645 entries 
representing hairpin precursor miRNAs, expressing 35828 mature miRNA products, in 
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223 species. Only in humans, 1881 precursors, which code for 2588 mature miRNAs, have 
been described to date. 
In many species, there are multiple miRNA loci with related sequences that arose mainly 
from gene duplication. miRNAs with identical sequences at nucleotides 2-8 of the mature 
miRNAs are considered to be of the same miRNA family. miRNAs are highly 
phylogenetically conserved; so that among mammals 196 families are conserved. miRNA 
sisters generally act redundantly on target mRNAs, but distinct roles have also been 
suggested (Ventura et al., 2008).  
The nomenclature of miRNA genes is now reaching a consensus. However, those found in 
early genetic studies were named after their phenotypes (for example, lin-4, let-7 and 
lsy-6), whereas most miRNAs found from cloning or sequencing received numerical 
names (for example, miR-125 that actually is the homologue in other species of lin-4). 
Genes encoding miRNA sisters are indicated with lettered suffixes (for example, miR-26a 
and miR-26b). If the same mature miRNA is generated from multiple separate loci, 
numeric suffixes are added (for example, miR-26b-1 and miR-26b-2). Each locus produces 
two mature miRNAs: one from the 5ʹ strand and one from the 3ʹ strand of the precursor 
(for example, miR-125a-5p and miR-125a-3p). However, one arm (the “guide” strand) is 
usually much more prevalent and biologically active than the other (the “passenger” 
strand) (Ha and Kim, 2014) (Figure 1.5). 
1.3.3 Biogenesis of microRNAs 
miRNAs are generally transcribed by RNA polymerase II (Pol II) but RNA Pol III has also 
been shown to transcribe some viral miRNAs and some endogenous miRNA-like small 
RNAs derived from tRNAs. miRNA can be transcribed from independent genomic 
transcription units or from the introns of noncoding or coding transcripts or even from 
exonic regions. When several miRNA loci are in close proximity to each other, they 
constitute a polycistronic transcription unit and are generally co-transcribed. The miRNAs 
that come from introns of protein-coding genes can share the promoter of the host gene 
but often have distinct transcription start site. The product of the transcription is a 
primary miRNA (pri-miRNA) over 1kb in length that consists of a stem of 33–35 bp, a 
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terminal loop and single-stranded RNA segments at both the 5’ and 3’ sides (Figure 1.5) 
(Carthew and Sontheimer, 2009; Kim et al., 2009). 
In the canonical pathway the processing is started by the nuclear RNase III Drosha that 
crops the stem–loop to release the precursor harpin (pre-miRNA) of ~65 nucleotides in 
length. Drosha forms a complex called microprocessor together with its essential cofactor 
DGCR8 (DiGeorge syndrome critical region 8, also known as Pasha in D. melanogaster and 
as PASH-1 in C. elegans). Drosha and DGCR8 are conserved in animals and their 
deficiency causes lethality early in embryogenesis.  
Pre-miRNAs are subsequently exported by Exportin 5 from the nucleus to the cytoplasm 
where they are processed by the next RNAaseIII enzyme Dicer in complex with TRBP 
producing a ~20-bp miRNA duplex. Dicer binds the pre-miRNA simultaneously at its 5’ 
end and 3’ end with preference for those miRNAs with two-nucleotide-long 3’ overhang 
previously generated by Drosha. TRBP acts modulating the processing efficiency and 
tuning the length of mature miRNAs, but in mammals, unlike its Drosophila homologues 
Loqs, it does not seem to be essential for Dicer-mediated pre-miRNA processing.  Dicer1 
deletion in mouse results in early embryonic lethality and Dicer1-knockout embryonic 
stem cells show strong defects in cell proliferation and differentiation.  
The resulting double-stranded RNA molecule is loaded onto the RNA-induced silencing 
complex (RISC) that consists of the small RNA guide strand bound to an Argonaute 
molecule as well as to auxiliary proteins. In flies, miRNA duplexes and siRNA duplexes 
are preferentially loaded onto AGO1 and AGO2, respectively. However, in humans, there 
are no such restrictions and the four AGO proteins (AGO1–4) are associated with almost 
indistinguishable sets of miRNAs. All four human AGO proteins are capable of inducing 
translational repression and decay of target mRNAs through interaction with the 
translation machinery and mRNA decay factors. However, only AGO2 can slice perfectly 
matched target mRNA. RISC complex assembly involves two steps: the loading of the 
RNA duplex and its subsequent unwinding accompanied by the passenger strand release 
or less likely its direct cleavage by AGO2. AGO loading step is the moment when the 
selection of the “guide” strand is determined, being typically selected the one with 
relatively unstable terminus at the 5’ side. The released passenger strand is quickly  
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Figure 1.5 Biogenesis and Function of microRNAs 
Canonical and alternative pathways of miRNAs production are depicted. Pri-miRNAs are 
transcribed from cell genome, cropped by microprocessor and exported to the cytoplasm where 
it will be further processed by Dicer complex into a mature miRNA duplex. Only one strand will 
be selected and assembled with the RISC complex to prevent mRNA translation and/or to 
promote its degradation. Figure Modified from (Krol et al., 2010) 
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degraded resulting in a strong bias towards the guide in the mature miRNA pool. The full 
mature RISC complex will be now formed and ready to exert its function (Ha and Kim, 
2014; Krol et al., 2010). 
Some alternative pathways or steps have been described for miRNA biogenesis: Some 
pre-miRNAs are produced directly from very short introns (mirtrons) as a result of 
splicing and debranching, bypassing Drosha-DGCR8 step (Ruby et al., 2007). Also, an 
alternative pathway for some pre-miRNAs consists of an additional processing 
intermediate resulting from the cleavage of their 3’ arm by AGO2 previous to Dicer slicing 
(Diederichs and Haber, 2007). Moreover, processing of pre-miR-451 at least, also requires 
AGO2 cleavage, but is completely independent of Dicer. An additional trimming step of 
the 3’ end is in this case required to finish its maturation and ensure RISC complex 
loading (Cifuentes et al., 2010; Cheloufi et al., 2010). For a schematic representation of 
miRNA biogenesis and function see Figure 1.5.  
1.3.4 Function of microRNAs 
Once RISC complex is assembled, the miRNA strand will guide to target partially 
complementary sites at the 3’ untranslated region (3’UTR) of mRNAs, resulting in 
inhibition of mRNA translation or promotion of mRNA deadenylation and decay. 
Efficient mRNA targeting requires continuous base-pairing of miRNA nucleotides 2 to 8 
(the seed region). Although the mechanistic details of miRNA-mediated translational 
repression are not well understood, it is well stablished that the deadenylation that leads 
to decay of mRNAs is mediated by glycine-tryptophan protein of 182 kDa (GW182), a 
component of the RISC complex. GW182 is able to interact with the poly(A) binding 
protein (PABP) and to recruit deadenylases. Interestingly, the PABP regions targeted by 
GW182 are also recognized by many other translational factors, suggesting that these 
interactions may be subjected to sophisticated regulation. When RISC containing AGO2 
encounters a mRNA bearing sites nearly perfectly complementary to miRNA, the mRNA 
is endonucleolytically cleaved and degraded. Although rare in animals, this is a common 
mode of miRNA action in plants. Anyhow nowadays it is accepted that most (66–90%) of 
the miRNA-mediated repression end up with the degradation of the target (Jonas and 
Izaurralde, 2015).  
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1.3.5 Isomirs and regulation of microRNA turnover 
miRNA levels can be regulated from their biogenesis. Both their own transcription as well 
as the levels and activity of the proteins involved in their processing are tightly regulated. 
However, alterations in RNA sequence and/or structure can affect the miRNA turnover 
and maturation. 
Once transcribed miRNAs sequence can vary. In the last few years, next generation 
sequencing analysis has revealed variability in the individual miRNA sequences derived 
from the same precursor (pre-miRNA), giving rise to the termed “isomiRs” (Ameres and 
Zamore, 2013). Sequence heterogeneity in mature miRNAs can be produced through a 
variety of mechanisms. Several pri-miRNAs have been described to undergo post-
transcriptional A-to-I editing mediated by the enzyme ADAR (adenosine deaminase 
acting on RNA) that  involves the conversion of adenosine to inosine and affected their 
correct processing by Drosha or Dicer (Kawahara et al., 2007; Yang et al., 2006). Moreover, 
RNA tailing or non-templated nucleotide additions (NTA) has been described for pre-
miRNAs and mature miRNAs. Several noncanonical polyA polymerases (PAP) have been 
shown to add ribonucleotides to the 3’ end of pre-miRNAs and mature miRNAs in a 
template-independent manner. These enzymes are able to utilize not only adenine 
triphosphate (ATP) but also uridine triphosphate (UTP), and because of this are also 
called terminal uridyl transferases (TUTases or TUTs) (Heo et al., 2012; Heo et al., 2009). 
The identified TUTs are TUT1 (MTPAP), TUT2 (GLD2 or PAPD4), TUT3 (PAPD5), TUT4 
(ZCCHC11) and TUT7 (ZCCHC6) (Wyman et al., 2011). Of these enzymes, TUT4 and 
TUT7 have been shown to preferentially uridylate mature miRNA (Jones et al., 2012; Jones 
et al., 2009; Minoda et al., 2006; Thornton et al., 2015).  
The addition of polyU tails to the 3’ ends of pre-miRNAs has been reported to trigger 
their degradation in stem cells (Heo et al., 2009), while in somatic cells lacking Lin28, 
TUT-mediated mono-uridylation of pre-miRNAs facilitates their processing (Heo et al., 
2012). The impact of 3’NTA on mature miRNAs varies depending on the organism and 
the miRNA examined. Adenylation has been reported to increase the stability of certain 
plant miRNAs (Lu et al., 2009), while in mammals it is not yet established whether 
adenylation stabilizes the miRNA (Katoh et al., 2009) or interferes with its loading into the 
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RISC complex, reducing its effectiveness (Burroughs et al., 2010). Uridylation of miRNAs 
leads to degradation in Chlamydomonas (Ibrahim et al., 2010) and plants, where it prevents 
their methylation (Zhao et al., 2012). In mammals there is no evidence for such an effect of 
uridylation on mature miRNA, but it has been shown to specifically reduce the function 
of miR-26a, miR-126-5p and miR-379 (Jones et al., 2012; Jones et al., 2009). Finally it is 
worth to mention that miRNAs can also be modified by terminal trimming of nucleotides.  
All these mechanisms increase the repertoire of regulatory miRNAs that can be generated 
in a cell and therefore amplify the possibilities for miRNA-mediated regulation of gene 
expression (Ameres and Zamore, 2013). 
1.3.6 miRNA in the T cell response 
High-throughput miRNA profiling has described specific patterns of miRNAs expression 
during haematopoiesis as well as immune cells development, activation and function, 
suggesting  a role for microRNAs in cell lineage specification and effector functions 
(Kuchen et al., 2010; Landgraf et al., 2007; Monticelli et al., 2005). Studies using mice 
deficient for genes involved in the miRNA biogenesis pathway, such as Dicer and Drosha, 
provided evidences for the central role of miRNAs in the regulation of both development 
and homeostasis of the immune system and specifically Th cell differentiation (Cobb et al., 
2006; Chong et al., 2008; Muljo et al., 2005). T cell activation promotes the shortening of 
mRNA 3’ untranslated regions (3’UTR) (Sandberg et al., 2008), which goes in accordance 
with an apparent global downregulation of miRNAs after T cell activation (Bronevetsky et 
al., 2013). Additional studies have identified the function of individual miRNAs in Th 
effector function. For example, miR-181a has been identified as a regulator of T cell 
development (Li et al., 2007). Some miRNAs, such as miR-29 or miR-146, seem to be 
important for the differentiation of a particular type of T helper cells (Th1 and Tregs 
respectively) (Lu et al., 2010; Steiner et al., 2011), while others, such as miR-155 or miR-
125, seem to inhibit effector T cell differentiation in general (Rodriguez et al., 2007; Rossi 
et al., 2011). Moreover, the miR-17~92 cluster regulates several aspects of T cell activation 
and their overexpression causes lymphoproliferation and autoimmunity (Xiao et al., 
2008). miR-17 and miR-92 enhance T cell proliferation while miR-19, another member of 
the cluster, promotes the survival of activated T cells (Steiner et al., 2011; Xiao et al., 2008).  
In another study, miR-17 and miR-19b were shown to promote Th1 responses through 
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multiple processes like promoting proliferation or IFN-γ production, while suppressing 
iTregs differentiation (Jiang et al., 2011). Finally it is worth to mention that miR-155 is the 
miRNA most highly induced by TCR stimulation. Its deficiency decreases T cell 
dependent immune responses and analysis of AGO2 binding sites in mRNA from 
activated T cells identified more than 300 containing miR-155 seed recognition sequences 
(Loeb et al., 2012). 
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2 OBJECTIVES 
The general objective of this thesis was focused on the analysis of miRNAs and their 
regulation during T cell responses. The following specific issues were covered:  
1. Analysis of the miRNA exchange between immune cells during Immune Synapsis 
 miRNA profile of exosomes produced by immune cells 
 Exosomal secretory machinery during immune synapsis 
 Transfer of exosomes at the immune synapse 
 miRNA transfer at the immune synapse  
 Consequence of miRNA transference in the recipient cell 
 
2. Study of T lymphocyte miRNA profile regulation during T cell activation  
 miRNA repertoire of T cells activated by different subsets of Dendritic Cells 
 Common targets of miRNAs regulated after T cell activation 
 pik3r1 regulation as an example of a target of upregulated miRNAs after T cell 
activation 
 Validation of miR-132-3p inhibition of pik3r1. 
 
3. Analysis of the post-transcriptional regulation of miRNA after T cell activation  
 Regulation of Terminal Uridyltransferases during T cell activation  
 3’ non-templated nucleotide additions to miRNAs during T cell activation 
 Regulation of miRNAs turnover by 3’ non-templated nucleotide additions 
 Impact of TUT4 absence on uridylation of miRNAs  
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3 MATERIALS AND METHODS 
3.1 MATERIALS  
3.1.1 Mice 
C57BL/6, OT-II and Zcchc11 deficient mice were bred under specific pathogen-free 
conditions according to European Commission recommendations at CNIC animal facility.   
3.1.2 Cell lines and culture 
We used two human Jurkat-derived T-cell lines J77cl20 (TCR Vl.2 V8) (Niedergang et 
al., 1995) and CH7C17 (Vβ3 TCR specific for HA peptide) (Hewitt et al., 1992) and tree  
lymphoblastoid B-cell lines Raji (Burkitt lymphoma), HOM-2 (HLA-DR1 EBV-
transformed) and BLS-1 (HLA class II-null B-LCL, generated from cells of patients with 
type II Bare Lymphocyte Syndrome) (Hume et al., 1989).  
Stable cell line clones overexpressing CD63-GFP were generated by transfection and 
selection with G418 (1 mg ml-1). The CD63-GFP cell lines were subsequently transduced 
by lentiviral infection (see method) to overexpress miR-335 or miR-101 and selected with 
blasticidin (5 µg ml-1) and G418 (2 mg ml-1); the resulting cell lines were designated as 
follows: J77-CD63-GFP-miR335 (J-335), J77-CD63-GFP-miR101 (J-101), CH7C17-CD63-
GFP-miR335 (C-335) and CH7C17-CD63-GFP-miR101 (C-101). 
Above cells were cultured in RPMI (Sigma) containing 10% fetal bovine serum 
(Invitrogen) plus the mentioned antibiotics when needed.  
3.1.3 Human primary cells 
Human peripheral blood mononuclear cells were isolated from buffy coats from healthy 
donors by separation on a biocoll gradient (Biochrom). After 15 min of adhesion step at 
37ºC, no adherent cells were cultured 2 d in the presence of phytohemagglutinin (PHA) (5 
μg ml-1) to induce lymphocyte proliferation. To obtain T lymphoblasts IL-2 (50 U ml-1) was 
added to the medium every 2 d during 8 d. To obtain SEE-specific T lymphoblasts cells 
were cultured 10 d in the presence of SEE.  
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After adhesion step, adherent monocytes were cultured in the presence of IL-4 and 
GMCSF during 6 d to induce their differentiation into DCs. Maturation of DCs was 
promoted then by adding lipopolysaccharide (LPS) (10ng ml-1). 
3.1.4 Mouse primary cells 
Mouse naive CD4+ T cells were obtained from cell suspensions of lymph nodes or spleen 
from C57BL/6 or OT-II transgenic mice. Cell suspensions were incubated with 
biotinylated antibodies against CD8, CD19, CD25, CD11b, CD11c, CD45R, MHC-II (I-Ab), 
DX5, IgM, Gr-1 and F4/80 and subsequently with streptavidin microbeads (MACS; 
Miltenyi Biotec). CD4+ T cells were negatively selected in auto-MACS Pro Separator 
(Miltenyi Biotec) according to the manufacturer's instructions. The cells were then labeled 
with antibodies to CD4, CD62L and CD25 (BD Biosciences) and analyzed by flow 
cytometry to confirm their purity and naive status (data not shown).  
Conventional DCs were derived from wild type bone marrow cell suspensions after 
culture on non-treated 150-mm Petri dishes with 20 ng ml-1 recombinant GM-CSF 
(Peprotech). Cells were passed every 2 d and collected on day 9 and subsequently 
stimulated with 100 ng ml−1 LPS from Escherichia coli (Sigma) for their maturation. At this 
point DC preparations were characterized as CD11c+ MHCII+ Ly6G-. Alternatively, when 
pDCs and cDCs were required bone marrow cell suspensions were cultured in the same 
medium but with 100 ng ml-1 Flt3-ligand (Preprotech) instead of GM-CSF. After 8 d 
maturation was induced by overnight incubation with 6 µg ml-1 of cytosine-phosphate-
guanosine (CpG) oligodeoxynucleotide-1826: TCCATGACGTTCCTGACGTT. pDCs and 
cDCs were isolated using MACS system B220-labeled beads and auto-MACS Pro 
Separator (Miltenyi Biotec) being pDCs B220+ fraction and cDCs B220- fraction.  
Mouse primary cells were cultured in RPMI 1640 medium supplemented with 10% fetal 
bovine serum, 100 U ml-1 of penicillin and streptomycin, 10 mM Hepes, 50 μM 2-
mercaptoethanol and 1mM sodium pyruvate and the corresponding factors mentioned 
above for each cell type.  
3.2 METHODS 
3.2.1 Cell transfection 
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J77 or Raji cells were transfected with CD63-GFP, CD44-GFP, EGFP, LAT-GFP or CD38-
GFP plasmids by electroporation as previously described (Robles-Valero et al., 2010). Cells 
were resuspended in Opti-MEM (GIBCO) (5·107 ml-1) with 20 μgr of DNA plasmid and 
electroporated with Gene Pulser Xcell (Biorad) at 1200 μFa, 240 mV during 30msec in 
4mm Bio-Rad cuvettes. CD63-GFP positive cells were FACS sorted, cloned and cultured 
in RPMI containing 2 mg ml-1G418 (Invitrogen).  
HEK cells were co-transfected with Psicheck2 reporter plasmids for pik3r1 3’UTR 
fragments and control GFP plasmid or a miR-132-3p-GFP plasmid with Lipofectamine-
2000 (Invitrogen) according to manufacturer’s instructions. GFP+ cells were sorted at 
FACSAria flow cytometer (BD Biosciences) before downstream analysis.  
3.2.2 Lentiviral infection 
 J77-CD63-GFP cells over-expressing miRNA-355 or miRNA-101 were generated by 
lentiviral infection. HEK293T cells were cotransfected (Lipofectamine-2000; Invitrogen) 
with miRVec plasmids encoding the desired microRNA (Geneservice) and pCL-Ampho 
plasmid (RetroMax). Supernatants were collected after 48-72 h, filtered (0.45 μm), and 
added to J77-CD63-GFP cells. The mix was centrifuged (1200xg, 2h) and incubated for 4 h 
at 37ºC. Medium was replaced with RPMI containing blasticidin (5 g ml-1) and G418 (2 
mg ml-1). To silence nSMase2, HEK293T cells were cotransfected with corresponding 
shRNA pLKO system plasmids (Open biosystems) and pCMV-ΔR8.91-(Delta 8.9) and 
pMD2.G-VSV-G. Supernatants were added to J77-CD63-GFP-miR-335 (J-335) cells, which 
were cultured in RPMI containing 4 μg ml-1 puromcyin. 
3.2.3 Nucleofection of synthetic RNAs 
Synthetic RNAs that correspond to canonical or di-uridylated miRNAs (Integrated DNA 
Technologies) were nucleofected into freshly isolated naive CD4 T cells using Amaxa 
Mouse T cell Nucleofector Kit and Amaxa Nucleofector II (Lonza) according to the 
manufacturer's instructions.  
3.2.4 Cloning 
Two different fragments of the 3’UTR of pik3r1 containing the two potential binding sites 
of miR-132-3p were cloned into psiCHECK2 vector (Promega). The first fragment 
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comprises the sequence from 71 to 362 bp and the second from 2957 to 3162. See Figure 
4.18A for a diagram of the 3’UTR of pik3r1 cloned. Gibson Assembly system (Gibson et al., 
2009), which is based on the efficient joining of several overlapping DNA fragments, was 
used for the cloning process. The desired fragments from 3’UTR of pik3r1 were amplified 
from genomic DNA using Q5 High-Fidelity DNA Polymerase (New England BioLabs) 
and the following primers:  
For site 1:   
5’-GCCCGGGAATTCGTTTCCAGCCCGACCTGTGAAC-3’  
5’-GGCCGCTCTAGGTTTGGCCTCTTTGTCCCTGCA-3’;  
For site 2:   
5’-GCCCGGGAATTCGTTTGGAGGGTTGGGACCTTGTGTT-3’  
5’-GGCCGCTCTAGGTTTG ACCTGTACTGGACATCTGCTTG. 
These primers add an extra sequence of 15 or 16 pb complementary to  psiCHECK2 vector  
in both ends of the fragment. This way, the amplified segment contains overlapping 
sequences with the vector. psiCHECK2 was linearized by PmeI (0,2 U μl-1, New England 
BioLabs) restriction enzyme digestion and subsequently dephosphorylated with Antartic 
Phosphatase (0,25 U/μl New England BioLabs) and purified with QIAquick PCR 
Purification Kit (Quiagen). The ligation of the vector with each amplified fragment was 
performed using the Gibson Assembly Master Mix (New England BioLabs) in a ratio of 
5:1 (insert:vector) following manufacturer’s instructions. 
3.2.5 Fluorescence confocal microscopy 
For immunofluorescence assays, cells were plated onto slides coated with poly-L-Lysine 
(50 μg ml−1, Sigma), incubated for 30 min, fixed with 2% Paraformaldehyde, blocked (BSA 
5%) and stained with the indicated primary antibodies (at 5 μg ml−1 for the purified ones 
and directly adding the supernatants form those monoclonals available in the lab) 
followed by alexa488- or Rhodamine Red X-labeled secondary antibodies ( 5 μg ml−1) (Life 
Thechnologies).  
The antibodies used throughout this thesis for immunofluorescences were: Monoclonal 
anti-human antibodies produced in the laboratory: anti-CD63 mAb (Tea 3/18), anti-CD3 
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mAb (T3b), anti-CD45 (D3/9), and anti-MHC-II (DCIS1/21). Commercial antibodies: 
Rabbit polyclonal anti-Hrs (Abcam), rabbit polyclonal anti-Zcchc11 (TUT4), rabbit 
polyclonal anti-Zcchc11 (TUT4) (Proteintech), Anti tubulin-FITC (Sigma) and Phalloidin-
alexa488 for F-actin labeling (Life Technologies). 
For live-cell imaging, Raji (preloaded with CMAC and SEE) and J77-CD63-GFP cells were 
added to coverslips coated with fibronectin (20μg ml−1, Sigma), mounted in Attofluor 
open chambers (Molecular Probes), and maintained at 37°C in a 5% CO2 atmosphere.  
Samples were examined with a Leica SP5 confocal microscope fitted with a 63x objective, 
and images were processed and assembled using Leica software. 
3.2.6 Immunoblotting 
Cells were lysed in lysis buffer (50 mM Tris pH7.5, 150 mM NaCl, 2 mM MgCl2, 1%NP-40, 
5mM EDTA) of RIPA (1% NP40, 0.5% deoxycholate, 0.1% SDS in TBS) depending on the 
experiment, both containing a protease inhibitor cocktail (Complete, Roche). Proteins 
were separated on 8 or 10% acrylamide/bisacrylamide gels and transferred to a 
nitrocellulose membrane. Membranes were blocked with 5% skim milk in TBS-T milk and  
incubated with specific primary antibodies (5 μg ml−1) and peroxidase-conjugated 
secondary antibodies (5 μg ml−1), and chemiluminescence was measured with LAS-6000 
(Fujifilm). Band intensities were quantified with Image Gauge (Fujifilm) and results are 
expressed relative to the control condition. Proteo Extract subcellular proteome extraction 
kit (Calbiochem) was used for subcellular fractionation of proteins followed by western 
blot. 
The following antibodies were used for western blot throughout this thesis:  Anti-CD63 
mAb produced in our laboratory (Tea 3/18), rabbit anti-Hrs  (Abcam), anti-CD81 mAb 
(5A6, Santa Cruz), Anti-alpha Tubulin antibody (DM1A, Sigma)  rabbit polyclonal anti-
Zcchc11 (TUT4), rabbit polyclonal anti-Zcchc6 (TUT7) (Proteintech), goat polyclonal anit-
Zcchc11 (ProSci), anti-p150glued (BD Transduction Laboratories), monoclonal anti-EZH2 
(Cell Signaling), rabbit polyclonal anti-p85a (Millipore), polyclonal anti ezrin/moesin 
(ERMs) (90/3) (provided by Heinz Furthmayr, Stanford University, Stanford, CA). 
Secondary antibodies were goat anti-mouse Horseradish peroxidase (HRP) (31446, 
MATERIALS AND METHODS 
 
42 
Thermo Scientific) (1:5,000), goat anti-rabbit HRP (37460, Thermo Scientific) (1: 10,000) 
and donkey anti-goat HRP (Santa Cruz) (1:10,000).  
3.2.7 Exosome purification 
 Exosome producing cells were cultured in RPMI-1640 supplemented with 10% FBS 
(depleted of bovine exosomes by overnight centrifugation at 100000g), and exosomes 
were prepared from cell supernatants by several centrifugation and filtration steps (Thery 
et al., 2006). Briefly, cells were centrifuged (320g for 5 min) and the supernatant filtered 
through 0.22 μm membranes. Exosomes were pelleted by ultracentrifugation at 100000g 
for 60 min at 4ºC (Beckman Coulter Optima L-100 XP). 
3.2.8 Non-synaptic exosome uptake experiments 
Exosomes were purified as described above and added to recipient cells in a ratio 1:25 
(recipient:donor cells). After 16h, recipient cells were analyzed by flow cytometry. 
3.2.9 Conjugate formation and Transwell assays 
To distinguish B cells from T cells, B cells (Raji or Hom2) were loaded with the blue 
fluorescent tracker CMAC (chloromethyl derivative of aminocoumarin, Molecular 
Probes). B cells were incubated with SEE (Toxin Technology) or HA peptide (New 
England Peptide) as appropriate and mixed with J77 cells (native or expressing CD63-GFP 
± miR-335 or miR-101) or CH7C17 cells at a ratio of 1:8. Conjugation at 37ºC was 
continued for times indicated in each case. Where indicated, J77 cells were preincubated 
with manumycin-A (10μM), brefeldin (10 mg ml−1), nocodazol (5 μM), cytochalasin-D (20 
μM) or latrunculin-A (1 μM) (all from Sigma). In experiments with Raji-CD63-GFP cells, 
J77 cells were labeled with CMAC. Where indicated, Raji and J77 cells were prevented 
from coming into direct contact by separating with a 0.4 μm pore-size transwell 
membrane (Costar). This allows the passage of exosomes but precludes direct cell-cell 
interaction. When indicated, T cells were activated with phorbol myristate acetate (PMA) 
(50ng ml−1) plus Ionomycin (0.5 μg ml−1), anti-CD3 plus anti-CD28 (both at 5μg ml−1), or 
SEE (0.5 μg ml−1). 
3.2.10 Flow cytometry analysis and sorting 
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Cell samples were analyzed with a BD FACS Canto flow cytometer or BD LSR Fortessa 
and FACSDiva software (BD Biosciences) and FlowJo software. Viable cells were 
identified by propidium iodide or DAPI exclusion as convenient. Singlet cells were 
discerned with a stringent multiparametric gating strategy based on FSC and SSC (pulse 
width and height). For mouse CD4 T cells phenotyping to check purity of macs sorting 
and activation state (Results 4.2 and 4.3) the following antibodies were used: anti CD4, 
anti CD69, anti CD62L, anti CD25, and anti CD8 coupled with the appropriate 
fluorophore (All from BD Biosciences). For immune synapse experiments (Results 4.1) T 
cells and APCs were distinguished by CMAC staining and GFP fluorescence. 
When stated, cells were sorted on a FACSAria flow cytometer (BD Biosciences). Raji cells 
were isolated after coculture with T cells by sorting for CMAC-positive singlet cells 
(Results 4.1). When indicated, Raji cells were also sorted based on CD63-GFP levels. 
Cocultures of cDCs or pDCs with CD4+ T cells (Results 4.2) were discriminated by 
staining of MHC-II and CD4 plus CD69. 
3.2.11 UTR reporter assays  
Psicheck2 dual luciferase reporter vector (Promega) have been used twice along this 
thesis. It comprise the gene of Firefly luciferase as a normalizing gene and the luciferease 
Renilla reniformis gene downstream of the cloning site. The vectors cloned with the full-
length 3’UTRs of SOX4 and UBE2F and the SOX4 3’UTR segment (base pairs 449-509) 
containing the wild-type or mutated (base pair 483) miR-335 seed sequence were a gift 
from Dr. J. Massagué (Tavazoie et al., 2008) (Memorial Sloan-Kettering Cancer Center, 
NY). Raji cells were transfected by electroporation and, 16h later, cocultured with J-335 or 
J-101.  
For validation of pik3r1 as a target of miR-132-3p, the dual reporter vector was cloned 
with the fragments for binding sites of miR-132-3p as mentioned above in section 3.2.4 
Cloning and cotransfected with control or miR-132-3p overexpressing vectors.  
After 24h, cells were lysed and the ratio of Renilla and Firefly luciferase activities was 
measured by the dual luciferase assay (Promega). Renilla and Firefly Luciferase. 
3.2.12 Mouse primary T cell polyclonal activation 
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Naive CD4+ T cells were obtained from cell suspensions of lymph nodes or spleen by 
negative selection as explained above in under Mouse primary cells. After isolation naïve 
T cells were either directly lysed or cultured (106 cells ml-1) with 2μg ml-1 of anti-CD28 on 
plates previously coated with 10 μg ml-1 of anti-CD3 (BD Biosciences). Alternatively, cells 
were maintained in the naive state in the presence of 4 ng ml-1 of interleukin 7 
(Peprotech). The activation status of CD4 T cells was assessed at the indicated time points 
by flow cytometry after staining with antibodies against CD4, CD25, and CD69 (BD 
Biosciences). Data were acquired and analyzed with a FACSFortessa flow cytometer and 
FACSDiva (BD Biosciences) or FlowJo software. 
3.2.13 Antigen specific primary T cell stimulation 
When indicated, dendritic cells (DCs) were used to stimulate OT-II CD4 T cells. DCs were 
derived from bone marrow as described above under Mouse primary cells. OT-II CD4 T 
cells were cocultured with the corresponding subset of DCs (8:1 T cell/DC ratio) in the 
presence or absence of ovalbumin (OVA) peptide for 18 h. When required, cells were 
stained for CD4 and MHCII for subsequent sorting of the CD4 T cell fraction on a 
FACSAria flow cytometer (BD Biosciences). The activation status of CD4 T cells was 
assessed by flow cytometry like in 3.2.12.  
3.2.14 Human T lymphoblast stimulation 
Human T lymphoblasts were obtained as  explained in page 37 in Human primary cells   
and later stimulated either with anti-CD3 and anti-CD28 coated beads (Gibco) or with 
phorbol myristate acetate (PMA) and ionomycin.  
3.2.15 RNA isolation 
Total RNA was extracted with QIAzol lysis reagent (Qiagen) and the miRNeasy mini kit 
(Qiagen). Purity and concentration were measured in a Nanodrop-1000 
spectrophotometer (Thermo Scientific) and RNA integrity was assessed using the Agilent 
2100 Bioanalyzer  or by ethidium bromide labeling on a 1.5% agarose gel. 
3.2.16 microRNA microarrays 
The Agilent 2100 Bioanalyzer for total RNA (RNA nano chips) and for small RNA (small 
RNA chips) were used to assess the large and small RNA profiles. Microarray 
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experiments were performed using the human microRNA microarray from Agilent for 
data from Results 4.1. Arrays were performed on three different RNA preparations from 
Raji and J77 cells and their exosomes, and two preparations each from human dendritic 
cells, and their exosomes. Microarray for mouse microRNA from Agilent were used for 
Results 4.2. 
3.2.17 Small RNA cloning and sequencing (miR-seq library preparation, 
sequencing and generation of FastQ files) 
Total RNA (1 μg) was used to generate barcoded miR-seq libraries using the TruSeq 
smallRNA sample preparation kit (Illumina). Briefly, 3´ and 5´adapters were first ligated 
to the RNA sample. Next, reverse transcription followed by PCR amplification was used 
to enrich cDNA fragments with adapters at both ends. Adapter-ligated cDNA fragments 
from different samples were pooled and run on a 6% polyacrylamide gel. The band 
between 147 and 180 base pairs, corresponding to the pooled miRNA libraries including 
slightly longer fragments (potential IsomiRs with 3’NTAs ), was purified from the gel. 
Finally, the quantity and quality of the pooled miR-seq libraries were determined using 
the Agilent 2100 Bioanalyzer High Sensitivity DNA chip. Libraries were sequenced on a 
Genome Analyzer IIx (Illumina). FastQ files for each sample were obtained using 
CASAVA v1.8 (Illumina). Library preparation and sequencing was performed by CNIC 
genomic unit. 
3.2.18 Next generation sequencing analysis and statistics 
Raw FASTQ files were trimmed for adapter contamination using REAPER from the 
Kraken package (Davis et al., 2013). All reads were mapped against miRNA precursors 
obtained from miRBase release 21 (Kozomara and Griffiths-Jones, 2014) using BLASTn. A 
custom pipeline interrogated each read to determine which miRNAs originated from 
which precursor and which arm (either 5’ or 3’). Extra nucleotides that could not be 
explained by the associated miRNA precursor sequence were flagged as non-canonical 5’ 
or 3’ extensions. Count data for canonical matches and non-canonical extensions were 
stored for each sample in the tabular form. Count data were normalized and analyzed 
using R/BioConductor with the DeSeq2 package. Changes to either global miRNA levels 
or individual miRNA modifications were viewed as significant if they had an absolute 
MATERIALS AND METHODS 
 
46 
Log Fold-Change > 0.5 and an adjusted P-Value < 0.05. All data and scripts used are 
available.  
3.2.19 mRNA reverse transcription and quantitative real time PCR  
For data corresponding to Results 4.1 mRNA quantification was performed by TaqMan 
real-time PCR (Applied Biosystems) according to the manufacturer’s instructions. The 
following TaqMan Gene expression Assays (Applied Biosystems) were used: SMPD3 
(nSMase2) (Hs00218713_m1) while GAPDH (Hs02758991_g1) and HPRT 
(Hs01003267_m1) were used as endogenous controls. For data corresponding to Results 
4.2. and 4.3 cDNA was synthesized using the High Capacity cDNA Reverse Transcription 
Kit (Applied Biosystems). Expression analysis by quantitative PCR was performed with 
SYBRgreen PCR master mix (Applied Biosystems), and the corresponding primers (listed 
in Table 3.1). B-actin and Yhwaz (tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta) genes were used as endogenous controls. 
Data were acquired and analyzed using the ABI Prism 7900HT Sequence Detection 
System (Applied Biosystems) and Biogazelle QBasePlus software (Biogazelle). Data are 
presented in relative mRNA levels to endogenous controls.   
Oligo Name Sequence (5' to 3') 
Mouse YWHAZ (Forward) CGTTGTAGGAGCCCGTAGGTCAT 
Mouse YWHAZ (Reverse) TCTGGTTGCGAAGCATTGGG 
Mouse b Actin (Forward) CAGAAGGAGATTACTGCTCTGGCT 
Mouse b Actin (Reverse) TACTCCTGCTTGCTGATCCACATC 
Mouse B2M (Forward) TTCTGGTGCTTGTCTCACTGA 
Mouse B2M (Reverse) CAGTATGTTCGGCTTCCCATTC 
Mouse Pik3r1 v1 (Forward) ACACCACGGTTTGGACTATGG 
Mouse Pik3r1 v1 (Reverse) GGCTACAGTAGTGGGCTTGG 
Mouse Pik3r1 v2 (Forward) ATTTCACCCCCTACTCCCAAG 
Mouse Pik3r1 v2 (Reverse) AGTCGAACATTCCAGTCCTTT 
Mouse TUT4 (Forward) AAGTCAGAAATTGGGACCAGC  
Mouse TUT4 (Reverse) TGGCAGCGTTTACTTTACATGAT 
Mouse TUT2 (Forward)  AAACTCAATTTTGGGTCGTCCA 
Mouse TUT2 (Reverse)  GTGCATCTATAAGTTGCTGGTGT 
Human HPRT1 (Forward) CCTGGCGTCGTGATTAGTGAT 
Human HPRT1 (Reverse) AGACGTTCAGTCCTGTCCATAA 
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Human B2M (Forward) GAGGCTATCCAGCGTACTCCA 
Human B2M (Reverse) CGGCAGGCATACTCATCTTTT 
Human PIK3R1 (Forward) CGGCGAAGTAAAGCATTGTG 
Human PIK3R1 (Reverse) ACATTGAGGGAGTCGTTGTG 
Human TUT4 (Forward) TCAACAGGTGGCTGGTTCAGCTCAG 
Human TUT4 (Reverse) TAGCAGCTGACTGGGAAGAGTTCTG  
Human TUT2 (Forward) CTACTGTTTATTCACACCAGC 
Human TUT2 (Reverse) CTCTTCCTTCCTCGAAATAATG 
 
Table 3.1 Primers for mRNA qPCR used in this thesis 
 
3.2.20 Reverse transcription and RT-qPCR of mature canonical miRNA 
For Results 4.1 data mature miRNA quantification was performed by TaqMan real-time 
PCR (Applied Biosystems) according to the manufacturer’s instructions using the 
following TaqMan miRNA Assays: hsa-miR-335 (000546), hsa-miR-92a (000431). HY3 
(001214) and RNU19 (001003)  were used as endogenous controls. For data corresponding 
to Results 4.2.and 4.3 cDNA was synthesized and mature miRNAs were quantified by 
miRCURY LNA Universal RT microRNA PCR (Exiqon), using miRNA LNA primers 
(Exiqon) and SYBRgreen PCR master mix (Applied Biosystems). RNU1A1 and RNU5G 
RNAs were used as endogenous controls  
Quantitative miRNA expression data were acquired and analyzed using the ABI Prism 
7900HT Sequence Detection System (Applied Biosystems). Data were further analyzed 
using BiogazelleQBasePlus software (Biogazelle). Results are expressed in arbitrary units 
relative to endogenous controls. 
3.2.21 Reverse transcription and qPCR of synthetic miRs and isomiRs  
Levels of the synthetic miRNAs previously nucleofected into T cells were analyzed by a 
variation of miQPCR method(Benes et al., 2015). In bief 60 ng of total RNA were ligated to 
an oligonucleotide adapter (miLINKER) followed by retrotranscripition to cDNA. 
Quantitative PCR was then performed with Taqman PCR master mix (Applied 
Biosystems) using both specific primers and LNA Taqman probes. Quantitative data of 
synthetic RNA levels were acquired and analyzed using the ABI Prism 7900HT Sequence 
Detection System (Applied Biosystems). Data were further analyzed using 
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BiogazelleQBasePlus software (Biogazelle). snoRNA 420 and snoRNA 412 were used as 
endogenous controls for normalization and results are expressed in arbitrary units.  
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4 RESULTS 
4.1 Unidirectional transfer of microRNA-loaded exosomes from T-cells 
to Antigen Presenting Cells 
4.1.1 miRNA profiles of immune cells and their exosomes 
 To determine the miRNA repertoire of exosomes secreted by immune cells, we isolated 
exosomes from cell supernatants of the Raji B cell line, the Jurkat-derived J77 T cell line, 
and primary dendritic cells (DCs) derived from human monocytes. Exosomes were 
isolated by a series of microfiltration and ultracentrifugation steps (Thery et al., 2006), and 
exosome identity was assessed by extensive protein analysis with LC-MS/MS technology. 
About 60% of proteins found in the analyzed exosome samples have been previously 
found in exosomes; these include the tetraspanins CD63, CD81 and CD9, proteins 
involved in membrane transport and fusion (Rab GTPases, annexins and fotillin), and 
other exosomal markers such as Tsg101 (Annex Table 9.1). Moreover, exosomes derived 
from T lymphocytes and from APCs both contained RNA. Profiling of RNA isolated from 
exosomes and their donor cells indicates that exosomes are highly enriched in small RNA 
species (Figure 4.1). Agilent miRNA microarray analysis showed that certain miRNAs are 
Figure 4.1  Exosomes are enriched in small RNA  
RNA from immune cells and their exosomes was assessed with the Agilent 2100 Bioanalyzer. The 
percentage of small RNAs (<30 nucleotides) was higher in exosomes than in their donor cells. FU, 
fluorescence units; nt, nucleotides. 
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expressed at higher levels in exosomes than in their donor cells, and vice versa (Figure 4.2 
and Annex Table 9.2). The hierarchical clustering and the principal component analysis 
(PCA) of the array data grouped the samples according to their cellular or exosomal 
origin (Figure 4.2A, B). Several miRNAs (for example, miR-760, miR-632, miR-654-5p and 
miR-671-5p) were significantly more abundant in exosomal samples from all cell types; 
others, for example miR-335, were found only in exosomes derived from the primary 
DCs; in contrast, others (for example, miR-101, miR-32 and miR-21*) were more highly 
represented in cells than in exosomes (Figure 4.2C). These data indicate that specific 
miRNA populations are selectively sorted into exosomes.  
 
Figure 4.2 microRNA profiles of exosomes and their parental cells 
(A) Microarray analysis of exosomal miRNAs vs the miRNAs of their respective donor cells. 
Exosomes were isolated by serial centrifugation and filtration steps from supernatants of donor 
cells cultured in RPMI-1640 supplemented with exosome-depleted FBS (10%). Total RNA, 
including microRNA, was isolated from exosomes and their donor cells and miRNA profiles were 
assessed by microarray technology. The panel shows the hierarchical clustering of the vsn-
normalized array data in the log2 scale averaged per biological replicate for each origin 
(Exosomes/cells) and cell type (DC: dendritic cells; J77: Jurkat-derived J77 T cell line and Raji: Raji 
B cell line). (B) Principal component analysis (PCA) of all normalized array data. Each point 
represents a hybridized sample: i.e. different biological samples per origin and cell type. X-axis, 
first principal component (PC1); Y-axis, second principal component (PC2). Cell samples, red; 
exosomal samples, blue. (C) Heatmap of the vsn-normalized data for selected miRNAs. For 
visualization purposes the expression profiles were centered on the median of the profile. The scale 
bar across the bottom depicts standard deviation change from the mean. (D) Scatterplots of the 
exosome vs cell averaged array data in each cell type and of Raji exosomes vs J77 exosomes. The 
correlation is shown. 
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Consistently, there was lower overall similarity between the miRNA repertoire in 
exosomes and their corresponding cells than between the exosomes of different cellular 
origin (Figure 4.2D). 
4.1.2 Multivesicular bodies from T lymphocytes polarize towards the IS  
To analyze the capacity of cells to take up immune exosomes, we generated Raji B and J77 
T cells stably expressing the exosomal marker CD63 fused to GFP. The tetraspanin CD63 
is very abundant in exosomes, and inside cells localizes mainly to MVBs and lysosomes, 
with only a small pool present at the plasma membrane (Pols and Klumperman, 2009). 
Western blot and cytometry analyses confirmed the presence of CD63-GFP in exosomes 
released by these cells (Figure 4.3). The purified CD63-GFP exosomes were then incubated 
with non-transfected J77 cells or Raji cells (recipient cells) for 16h. Flow cytometry analysis 
revealed that both J77 T and Raji B cells have the capacity to take up immune exosomes 
(Figure 4.4A). It is important to highlight that Raji B cells take up T cell- derived exosomes 
to a greater extent than their own exosomes and vice-versa. Moreover, CD63-GFP was 
detected at the surface of recipient cells by confocal microscopy (Figure 4.4), suggesting 
that exosomes are not internalized but remain attached to the recipient plasma membrane. 
 
Figure 4.3 Exosomes contain CD63-GFP 
(A)  J77, J77-CD63GFP and Raji-CD63GFP cells were cultured in exosome-depleted medium for 24 
h and released exosomes were purified from supernatant by ultracentrifugation. Both whole cell 
and exosomes (denoted as Ex) lysates from each cell type were analyzed by immunoblotting for the 
presence of CD81 and CD63 tetraspanins. (B) J77-CD63GFP cells were cultured in exosome-
depleted medium for 24 h under resting conditions or with the indicated activation stimuli 
(Ionomycin (Iono), Staphylococcus enterotoxin superantigen-E (SEE), Phorbol myristate acetate 
(PMA) or anti-CD3). Released exosomes were purified from supernatant by ultracentrifugation and 
analyzed by immunoblot for the presence of CD81 and CD63 tetraspanins. (C) Untransfected J77 
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cells and J77 cells stably expressing CD63-GFP (J77-CD63-GFP cells) were cultured in exosome-
depleted medium for 24 h and exosomes were purified from supernatants by ultracentrifugation. 
Exosomes were labeled with anti-CD63-phycoerythrin and analyzed by flow cytometry. 
To address whether exosomes mediate the transfer of miRNA during cognate immune 
interactions, we first studied the intracellular distribution of MVBs—the compartments 
from which exosomes arise—during the formation of an IS. In these experiments, Raji B 
cells were pulsed with Staphylococcus enterotoxin superantigen-E (SEE) and then 
incubated with TCR-Vβ8+ J77 cells. MVB localization was assessed by 
immunofluorescence analysis of CD63 and a component of the ESCRT-0 (endosomal 
sorting complex required for transport) Hrs. In the presence of SEE, which promotes 
formation of a fully functional IS, the MVBs of the J77 T lymphocyte lost their random 
cytoplasmic distribution and congregated near the IS (identified by CD3 and actin 
staining); in contrast, the localization of MVBs in the Raji B cell remained unchanged 
(Figure 4.5A). Similar results were obtained in experiments in which CH7C17 T cells, 
bearing an influenza hemagglutinin (HA) peptide-specific TCR,  were conjugated to HA 
peptide-pulsed Hom2 B cells, thus confirming that antigen-induced formation of an IS 
polarizes T cell MVBs to the contact site (Figure 4.5B, C). Live cell imaging of CD63-GFP- 
 
 
Figure 4.4 Uptake of CD63-GFP exosomes by immune cells 
(A) Uptake of CD63-GFP exosomes by T cells and B cells (recipient cells). Untransfected cells were 
incubated with CD63-GFP exosomes for 16h and analyzed by flow cytometry. Data represent the 
percentage of GFP-positive cells (± s.e.m.) of three independent experiments. Open bars: no 
exosomes. Striped bars: Raji exosomes. Filled bars: J77 exosomes. (B) Confocal microscopy 
detection of CD63-GFP (green) on the surface of recipient cells (Raji) after incubation with J77-
CD63-GFP exosomes. Cell membranes were stained for the cell surface molecule CD45 (red) and 
nuclei were stained with HOESCHT (blue). Images show maximal projections of confocal images 
(Projection), one representative confocal section (Section) and the DIC images. Scale bar: 10 μm. 
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expressing J77 T cells encountering SEE-pulsed Raji B cells revealed that the MVBs of the 
T cells move to the IS during the first 10 min (Figure 4.5D, and Supplementary Movie1) 
 
4.1.3 The immune synapse promotes the transfer of exosomes from the T cell 
to the antigen presenting cell 
 
 
Figure 4.5 MVBs in T cells translocate to the IS 
(A) J77 T cells were conjugated with SEE-pulsed or non-pulsed Raji B cells loaded with CMAC (blue). 
After 30 min, cells were fixed and stained for the MVB marker Hrs (red), CD3 and actin (both green). 
Plates show maximal projections of confocal images and the DIC images. (B)  CH7C17 T cells were 
conjugated with HA-loaded or non-loaded HOM2 B cells (blue). After 30 min, cells were fixed and 
stained for CD63 (green), CD3 and actin (both red). Plates show maximal projections of confocal images 
and the DIC images. (C)  Percentage of T and APC cells in which CD63, Hrs and CD3 relocalized to the 
T cell–APC contact area in the presence of HA peptide (filled bars) or its absence (open bars). Data are 
the arithmetic means ± s.e.m. of four experiments. * p < 0.03 compared with the absence of antigen 
(Mann Whitney test). (D)  Live cell imaging of J77-CD63-GFP cells seeded on fibronectin-coated 
coverslips and conjugated with SEE-primed Raji cells (blue). Cells were monitored by time-lapse 
confocal microscopy at 30-s intervals. Plates show maximal projections of confocal images. Scale bars: 
10 μm 
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To investigate whether the IS promotes the transfer of exosomes from T cells to APCs, 
CD63-GFP T cells were cultured with Raji cells (stained blue with CMAC) for 16 h, by 
which stage most conjugates will have separated. The coculture was analyzed by flow 
cytometry for the transfer of CD63-GFP. SEE-pulsed Raji cells acquired CD63-GFP from 
the T cells, whereas transfer in the absence of SEE was negligible (Figure 4.6A). No 
transfer of GFP signal was detected when the assay was performed in the opposite 
direction (from Raji-CD63-GFP to J77 cells) (Figure 4.6A) or when using J77 cells 
overexpressing non-exosomal membrane or cytoplasmic proteins (CD69-GFP and GFP) 
(Figure 4.6B). In addition, we also detected transfer of other molecules related to exosomes 
and vesicles, such as LAT (Figure 4.6C). 
 
Figure 4.6 Ag recognition induces transfer of exosomes from T cell to APC 
(A) Left: J77-CD63-GFP donor cells were conjugated with SEE-primed or unprimed Raji cells 
(recipient, in blue). Right: Raji-CD63-GFP donor cells (±SEE) were conjugated with blue-labeled J77 
recipients. After 16 h cocultures were analyzed by flow cytometry. Bar chart shows the percentage ± 
s.e.m. of positive recipient cells (n=9, p<0.001, Student’s t-test). (B)  J77 cells  transfected with CD69-
GFP or GFP were conjugated with SEE-primed Raji cells (blue) and analyzed as in (A). (C) J77-LAT-
GFP cells (donor) were conjugated with SEE-loaded or unloaded Raji cells (recipient; blue). Donor 
and recipient populations were analyzed by flow cytometry after 24 h coculture. Raji recipients 
acquired LAT-GFP in an antigen-dependent manner. Dot plot of one representative experiment is 
shown. 
 
To define the requirement for cell-cell contact, we separated donor and recipient 
populations by a 0.4 m pore-size Transwell membrane. J77-CD63-GFP T cells in 
transwell assays were treated with anti-CD3 plus anti-CD28 to activate them and 
therefore enhance exosome release ((Blanchard et al., 2002) and Figure 4.3). Although T 
cell CD69 levels indicated that cells had been activated to the same extent as after 
formation of an IS, no CD63-GFP was detected on APC recipient cells, whether or not 
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these were loaded with SEE (Figure 4.7A and Figure 4.8A). Also, in contact (non-
Transwell) cocultures, stimulation with CD3 and CD28 Abs in the absence of SEE did not 
support CD63-GFP transfer (Figure 4.7B,C). Moreover, CD63-GFP transfer in standard (in 
the presence of SEE) contact cocultures was abolished by addition of the actin 
cytoskeleton inhibitors cytochalasin-D and latruculin-A, which disrupt the IS (Valitutti et 
al., 1995), whereas the microtubule inhibitor nocodazol had no effect (Figure 4.8A). These 
results indicate that cell-cell contact and T-cell activation by themselves do not support 
exosomal transfer. 
 
Figure 4.7 Cell-Cell contact and T cell activation are not sufficient for the exosomal transfer  
(A) Transwell experiments were performed with donor and recipient cells placed in the upper and 
lower chambers as indicated. CD63-GFP signal was measured on the recipient cells after 16h by 
FACS, and compared with the signal from antigen-stimulated contact cultures at the same T-
cell:APC ratio. (B and C) J77-CD63-GFP cells (donor) were conjugated with Raji cells (recipient; 
blue) in the presence of CD3 and CD28 Abs, SEE or PMA+Ionomycin. The cocultures were 
analyzed by flow cytometry 24 h later, donor cells for expression of the activation marker CD69 
and recipients for the acquisition of CD63-GFP. A representative experiment is shown in (B) and 
the percentage ± s.e.m. of positive cells of 3 independent experiments in panel (C).  
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Figure 4.8 Cognate immune interactions induce exosomal uptake and fusion 
(A)  FACS analysis of the percentage of GFP-positive Raji cells after incubation with J77-CD63-GFP 
cells in contact coculture as in Figure 4.6A (control), in the presence of inhibitors of actin 
(latrunculin-A, LatA or cytochalasin-D, CytD) or tubulin (nocodazol, NCD), or after incubation 
with separation of donors and recipients by a 0.4 m pore-size transwell membrane (Twell). T cells 
in transwells were activated with CD3+CD28 Abs and Raji cells were loaded with SEE. (B) J77-
CD63-GFP donor cells were conjugated with a 1:1 mix of two B cell lines: Raji cells (black) and BLS-
1 cells (blue) and analyzed as in (A). Bar chart shows percentages ± s.e.m. of positive recipient cells 
(n=6, p<0.005, Mann Whitney test). Maximal projections of confocal images and the DIC of a triple 
conjugated  formed by J77-CD63-GFP (green), Raji cells (black asterisk) and BLS-1 ( CMAC stained 
and blue asterisk), stained for CD3 (red) are shown. (C) Confocal analysis of Raji cells that acquired 
CD63-GFP directly from J77-CD63-GFP after IS formation (IS-dependent transfer) or after external 
administration of CD63-GFP exosomes isolated from J77-CD63GFP supernatants (non-synaptic 
uptake). Cell were stained for MHC-II (red). Images show maximal projections of confocal images, 
one representative confocal section, and the DIC images. Plots show cell perimeter fluorescence 
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To confirm that the exosomal transfer requires a functional IS, we cocultured J77-CD63-
GFP T cells with a mix of Raji B cells and BLS-1 B cells, which lack HLA class II and 
cannot form an IS (Hume et al., 1989). After 16 h, GFP signal was detected on SEE-primed 
Raji B cells (Figure 4.8B). In contrast, BLS-1 B cells did not trigger CD63 translocation or 
CD3 clustering (Figure 4.8B, right panel). These findings indicate that while T and APCs 
can both take up immune exosomes, cognate immune interactions promote the transfer of 
exosomes from the T lymphocyte to the APC and their unidirectional acquisition by the 
conjugated APC. 
We next analyzed the mechanism of exosome uptake by APCs. In post-conjugated Raji 
cells, which had acquired CD63-GFP upon IS formation, the CD63-GFP colocalized at the 
plasma membrane with endogenous MHC-II molecules, indicating that the exosomes 
either remained attached or had fused with the cell surface. Intensity profiles around the 
cell perimeter indicate similar distributions of both molecules in the plasma membrane 
(Figure 4.8C). In contrast, in Raji cells that had acquired CD63-GFP by direct addition of 
exosomes isolated from J77-CD63-GFP cells (non-synaptic uptake), the GFP signal 
appeared as aggregates attached to the plasma membrane and did not coincide with 
endogenous plasma membrane MHC-II (Figure 4.8C). To find out whether T cell 
exosomes are fused or only adhered to the APC plasma membrane, we treated the Raji 
cells with trypsin. Trypsin treatment did not decrease the GFP signal acquired by SEE-
loaded Raji cells from conjugated J77-CD63-GFP, indicating that exosomes transferred 
upon immune synapsis can fuse with the APC plasma membrane or be internalized 
(Figure 4.8D). In contrast, trypsin decreased the fluorescence signal of Raji cells that 
acquired CD63-GFP by non-synaptic uptake (Figure 4.8D). These results suggest that the 
IS might not only promote the secretion of exosomes from T cell to APC, but might also 
induce the fusion of these exosomes with the plasma membrane of the recipient cell. 
 
intensity profiles of the green and the red signals. A.R.U.: arbitrary relative units. Scale bar: 10 μm 
(D) Raji cells (±SEE) were treated as in (C). FACS analysis of the effect of trypsin on the CD63-GFP 
content of Raji cells that acquired exosomes by IS-dependent transfer or non-synaptic uptake. White 
bars, control; grey bars, 10' trypsin; black bars, 10'+10' trypsin. Bar chart shows percentages ± s.e.m. 
of positive cells (n=3). 
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4.1.4 The immune synapse promotes the transfer of exosomal microRNA  
To demonstrate delivery of exosomal miRNA from T cell to APC after IS formation, we 
stably over-expressed miR-335 in J77-CD63-GFP T cells (Figure 4.9A). This miRNA is not 
normally expressed in the donor (J77) or recipient (Raji) cells, but is sorted to the 
exosomes of primary immune cells (DCs and T lymphoblasts) (Figure 4.9A, Figure 4.2C, 
Annex Table 9.2). J77-CD63-GFP cells expressing miR-335 (J-335) were co-cultured with 
unprimed or SEE-primed Raji B cells (stained blue with CMAC), and after 24h the Raji 
Figure 4.9 Exosomal miRNA-
335 is transferred from T cell to 
APC in an Ag-specific manner 
 (A) Levels of miR-335 were 
assessed by quantitative RT-
PCR in primary dendritic cells 
and T lymphoblasts, and in Raji 
and J77 cells. J77-CD63-GFP 
cells were stably transduced 
with miR-335 (J-335 cells) or 
miR-101 (J-101 cells), and miR-
335 levels were determined by 
qRT-PCR in cells and derived 
exosomes. (B)  miR-335 levels in 
SEE-primed Raji cells sorted 24 
h after conjugation with J-335 
cells. J-101 were used as control 
donor cells. Left panel, Data are 
representative of seven 
independent experiments 
(mean and s.e.m), p=0.014 (one 
sample t test). Right panel, Raji 
cells that had acquired 
respectively low and high levels 
of C63GFP were sorted. n=5 
independent experiments; 
p=0.04 (one sample t test); error 
bars represent s.e.m. (C)  miR-
335 levels in HA-primed HOM-
2 cells sorted 24 h after 
conjugation with CH7C17 cells 
overexpressing miR-335 (C-
335). CH7C17 cells 
overexpressing miR-101 (C-101) 
were used as control donor cells. Data are representative of five experiments (mean and s.e.m.). (D)  
miR-335 and miR-92a levels in SEE-primed Raji cells sorted 24h after conjugation with primary T 
lymphoblasts expressing miR-335 and miR-92a endogenously. Data are representative of three 
experiments (mean and s.e.m.), p=0.026 (one sample t test)  A.U., Arbitrary Units. 
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cells were sorted by flow cytometry and their miR-335 content analyzed by RT-PCR. miR-
335 was transferred to Raji cells only in the presence of SEE (Figure 4.9B). Raji cells that 
acquired high amounts of CD63-GFP contained correspondingly high amounts of miR-
335, demonstrating correlation between the transfer of miR-335 and exosomal proteins 
(Figure 4.9B). To demonstrate that miR-335 is not expressed de novo in Raji cells after IS 
formation, we repeated the experiment with J77-CD63-GFP cells stably over-expressing 
miR-101 (J-101); conjugation with these cells did not induce expression of miR-335 in Raji 
cells (Figure 4.9B). The ability of a peptide antigen-specific IS to transfer miRNA was 
further demonstrated in CH7C17 cells overexpressing miR-335 (C-335) and conjugated to 
HA-loaded Hom-2 cells (Figure 4.9C), demonstrating antigen-specific directional transfer 
of exosomal miRNA from T cell to APC. We also investigated the transfer of endogenous 
miRNAs by primary SEE-specific T lymphocytes. These cells transferred endogenous 
miR-335 and miR-92 to Raji APCs in a SEE-specific manner (Figure 4.9D).  
 To confirm that microRNA transfer is mediated by exosomes, we blocked exosome 
production in J-335 cells. Ceramide, whose biosynthesis is regulated by neutral 
sphingomyelinase-2 (nSMase2), triggers the budding of exosomes into MVBs, and 
inhibition of nSMase2 therefore reduces the secretion of CD63-containing exosomes 
(Trajkovic et al., 2008) and miRNAs (Kosaka et al., 2010). Accordingly, the secretion of 
exosomes by J77 cells was impaired when nSMase2 activity was reduced either by 
addition of the inhibitor manumycin A (Figure 4.10A) or by shRNA silencing (Figure 
4.10B,C). Targeting of nSMase2 activity inhibited the IS-dependent transfer of CD63-GFP 
(Figure 4.10D,E) and miRNA-335 (Figure 4.10F,G). Transfer of CD63-GFP and miR-335 
was also blocked by brefeldin (Figure 4.10D,F), which inhibits the guanine nucleotide-
exchange protein BIG2 and regulates the constitutive release of exosome-like vesicles 
(Islam et al., 2007). In contrast, transfer of CD63-GFP occurred normally from Hrs-
interfered J77 cells (Figure 4.10E,H), in agreement with previous studies that 
demonstrated that the ESCRT system is unnecessary for the release of exosomes and 
microRNA (Kosaka et al., 2010; Trajkovic et al., 2008). 
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Figure 4.10 Inhibition of exosomes 
biogenesis impairs transfer of 
exosomal miRNAs and proteins 
through the IS 
(A) J77 cells were cultured in exosome-
depleted medium for 24 h, in the 
presence of inhibitors of nSMase2 
(manumycin A, Manu) or BIG2 
(brefeldin, Brefel). Purified exosomes 
secreted by equal numbers of control or 
treated cells were analyzed by 
immunoblotting for the presence of the 
exosome marker CD81. Densitometric 
analyses were performed, and the ratio 
between the treated and the control 
condition is shown. (B) CD81 
immunoblot of exosomes purified from 
equal numbers of cells transduced with 
control or nSMase2 shRNA. 
Densitometric analyses were performed, 
and the ratio between the silenced and 
the control condition is shown. (C)  
TaqMan RT-PCR was performed to 
confirm the silencing of nSMAse2 
mRNA on J-335 transduced with 
shnSMase2 or shControl.  (D)  FACS 
analysis of the CD63-GFP content of Raji 
recipients cells after conjugation with J-
335 cells in the presence of manumycin 
or brefeldin. Data are the percentage ± 
s.e.m. of Raji-GFP positive recipient cells 
relative to the SEE-loaded control 
condition. n=5 independent experiments; 
p ≤ 0.001 (one sample t test). (E) FACS 
analysis of the CD63-GFP content of Raji 
recipient cells after coculture with J77-
CD63GFP cells expressing shnSMase2 or 
siHrs. Data are the percentage ± s.e.m. of 
Raji-GFP positive recipient cells relative 
to the SEE-loaded control condition. n=8 
independent experiments, *, p = 0.0005 
(one sample t-test). (F) RT-PCR analysis 
of miR-335 in Raji cells sorted after 
conjugation with J-335 cells in the 
presence of manumycin or brefeldin. n=3 
independent experiments; *, p = 0.03 
(unpaired t test) (G) qRT-PCR analysis of 
miR-335 in Raji cells sorted after 
conjugation with J-335 transduced with shnSMase 2 or shControl. n=4 independent experiments, * p = 
0.012 (unpaired t test); error bars represent s.e.m.. (H)  Control RNA duplex or different siRNA against 
Hrs were delivered by electroporation into J77-CD63GFP cells. The efficiency of the knock-down was 
demonstrated by Western blotting. Tubulin is shown as a loading control. 
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4.1.5 Transferred microRNAs regulate gene expression on the antigen 
presenting cell 
To determine whether synaptically transferred miRNA-335 is functional in the recipient 
APC, we carried out luciferase reporter assays with full-length 3´UTR constructs of the 
miR-335 target SOX4 and the miR-335–insensitive UBE2F (Tavazoie et al., 2008). Raji cells 
transfected with luciferase constructs were cocultured with J-335 cells and luciferase 
activity was assessed. Expression from the SOX4 3´UTR was significantly reduced in SEE-
primed Raji cells that had been in contact with J-335 cells, whereas expression from the 
 
Figure 4.11  Synaptically transferred miR-335 down-regulates target gene expression in the APC  
(A) Raji cells were transfected with reporter constructs consisting of the luciferase sequence placed 
upstream of the full length 3´UTR of either the miR-335 target gene SOX4 or the control gene 
UBE2F. Luciferase activity was assayed 24 h after coculture of SEE-loaded Raji with J77-miR-335 
cells or control J-101 cells (synaptic transfer) or after addition of derived exosomes to SEE-loaded 
Raji cells (non-synaptic uptake). (B) Experiments as in (A) performed with Raji recipient cells 
expressing the wild-type of mutated seed sequence for miR-335 from the SOX4 3´UTR. Luciferase 
activities are shown relative to control incubations with untreated Raji cells. Data are means ± 
s.e.m.; n= 5 independent experiments, *p<0.05 (Newman-Keuls multiple comparison test). 
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UBE2F 3´UTR was unaffected (Figure 4.11A). Expression from these 3´UTR reporters was 
not affected by coculture of Raji cells with J-101 cells, indicating that the process is not a 
general effect of IS formation but rather involves the direct transfer of the specific miRNA. 
Reduction in luciferase activity after conjugate formation was also detected in Raji cells 
expressing base pairs 449-509 of the SOX4 3´UTR, which encompasses the miR-335 seed 
sequence; and inhibition of luciferase expression was abolished by mutation of this 
sequence (Figure 4.11B). The IS thus guides the transfer of functional miRNA from the T 
cell to the APC. Contrasting with IS-dependent miRNA transfer, addition of exosomes 
isolated from J-335 cells to transfected Raji cells had no effect on luciferase activity (Figure 
4.11A,B), indicating that any miR-335 acquired in this way was non-functional. 
 
4.2 Regulation of T cell miRNAs profile during activation  
4.2.1 miRNA profile of CD4+ T cells after activation by different dendritic 
cells subsets.  
To analyze the miRNA profile of CD4 T cells after cognate interactions with different 
types of APCs, we cocultured freshly isolated CD4 T cells  from OT-II transgenic mice 
with in vitro derived conventional or plasmacytoid dendritic cells (cDCs or pDCs) in the 
presence or absence of ovalbumin (OVA) peptide. After 18 h of coculture we monitored 
the CD69 expression levels of the T cells (Figure 4.12) and subsequently we sorted them 
from the coculture by flow cytometry. As expected, activation was greater in the coculture 
with cDCs (Figure 4.12A) than with pDCs (Figure 4.12B) being the first one similar to the 
control of polyclonal activation with anti CD3 and anti CD28 (Figure 4.12C). Total RNA 
was then isolated and miRNA profile analyzed by Agilent microarray. We found 25 
differentially expressed miRNAs (Log Fold Change < 0.5 or >-0.5 and adjusted p vale < 
0.05) when we compared the presence or absence of antigen regardless the type of APC 
(Figure 4.13A). In T cells activated by cDCs-OVA we found 34 miRNAs differentially 
expressed being 21 of them coincident with the previous group (Figure 4.13B, in bold 
common ones). When we analyzed the changes in the case of pDCs-OVA we found only 
10 miRNAs changing significantly (Figure 4.13C). However, when we compared the two 
types of activation, we detected only 1 miRNA specifically upregulated after the T  cell  
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encounter with a cDCs as well as 5 miRNAs specific of the activation exerted by pDCs 
(Figure 4.13D). We next validated the microarray data by RT-qPCR for some of the 
miRNAs. miR-17, miR-18a and miR-132 were significantly upregulated in cDC mediated 
activation  and also with pDC but in a lower extent (Figure 4.14A). miR-467b was 
significantly downregulated in cDC mediated activation. miR-26a and miR-150 show also 
a tendency of decrease both with cDCs and pDCs (Figure 4.14B).  
Unfortunately, when we analyzed the miRNAs that appeared to be differentially 
expressed in microarray data between pDCs- or cDCs-driven activation, some of them 
were not even detectable by qPCR (miR-494, miR-188-5p, miR-1224, data not shown) or 
data were not reproduced (miR-680 Figure 4.14D). Only the specific upregulation miR-720 
after cDC activation was detected although not in significant levels (Figure 4.14C). 
 
Figure 4.12 CD4 T cell activation after coculture with different DCs subsets 
(A) CD4 T cells from OT-II mice were coculture with cDCs in the absence (upper panel) or presence 
(lower panel) of OVA peptide. CD4 T cells were gated and analyzed for the activation markers 
CD25 and CD69. (B) The same procedure was done with cocultures with pDCs in the absence 
(upper panel) or presence (lower panel) of OVA peptide. (C) CD4 T cells were analyzed in naïve 
conditions (upper panel) or after polyclonal stimulation with anti CD3 and anti CD28 antibodies 
(lower panel).  
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Figure 4.13 microRNA profile of CD4 T cells activated with different subsets of cDCs 
CD4 T cells from OT-II mice were cocultured with either cDCs or pDCs in the presence or absence 
of OVA peptide and their microRNA analyzed by miRNA microarray. (A) Differential miRNA 
expression in the presence or absence of OVA peptide independently of the DC subset. (B) 
Comparison of miRNAs expression for specific stimulation by cDCs loaded or not with OVA 
peptide. (C) Same analysis for stimulation by pDCs without or with OVA. (D) Differentially 
expressed miRNAs for cDCs stimulation was compared to those for pDCs stimulation. miRNAs 
that were differentially upregulated in a significant level with each type of stimulation are 
represented. 
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Figure 4.14 Several miRNAs are differentially expressed after CD4 T cells activation 
Selected miRNAs detected by microarrays in Figure 4.13 were validated by RT-qPCR. (A) miR-17, 
miR-18 and miR-132 were significantly upregulated after stimulation with cDCs-OVA. (B) miR-26a, 
miR-150 and miR-467b were downregulated after stimulation with cDCs-OVA although only miR-
467b was significantly different by RT-qPCR analysis. (C) miR-720 was specifically upregulated 
with cDC stimulation but not in a significant level. pDCs stimulation did not change miR-720 level 
in concordance with microarray analysis (D) miR-680 levels by RT-qPCR were lower for both cDC-
OVA and pDC-OVA although not in significant level, contrasting with microarray data. RNU1A1 
and RNU5G were used as endogenous controls. A. U.: arbitrary units (n=8). ***P<0.001; **P<0.05; 
ns, non-significant. 
 
The expression of the identified miRNAs was also assessed in CD4 T cell activation upon 
treatment with concanavalin-A (ConA) followed by expansion with recombinant 
interleukin 2 (IL-2). A clear upregulation of miR-17, miR-18 and miR-132 was detected. 
The three miRNAs showed the higher levels at 24h post stimulation but for miR-132 basal 
levels were recovered after around 4 d while miR-17 and miR-18 still maintain high levels 
after 8 d (Figure 4.15A). We observed similar behavior for the downregulated miRNAs. 
miR-26a and miR-150 decreased sharply their levels only 24h post stimulation being the 
lowest after 3 d and maintained until 8 d. However, miR-467b was only slightly decreased 
after 3 d and its levels were not consistent through time (Figure 4.15B). Finally, in the case 
of miR-720, there was only a very slight increase with this type of activation only after 3 d 
of stimulation (Figure 4.15C). Overall, these data indicate that there is a specific profile of 
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miRNAs regulated after T cell activation that changes depending on the APC that is 
stimulating the T cell. As expected, the profile of miRNAs that change after cDC exerted 
activation is more similar to that of the ConA  activation that is a strong signal for T cell 
stimulation.  
 
Figure 4.15 miRNAs regulation during time upon T cell activation 
miRNA levels were assessed by RT-qPCR in freshly isolated mouse naive CD4 T cells in different 
time points of activation with ConA followed by IL-2. (A) Upregulated miRNAs kinetics: miR-17, 
miR-18 and miR-132. (B) Downregulated miRNAs kinetics: miR-26a, miR-150 and miR-467b. (C) 
miR-720 regulation during time. miRNA levels were normalized to RNU1A1 and RNU5G and are 
presented in arbitrary units (n=2). 
 
 
4.2.2 Common predicted targets of miRNAs upregulated upon CD4 T cell 
activation  
There are different tools available that predict in silico the mRNA targets of a given 
miRNA, but unfortunately due to the intrinsic difficulty of the prediction none of them is 
perfect. Thus, to improve the prediction we used a program that combines several 
prediction tools as well as databases for experimentally validated targets  (Tabas-Madrid 
et al., 2014), to identify the possible common mRNA targets of the miRNAs that were 
down- or up-regulated after T cell activation. Signaling pathways where the target genes 
are implicated were studied with Ingenuity Pathway Analysis (IPA) tool. Interestingly, 
genes regulated by the miRNAs upregulated after T cell activation were related to 
immune response. The most represented ones are presented in Figure 4.16.  We focus our 
attention on those mRNA targets that have the higher number of predicted miRNAs 
modulating them and specifically those interactions that have not been experimentally  
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validated yet. Some of these genes are shown in Table 4.1 with the combined prediction 
score of our prediction tool. 
4.2.3 PIK3R1 is a target of the miRNAs upregulated during T cell activation 
Pik3r1 (Phosphoinositide-3-Kinase, Regulatory Subunit 1 Alpha) gene encodes p50a, p55a 
and p85a, regulatory subunits of PI3Kinase that provide at least three functions to the 
catalytic subunits p110; stabilization, inactivation of kinase activity in the basal state and 
recruitment to pTyr residues in receptors and adaptor molecules. The engagement of the 
p85 SH2 domains by pTyr relieves the p85-mediated inhibition of the catalytic subunits 
and also brings them in contact with their lipid substrates in the membrane 
(Vanhaesebroeck et al., 2010). Thus, the proteins encoded by pik3r1 are negative regulators 
of the PI3K signaling pathway which is one of the signaling pathways that arise from TCR 
and co-receptors engagement. Taking into account its described function, pik3r1 gene 
 
Figure 4.16 Signaling Pathways of upregulated miRNAs Targets 
Genes regulated by 7 or more upregulated miRNAs during T cell activation were analyzed with 
Ingenuity Pathway Analysis to find common pathways of these targets. Those pathways with 
higher score are shown.  
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Table 4.1 Targets of upregulated 
miRNAs in CD4 T cells 
Prediction of the Targets of the miRNAs 
upregulated in CD4 T cells from OT-II 
Mice after stimulation with cDCs loaded 
with OVA peptide. Prediction was 
performed with a combinatorial method 
of different available prediction tools. 
Higher combined prediction score 
denotes more confidence in the 
prediction 
 
 
Gen 
Number of 
miRNAs 
Combined 
Prediction SCORE 
Tnrc6b 12 0.8084745 
Eif4g2 11 0.7353566 
Tnrc6a 11 0.6859481 
Sox5 11 0.6671118 
Pik3r1 11 0.6514733 
Tbc1d2b 11 0.5969837 
Tbxas1 11 0.5769961 
Syncrip 11 0.5662375 
Gsk3b 11 0.5640294 
Neo1 11 0.5611467 
Zfp664 11 0.5451551 
Rdx 11 0.5301558 
specifically captured our interest among those predicted targets of the miRNAs 
upregulated after T cell activation. Indeed pik3r1 was predicted to be inhibited by 11 of 
the 12 miRNAs upregulated in T cells after cognate interaction with cDCs (Table 4.1). The 
specific list of these miRNAs and their logFoldChange of  naïve vs cDC-OVA stimulated 
CD4 T cells is presented in (Table 4.2). 
We next studied the expression of the gene 
as well as some of the miRNAs predicted to 
target it during T cell activation. p85 and 
p50 proteins and mRNA levels of the two 
corresponding alternative transcripts of 
pik3r1 were decreased during time in CD4 T 
cells stimulated with anti CD3 and anti 
CD28 for 7 d (Figure 4.17A,B and C). On the 
other hand miR-17-5p, miR-18a and miR-
132 that are predicted to target pik3r1 were 
inversely regulated (Figure 4.17D). These 
data indicate that the negative regulator of 
PI3K, pik3r1, might be directly regulated by 
miRNAs during T cell activation. 
miRNA logFC adjpv 
mmu-miR-155-5p 3,746 0,003 
mmu-miR-132-3p 2,865 0,031 
mmu-miR-18a-5p 2,752 0,025 
mmu-miR-34a-5p 2,041 0,012 
mmu-miR-31-5p 2,012 0,042 
mmu-miR-17-5p 1,928 0,008 
mmu-miR-106a-5p 1,867 0,018 
mmu-miR-193a-3p 1,661 0,018 
mmu-miR-21a-5p 1,330 0,042 
mmu-miR-17-3p 1,307 0,039 
mmu-miR-20a-5p 1,190 0,031 
mmu-miR-146a-5p 0,936 0,048 
 
Table 4.2 miRNAs predicted to target pik3r1 
A total of 11 out of the 12 miRNAs 
upregulated after CD4 T cell stimulation by 
cDC-OVA are predicted to be targeting 
pik3r1. The only miRNA not predicted to 
target is presented in gray.  
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4.2.4 miR-132 targets pik3r1 
Next, the predicted site sequences of miRNA binding were studied on the 3’UTR of pik3r1 
(Table 4.3) with a combination of prediction programs. Apart from canonical sites two 
unusual sites were also predicted in 3’UTR of pik3r1. We decided to study in depth the 
interaction between miR-132-3p with pik3r1 because it has two different predicted binding 
sites and its role in the context of T cell activation has not been well analyzed. With this 
purpose, we cloned into luciferase reporter vectors two regions of the 3’UTR of pik3r1 
containing the two predicted target sites for miR-132-3p. For Site 1 we cloned the 
fragment from 71 to 362 bp and for Site 2 we cloned from 2957 to 3162 bp of 3’UTR. 
 
Figure 4.17 pik3r1 is downregulated during upon T cell activation 
 (A) mRNA relative levels of the two main transcripts of pik3r1 were measured by qPCR. Levels 
were normalized to Yhwaz and β-actin housekeeping genes (n=2). (B) Western blot analysis of p85α 
and p50αprotein content in CD4 T cells after activation with anti-CD3 plus anti-CD28. 
Representative Immunoblots (n=3). ERMs were included as a loading control. (C) Protein levels of 
p85 and p50 in B normalized to ERMs. (D) miRNA levels in CD4 T cells after activation with anti-
CD3 plus anti-CD28. Levels are normalized to RNU1A1 and RNU5G and presented in arbitrary 
units (n=2). 
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(Figure 4.18A). We co-transfected into HEK cells the reporter plasmids either with a 
control plasmid or a plasmid for the overexpression of miR-132-3p. GFP positive cells 
were subsequently sorted by flow cytometry to analyze only cells transfected with the 
miRNA overexpression plasmid or the control. miRNA-132 levels were also assessed by 
RTqPCR (Figure 4.18B). Cells were then lysed and luciferase levels analyzed. Both sites 
resulted to be targeted by miR-132 since luciferase levels were significantly lower when 
cells were co-transfected with miR-132 plasmid compared to the control plasmid (Figure 
4.18C). Thus our data experimentally demonstrate for the first time the inhibition of pik3r1 
by miR-132-3p.  
 
 
Table 4.3 pik3r1 3’UTR miRNA binding sites sequences 
The predicted binding sites for upregulated miRNAs at 3’UTR of pik3r1 mRNA were analyzed 
with a prediction tool that combines different prediction programs currently available.  Seedmach 
type, sequence and location as well as the specific programs that predict this binding are shown for 
each interaction.   
 
Canonical sites 
miRNA Start End 
Seedmatch 
Sequence 
Seedmatch 
type 
3'  
pairing 
# sites Prediction Programs 
mmu-miR-106a-5p 1377 1383 GCACTTT 7mer-m8 - 1 targetscan,miranda,findtar 
mmu-miR-132-3p 3082 3088 GACTGTT 7mer-m8 - 
2 
targetscan,miranda,findtar 
mmu-miR-132-3p 175 181 GACTGTT 7mer-m8 - targetscan,miranda,findtar 
mmu-miR-146a-5p 3359 3365 GTTCTCA 7mer-m8 13-17 1 targetscan,rnahybrid,findtar 
mmu-miR-17-5p 1377 1383 GCACTTT 7mer-m8 - 1 targetscan,miranda,findtar 
mmu-miR-20a-5p 1377 1383 GCACTTT 7mer-m8 - 1 targetscan,miranda,findtar 
mmu-miR-21a-5p 2400 2406 TAAGCTA 7mer-m8 - 
3 
targetscan,findtar 
mmu-miR-21a-5p 904 910 ATAAGCT 7mer-m8 - targetscan,miranda,findtar 
mmu-miR-21a-5p 2937 2943 TAAGCTA 7mer-m8 - targetscan,findtar 
mmu-miR-34a-5p 2299 2305 ACTGCCA 7mer-m8 - 1 targetscan,findtar 
Unusual sites 
miRNA Start End Seedmatch Sequence 
    
mmu-miR-21a-5p 1154 1162 TGATAAGCT 
    
mmu-miR-155-5p 1442 1465 
AGTTTGGTAGTCAT
TAGCAATTAA     
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4.3 3’ Nucleotide Additions to Mature miRNA control their turnover 
during T cell activation  
4.3.1 TUT4 is downregulated during T cell activation 
To investigate the molecular mechanism underlying the post-transcriptional modification 
of miRNAs during T cell activation, we studied the regulation of terminal uridyl 
transferases (TUTases) during this process. The mRNA transcript levels of TUTases 
1,2,3,4,5 and 7 in CD4 T cells were determined before and after polyclonal stimulation 
with anti-CD3 and anti-CD28 antibodies for 48h. TUT4 and TUT7, the two enzymes 
predominately responsible for uridylation, were decreased upon T cell activation, 
whereas TUT1 and TUT5 were upregulated, and TUT2 and TUT3 were unaltered (Figure 
4.19A). Reduction of TUT4 mRNA levels was confirmed in human T cell blasts stimulated 
polyclonally (Figure 4.19B) and in antigen-specific experiments in which CD4 T cells from 
transgenic OT-II mice were cocultured with bone marrow-derived dendritic cells loaded 
with OVA peptide (Figure 4.19C). We detected a very transient upregulation of TUT4  
Figure 4.18 miR-132-3p targets 
pik3r1   
(A) 3’UTR of pik3r1 cloning 
strategy. Fragments from 71 to 
362 bp and from 2957 to 3162 bp 
containing the two binding sites 
predicted for miR-132-3p were 
cloned into the psiCheck2 
vector. (B)  miR-132-3p levels in 
HEK cells after transfection. 
Levels were normalized to 
RNU1A1 and RNU5G and 
presented in arbitrary units. (C) 
HEK cells were transfected with 
indicated plasmids, GFP+ cells 
sorted and Renilla and Firefly 
luciferase signal measured. Data 
are presented in Renilla 
Luciferase signal relative to 
Firefly (n=5). T test **P<0.05.  
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Figure 4.19 TUT4 expression is downregulated after T cell activation 
(A) RNA levels of TUT1,2,3,4,5 and 7 assessed by RT-qPCR in freshly isolated mouse naive CD4 T 
cells or cells activated with anti-CD3 and anti-CD28 for 48 h. mRNA levels were normalized to β-
actin and Yhwaz housekeeping genes and are presented in arbitrary units (n=7). (B) TUT4 mRNA 
levels in human T lymphoblasts measured by RT-qPCR after two different activation stimuli: PMA 
with Ionomycin and anti-CD3 plus anti-CD28 (n=3). (C) Mouse naive CD4 T cells from OT-II mice 
specific to OVA peptide were cocultured with cDCs in the absence or presence of the peptide. TUT4 
mRNA levels were determined by RT-qPCR as in (A) (n=5). (D) Early time course of TUT4 mRNA 
levels quantified by RT-qPCR in activated mouse CD4 T cells (n=3). (E) Long-term time course of 
TUT4 mRNA levels in activated mouse CD4 T cells (n=3). (F) Western blot analysis of TUT4 protein 
content in CD4 T cells after activation with anti-CD3 plus anti-CD28 or with concanavalin A 
followed by expansion with interleukin 2. Representative Immunoblots (n=3). ERMs were included 
as a loading control. (G) Western blot analysis of TUT7 protein at different time points after 
antibody activation of CD4 T cells. Representative Immunoblots (n=3). p150 was included as a 
loading control. Numbers below blots show normalized densitometry values relative to naive T 
cells. Error bars in A-C represent standard deviation; ***P<0.001; **P<0.05; ns, non-significant. 
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mRNA at 1h after stimulation (Figure 4.19D), but TUT4 mRNA levels decreased over the 
subsequent 24h and remained low at 96h (Figure 4.19E). Western blot analysis of TUT4 
protein showed a decrease at 24h after activation with anti-CD3 and anti-CD28 antibodies 
and upon treatment with concanavalin-A followed by expansion with recombinant 
interleukin 2 (Figure 4.19F). TUT7 protein content was also downmodulated after 
stimulation with CD3 and CD28 antibodies, albeit delayed compared with TUT4 (Figure 
4.19G). Immunofluorescence and subcellular fractionation experiments showed a 
predominant cytoplasmic confinement of TUT4, and T cell activation did not provoke any 
significant subcellular redistribution (Figure 4.20A and B). These data indicate a clear 
downregulation of TUT4 and TUT7, the TUTases implicated in miRNA uridylation, upon 
T cell activation. 
 
Figure 4.20 Subcellular localization of TUT4 
(A) Subcellular localization of TUT4 was assessed by immunofluorescence in mouse blast T cells. 
Cells were fixed and stained for TUT4 (red) and tubulin (green), and nuclei were stained with DAPI 
(blue). Plates show maximal projections of confocal images. (B) Western blot analysis of subcellular 
fractions of resting and activated human T cells. Cells were activated with phorbol myristate acetate 
and ionomycin (P+I). TUT4 protein content is shown for each fraction, together with tubulin 
(cytosolic protein), EZH2( nuclear protein) and ERMs (submembranous proteins)  
 
4.3.2 T cell activation alters the profile of miRNA 3’ non-templated nucleotide 
additions  
To assess the dynamics of isomiR generation during T cell activation, we performed a 
deep sequencing analysis on small RNAs from mouse CD4+ T cells in naive conditions 
(CD25-, CD62L+) and upon stimulation with anti-CD3 and anti-CD28 antibodies. The 
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homogeneity of replicates for each condition was confirmed by their proximity on the 
principal components analysis (PCA) (Figure 4.21A). T cell activation was confirmed by 
staining of the activation markers CD25 and CD69 (Figure 4.21B) and by the analysis of 
canonical (unmodified) miRNAs that are modulated upon T cell activation, which showed 
clear upregulation of miR-155-5p and members of the miR-17∼92 cluster (miR-17-5p, miR-
18a-5p, miR-19a-3p and miR-20a-5p),  whereas miR-150-5p and miR-26a-2-5p  were  
 
Figure 4.21 Small RNA deep sequencing analysis of naive and activated CD4 T cells 
(A) Principal component analysis of the eight libraries in the experiment. Naïve (N); Activated (A). 
(B) Activation markers CD25 and CD69 were analyzed in naive and activated CD4 T cells by flow 
cytometry. (C) Canonical miRNA analysis. Statistically significant data are presented (fold change 
>0.5 or <-0.5; adjusted p value <0.05). Negative fold change corresponds to downregulated 
miRNAs (green) and positive fold change corresponds to upregulated miRNAs (red). 
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downregulated (Figure 4.21C). These data are also in accordance with previous 
microarray data mention above in in section 4.2.1 (Figure 4.13D). Moreover a global 
downregulation of miRNA was detected in our deep sequencing data when miRNA count 
distributions were analyzed with Kolmogorov Smirnoff test, P <= 1e-4).  
 
 
Figure 4.22 The miRNA 3’ non-templated nucleotide addition (3’NTA) profile changes during T 
cell activation 
Deep sequencing libraries were generated from naive CD4 T cells or cells activated for 48h with 
anti-CD3 and anti-CD28 (n=4). (A) 3’ NTAs to all mature miRNAs are represented as the fraction of 
total counts (normalized) per mature miRNA in resting and activation conditions. (B) Total 
normalized counts of uridylated and adenylated miRNAs for the eight libraries examined (N: 
naive; A: activated CD3/CD28). (C, D) Comparison of the relative abundance of 3’ mono-uridine 
and oligo-uridines (C) and of 3’ mono-adenine or oligo-adenines (D) in individual miRNAs from 
naive and activated CD4 T cells. 
 
MiRNA modifications were classified as mono addition (one nucleotide) or oligo addition 
(two or more nucleotides). Uridylation and adenylation were identified as the most 
common modifications of miRNAs in CD4 T cells (Figure 4.22 A). A clear reduction of 
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miRNA uridylation, both mono and oligo additions, was observed in activated T cells, 
both when the data were analyzed globally (Figure 4.22B) and when examining each 
miRNA individually (Figure 4.22C). In contrast, adenylation remained unaltered after 
activation, both in the global (Figure 4.22B) and individual analysis (Figure 4.22D). 
 
Figure 4.23 Uridylated miRNAs are decreased upon T cell activation 
Individual miRNAs were analyzed for their 3’ end modifications by deep sequencing in naive and 
activated CD4 T cells. (A) Pie charts for selected miRNAs depict the fraction of counts for each type 
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 Abundance profiles of isomiR forms of example miRNAs are shown in Figure 4.23. As 
mentioned above, all uridylated miRNAs decrease after T cell activation. For each of the 
selected miRNAs, Figure 4.23A depicts the fraction of counts corresponding to each 
3’NTA and the canonical sequence, showing clear decreases in the percentages of the 
uridylated forms. The group of uridylated miRNAs that decreases after activation was 
selected and the log fold-changes in the abundance of each canonical and modified 
miRNA species between naive and activated conditions is shown in Figure 4.23B. This 
analysis shows that the reduction in uridylation (Figure 4.23B upper panel) does not 
correlate with alterations to the level of the corresponding canonical miRNA, which in 
many cases remained unchanged (Figure 4.23B lower panel). Moreover, the adenylated 
species corresponding to these miRNAs show a similar pattern of abundance changes to 
the canonical species, and thus do not appear to compensate the decrease in uridylation 
(Figure 4.23B middle panel). These data raise the conclusion that the regulation of 
uridylated miRNA levels is thus independent of the regulation of its canonical 
counterpart and of other 3’NTAs like adenylation. 
4.3.3 Uridylation targets mature miRNA for activation-dependent degradation  
Uridylation of mRNA is associated with its decay (Schmidt et al., 2011; Shen and 
Goodman, 2004) and a recent report shows that degradation of mRNA with shortened 
polyA-tails is promoted by 3’ uridylation, mediated by TUT4 and TUT7 (Lim et al., 2014). 
To investigate whether uridylation targets mature miRNAs for degradation during T cell 
activation, we transfected naive CD4 T cells with synthetic RNAs corresponding to 
canonical or di-uridylated miRNA sequences. The cells were subsequently either 
activated with anti-CD3 and anti-CD28 or maintained in culture in the presence of IL-7 to 
prevent naive T cell apoptosis. Levels of the synthetic miRNAs were measured with a 
variation of miQPCR ((Benes et al., 2015) see materials and methods) that distinguishes 
single nucleotide changes in the miRNA sequence. Synthetic canonical miR-151 and miR-
25 were stable upon T cell activation, whereas the levels of the di-uridylated forms 
of 3’NTA-modified and canonical miRNA dectected. A, adenine, C, cytosine, G, guanine and U, 
uracil. (B) A group of 14 miRNAs was selected from the set of uridylated miRNAs that decrease 
after T cell activation. Fold changes between the naive and activated state were calculated for the 
uridylated miRNAs (upper panel) and the corresponding adenylated miRNAs (middle panel) and 
canonical miRNA (lower panel). A negative log FC indicates downregulation after T cell activation. 
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dropped sharply (Figure 4.24). These data indicate that miRNA uridine tailing is an 
important mechanism for targeting a specific set of miRNAs for degradation, and that this 
process is tightly regulated during T cell activation. 
Figure 4.24 Uridylation 
promotes the decay of miRNAs 
during T cell activation 
Synthetic miRNAs were 
nucleofected into naive CD4 T 
cells, which were then activated 
with anti CD3 and anti CD28 or 
left resting in the presence of IL7. 
Levels of the synthetic miRNAs 
were analyzed by a customized 
qPCR method (MiQPCR). 
Synthetic RNA levels were 
normalized to endogenous 
controls snoRNA 420 and snoRNA 412 and are presented in arbitrary units (n=3). 
 
4.3.4 TUT4-dependent uridylation of mature microRNA  
To assess the role of TUT4 in the uridylation of mature miRNAs in CD4 T lymphocytes 
we examined TUT4-deficient mice (Jones et al., 2012). TUT4-deficient mice showed no 
significant aberration in the percentage of CD4 and CD8 T lymphocytes in thymus, spleen 
or peripheral lymph nodes (Figure 4.25A), and TUT4-deficient CD4 T cells proliferated 
normally and could be activated to the same extent as wild type T cells (Figure 4.25B and 
C). Basal levels of miRNA mono- and oligo-uridylation were lower in naive TUT4-
deficient CD4 T cells compared with wild type cells, as described for other tissues (Jones 
et al., 2012) (Figure 4.26A and B). Interestingly, miRNA mono- and oligo-adenylation were 
clearly higher in TUT4-deficient T cells. (Figure 4.26C and D). Previous reports indicate 
that TUT4 gene deficiency or knockdown does not modify the quantities of mature 
miRNAs in a variety of cellular contexts (Jones et al., 2012; Thornton et al., 2015). 
Accordingly, miR-seq data showed no significant differences in the levels of canonical 
miRNAs between TUT4-deficient and wild type CD4 T cells (data not shown), a finding 
validated for several mature miRNAs by qPCR (Figure 4.27A). 
We next sought to identify the specific miRNA targets of TUT4 in T cells. We initially 
designated as “TUT4 targets” the miRNAs that were significantly less uridylated in TUT4-
deficient CD4 T cells compared with wild type cells (Figure 4.26A and B). We considered  
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both mono-uridylated and oligo-uridylated species as targets (Annex Table 9.3A), and 
miRNAs whose mono- and oligo-uridylated forms were both lower in TUT4-deficient 
CD4 T cells are listed in Annex Table 9.3B. Levels of the canonical miRNAs corresponding 
to these uridylated miRNAs were not modified in TUT4-deficient cells, as determined by 
miR-seq and RT qPCR analysis (Figure 4.27A and B). These data provide the first evidence 
that TUT4 controls the uridylation of mature miRNAs in T lymphocytes. Although 
uridylated miRNAs are clearly less abundant in TUT4-deficient CD4 T cells, we could still 
detect some miRNAs with 3’ non-templated uridines. TUT4-deficient T cells showed no  
Figure 4.25 Analysis of TUT4-deficient lymphoid tissues and lymphocytes 
(A) Flow cytometry analysis of CD4 and CD8 in lymphoid organs (thymus, spleen and lymph 
nodes) of wild type and TUT4-deficient mice. (B) Flow cytometry analysis of the activation markers 
CD69 and CD25 in CD4 T cells from wild type and TUT4-deficient mice 24h after stimulation with 
anti-CD3 and anti-CD28. (C) Proliferation of wild type and TUT4-deficient CD4 T cells. Cells were 
stained with cell violet and subsequently stimulated with anti-CD3 and anti-CD28. Cell violet 
staining was analyzed by flow cytometry after 72h.  
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Figure 4.26 TUT4 dependent uridylation of mature microRNA  
Small RNA from naive wild type or TUT4-deficient CD4 T cells was analyzed by deep sequencing. 
Fold changes between wild type and TUT4-/- CD4 T cells calculated for mono-uridylated (A), 
oligo-uridylated (B),  mono-adenylated (C) and oligo-adenylated miRNAs (D). A negative fold 
change indicates lower levels than in wild type. 
 
 
Figure 4.27 Canonical miRNAs are not modified in TUT4-deficient T cells 
(A) RT-qPCR quantification of selected miRNAs in naive CD4 T cells from TUT4-deficient mice. miRNA 
levels are normalized to the mean levels of RNU1A1 and RNU5G RNAs and are presented in arbitrary 
units (n=3). (B) Comparison of the levels of the individual canonical miRNAs corresponding to the 
identified TUT4 uridylation targets between wild type nd TUT4-deficient CD4 T cells. 
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compensatory increase in the levels of TUT7 or any other TUTase (Figure 4.28A and B), 
but given the presence of TUT7 protein, it is likely that the remaining miRNA uridylation 
in TUT4-deficient mice is attributable to this enzyme. 
 
Figure 4.28 
Expression of other 
TUTases are not 
modified in TUT4 
deficient T cells.  
(A) RT-qPCR 
quantification of TUT1,2,3,4,5 and 7 mRNA in naive 
CD4 T cells from TUT4-deficient mice. Data are expressed 
relative to the mRNA levels in wild type cells (n=2). (B) TUT7 
protein content in wild type and TUT4-deficient CD4 T cells. 
ERMs were included as a loading control. 
 
 
Figure 4.29 The remaining uridylated miRNAs in TUT4 deficient T cells are downregulated 
after T cell activation 
Comparison of the relative abundance of 3’ mono-uridine and oligo-uridines (A) and of 3’ mono-
adenine and oligo-adenines (B) in individual miRNAs from naive and activated TUT4-deficient 
CD4 T cells. 
We further determined the impact of the lack of TUT4 on uridylated miRNAs during T 
cell activation. Despite the already low basal levels of uridylation in TUT4-deficient CD4 T 
cells (Figure 4.26A and B), cell activation still led to a reduction of the remaining 
uridylated miRNAs, while adenylation was again stable (Figure 4.29A and B). Analysis of 
the identified TUT4 miRNA targets (Annex Table 9.3. Targets of TUT4. during activation 
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of wild type T cells revealed that these species were downregulated while the 
corresponding canonical miRNAs remained stable (Figure 4.30 and Annex Table 9.4). 
TUT4 targets thus account for a substantial proportion of the uridylated miRNAs 
degraded upon T cell activation. 
 
Figure 4.30 TUT4 Targets and their corresponding canonicals during T cell activation 
(A) Comparison of the levels of individual uridylated miRNAs identified as TUT4 targets between 
naive and activated wild type CD4 T cells. (B) Comparison of the levels of the individual canonical 
miRNAs corresponding to the identified TUT4 uridylation targets between naive and activated 
wild type CD4 T cells. 
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5 DISCUSSION 
5.1 microRNAs are transferred during IS from T lymphocytes to Antigen 
Presenting Cells shuttled by exosomes 
5.1.1 EVs in cell-cell communication 
Cells release different types of vesicles into the extracellular space being exosomes those 
of endosomal origin. Extracellular Vesicles are increasingly recognized as important 
mediators of cell-to-cell communication (Simons and Raposo, 2009). They can transfer 
receptors, proteins, mRNA and microRNA to target cells via interaction with specific 
receptors. Extracellular vesicles derived from embryonic stem cells have been reported to 
reprogram hematopoietic progenitors through the delivery of mRNA (Ratajczak et al., 
2006a). The transfer of RNA species via microvesicles to endothelial cells induces 
angiogenesis (Deregibus et al., 2007; Skog et al., 2008) and progenitor mobilization 
(Zernecke et al., 2009). In the immune system, exosomal transfer of mRNA occurs 
between mast cells (Valadi et al., 2007), and viral miRNAs secreted by EBV-infected cells 
can be taken up by uninfected recipient cells (Pegtel et al., 2010). Synthetic miRNA 
mimetics and viral miRNAs have been reported to be transferred between leukocytes, 
although the direct involvement of exosomes/microvesicles in this case was not 
demonstrated (Rechavi et al., 2009). Exchange of proteins between immune cells has been 
extensively reported, but the mechanism of this transfer remains unclear (Davis, 2007). 
This phenomenon, which has been called trogocytosis, is considered to be an antigen-
specific event that requires the formation of an IS. Data presented in the first section of 
this thesis suggest that the mechanism for the transfer of certain proteins during IS is the 
directional release of exosomes. It is worth to mention that other mechanisms of 
intercellular transfer of molecules have been described in the IS like trans-endocytosis, 
nanotubes and gap junctions.  
5.1.2 IS as enhancer of directed intercellular communication  
In accordance with other reports, our data show that exosomes can be transferred 
between cells at a distance. T lymphocytes and DCs can acquire exosomes from the 
extracellular milieu (Izquierdo-Useros et al., 2009; Montecalvo et al., 2008; Segura et al., 
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2005a; Segura et al., 2005b). Uptake of isolated exosomes seems to be influenced by 
activation of donor T cells (Nolte-'t Hoen et al., 2009), the maturation state of recipient 
DCs (Izquierdo-Useros et al., 2009), and the presence of specific proteins like LFA-1 or 
ICAM-1 on exosomal or cellular membranes (Nolte-'t Hoen et al., 2009; Segura et al., 
2005b; Xie et al., 2010). TCR specificity was suggested not to be required for exosomal 
uptake (Nolte-'t Hoen et al., 2009); however, we found that TCR specificity and the 
presence of antigen enhance their acquisition. Interestingly, we observed that CD63 was 
not transferred in T-B contact cocultures in the presence of stimuli that activate T cells 
without forming an IS. These results indicate that cell-cell contact and T cell activation are 
not sufficient for the observed exosomal transfer, and that the presence of specific antigen 
that induces the formation of an IS is critical.  
Moreover, we have described that the exchange of exosomes is dependent on the 
formation of a fully functional IS. IS is such an intimate intercellular contact that provides 
ample opportunity for cell-cell communication often involving membrane fusion and the 
formation of several membrane structures. These processes facilitate the exchange of 
molecules not only from cell surfaces but also from the cytoplasm of the cells involved. 
However, the exact mechanism of IS-driven exosome transfer is still unsolved. At least 
two possibilities can be considered: i) transfer may occur through the IS itself; ii) 
exosomes could be released to the surrounding medium and acquired by the recipient 
cell, the IS thus making uptake more efficient than in the absence of cell-cell contact. Both 
possible routes have been described for IS-dependent transfer of cytokines and lytic 
factors (Huse et al., 2008). While cytokines such as TNFα and the chemokine CCL3 are 
released multidirectionally, IL2 and IFNγ are secreted within the IS between CD4+ T cell 
and APC (Huse et al., 2006). Directional secretion also occurs with lytic granules and 
factors released by CD8+ T cells during cytotoxic synapse with a target cell. In this case, 
directional and confined communication is especially important to safeguard surrounding 
cells from the cytotoxic action (Stinchcombe et al., 2001). In the IS between a CD4+ T cell 
and an APC, which occurs in the context of a cell-dense scenario such as a lymph node, 
directionality may ensure exclusive delivery of the exosomal signal to the specific target 
cell, without affecting surrounding bystander cells. Similarities between lytic-granule 
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release, exosome release at the IS, and neurotransmitter secretion at neuronal synapses are 
becoming increasingly evident (Huse et al., 2008). 
5.1.3 Polarization of the T-cell MVBs 
Polarized secretion is guided by the reorientation of the microtubule-organizing center 
(MTOC) toward the IS, which is accompanied either by the Golgi apparatus in cytokine-
releasing helper T cells or by lytic granules in cytotoxic T cells (Griffiths et al., 2010)  
(Calabia-Linares et al., 2011). Our data and others demonstrate that the formation of an IS 
also induces the polarization of T cell MVBs toward the IS and enhances the release of 
exosomes (Blanchard et al., 2002). Preliminary evidence suggests that the mechanism of 
MTOC reorientation and MVB traffic for polarized secretion at the IS involves local 
production of second messenger lipids such as diacylglcyerol and its negative regulator, 
diacylgycerol kinase  (Quann et al., 2009). Further work is needed to better define the 
mechanism of directed exosomal release and uptake. Nevertheless, plasma-membrane 
fusion of MVBs at the IS zone is supported by or findings of the specific translocation of 
T-cell MVBs toward a functional IS and the selective uptake of exosomes only by APCs 
expressing MHCII and therefore able to form this functional IS. On the other hand, the 
MVBs of APCs, whether DCs or B cells, do not translocate to the IS, indicating that 
although APCs might release exosomes during cognate interaction, polarized release as 
occurs in T cells is very unlikely.  
5.1.4 Exosomes uptake by the recipient cell 
In order for the exosomal cargo (both protein and genetic material) to be functional after 
delivery, it must avoid degradation in the recipient cell. Using fluorescently labeled 
exosomes, several studies have demonstrated internalization of exosomes by DCs and 
other phagocytes (Feng et al., 2010; Izquierdo-Useros et al., 2009; Montecalvo et al., 2012; 
Montecalvo et al., 2008). Although internalized exosomes colocalize with late 
endosomes/lysosomes (Feng et al., 2010; Morelli et al., 2004), alopeptides of exosomal 
origin are processed and later presented on the DC surface, demonstrating that exosomal 
cargo is not completely degraded (Morelli et al., 2004). Moreover, tumor-derived 
exosomes have been shown to fuse directly with melanoma cells membrane at low pH 
(Parolini et al., 2009), although in other cell lines internalization occurs via the endocytic 
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pathway, with proteins directed to lysosomes while lipids appear to be recycled (Tian et 
al., 2010). Previous works detected the transfer of functional mRNA and viral miRNA by 
isolated exosomes (Pegtel et al., 2010; Valadi et al., 2007). More recently luciferin-loaded 
exosomes have been reported to induce luciferase activity in luciferase-transfected DCs 
(Montecalvo et al., 2012) and  functional Cre mRNA has been described to be transferred 
by exosomes between hematopoietic cells to neurons leading to loxP excision in target 
cells (Ridder et al., 2014). Altogether, these works demonstrate the functional release of 
exosomal content into the cytosol.  
Exosomes have a similar protein and lipid content to retroviruses, and both use the same 
biogenesis pathway and cell-to-cell transmission mechanisms (Gould et al., 2003; 
Izquierdo-Useros et al., 2009). The finding that HIV can be delivered through the 
virological synapse between infected and uninfected T cells and successfully infects the 
recipient cell (Hubner et al., 2009) thus strengthens the case for exosomal delivery of 
functional cargo via the IS. In this regard, our work using 3’UTR-luciferase vectors to 
sense miRNA activity demonstrates that exosomally-transferred miRNA is functional 
only in IS-mediated cell-cell contacts: isolated exosomes added directly to recipient cells 
do not transfer functional miRNA. We propose that the IS acts as a highly-efficient 
platform that enhances functional, antigen-specific delivery of exosomal cargo to the 
cytosol of the recipient APC. It is however conceivable that in other systems (for example 
with a more phagocytic target) free exosomes might be able to deliver functional cargo. 
The elucidation of the mechanism by which exosomes are taken up by the recipient cell 
awaits conclusive direct live-cell imaging of exosome fusion and will help to explain these 
differences. 
5.1.5 Specific sorting of miRNAs into exosomes  
Complex mechanisms underlie the sorting of cargo into different populations of ILVs that 
in turn will determine their fate. Ubiquitinated proteins require the action of the ESCRT 
machinery to mediate degradative protein sorting (Raiborg and Stenmark, 2009) while 
other cargos such as CD63 and miRNAs are sorted in a ceramide-dependent pathway that 
generates another population of ILVs destined for secretion as exosomes (Kosaka et al., 
2010; Trajkovic et al., 2008). Indeed, our mechanistic studies with chemical inhibitors and 
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nSMase2 siRNA support this fact. Tetraspanins are also implicated in the recruitment of 
transmembrane proteins to exosomes and determine their composition (Chairoungdua et 
al., 2010; Perez-Hernandez et al., 2013). Our data and previous reports (Pegtel et al., 2010; 
Zhang et al., 2010) indicate that not all microRNAs can be incorporated into exosomes, 
and therefore that the packaging of specific miRNA populations into exosomes is 
selective. The mechanisms controlling this sorting are now beginning to be elucidated. 
Since proteins of the RNA-induced silencing complex (RISC) have been detected in 
exosomes (Gibbings et al., 2009), it is feasible that association with RISC components 
controls the packaging of miRNAs in exosomes. Blocking MVB formation by ESCRT 
depletion results in impaired miRNA silencing (Gibbings et al., 2009; Lee et al., 2009), thus 
suggesting that MVBs could be a miRNA crossroad to secretory pathway and gene 
silencing. Following the findings presented in this thesis, our lab also described a novel 
mechanism for the specific sorting of miRNAs inside exosomes. Exosomal miRNAs were 
found to contain specific sequence motifs that control their localization into exosomes. 
The protein heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) binds 
exosomal miRNAs and this binding is controlled by hnRNPA2B1 sumoylation 
(Villarroya-Beltri et al., 2013). Other potential mechanisms for the packaging of specific 
miRNAs in exosomes have been proposed like the 3’ NTA.  Uridylated miRNAs were 
found to be more represented in extracellular vesicles produced by B cell lymphoma cells 
claiming that this type of post-transcriptional modification was sort of a label for miRNAs 
export (Koppers-Lalic et al., 2014). However this mechanism of sorting was not occurring 
in T cells as we will comment on the third section of the thesis (see section 5.3.3 on page 
101).  
5.1.6 Functional delivery of microRNAs to the recipient cell  
Today there is no doubt that microRNAs are important modulators of the immune system 
(O'Connell et al., 2010; Sonkoly et al., 2008; Xiao and Rajewsky, 2009). Modification of 
gene expression in recipient cells by transferred genetic material could account for several 
exosome functions. This exosomal transfer of regulatory RNAs is potentially a powerful 
means of orchestrating gene expression during the generation of the immune response, 
and increases the complexity of communication between cells.  
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Our results show that the transfer of CD63 correlates with the transfer of one microRNA, 
miR-335, from the T cell to the APC being functional in the later. miRNA-335 is especially 
suitable for our technical approach since it is expressed in primary leukocytes, is highly 
enriched in exosomes, and its expression is negligible in Raji B cells. We demonstrate that 
miRNA-335 down-regulates translation of SOX-4 mRNA. This miRNA-335 target gene 
has been reported in breast cancer cells (Tavazoie et al., 2008). In contrast, Raji cells that 
were exposed to isolated exosomes without cellular contact showed no microRNA 
activity, and the exosomal protein signal could be removed by trypsin treatment. It is 
feasible that other exosomal microRNAs can also be transferred during immune synapsis. 
Our data show that levels of miR-92a, another miRNA abundant in exosomes, increase in 
Raji cells after conjugation with T lymphoblasts. However, since this miRNA is 
endogenously expressed by B cells we cannot distinguish between endogenous 
upregulation and horizontal transfer. 
In conclusion, the data obtained in the first section of this thesis establish a highly efficient 
intercellular mechanism for the transfer of regulatory genetic information exclusively in 
the microenvironment of the IS. Unlike other examples of RNA transfer via microvesicles, 
where non-synaptic release potentially allows the exchange of genetic material at a 
distance, our data indicate that during cognate immune interactions there is a 
unidirectional transfer of microRNA from the T to the APC. This genetic communication 
is antigen-driven and appears to be linked to the formation of the IS. The importance of 
exosome release in this process is demonstrated by the correlation of miRNA transfer with 
that of CD63 and by its blockade with inhibitors of exosome production. Our proposed 
model is presented in Figure 5.1 
There are however several issues that will require further investigation. Different 
activation states alter the repertoire of RNAs packaged into the EVs, so it is possible that 
different types of immune cells, for example differentiated T-helper lymphocyte subsets 
(Th1, Th2, Th17 and Treg), might secrete different EV-shuttled RNAs. The physiological 
relevance of protein exchange during IS formation is still unclear depending on the 
biological context, although its occurrence has been widely demonstrated. Some authors 
claim that trogocytosis-mediated uptake of MHC-peptide complexes by T cells might aid 
the selection of high-affinity T cells, or in contrast induce ‘fratricidal’ killing by CTLs. A 
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broader function of this kind of exchange, involving transfer of other molecules, might 
enable cells to acquire molecules (proteins, lipids and RNAs) that they do not synthesize 
themselves. It is very likely that these processes will affect signal transduction, allowing 
intercellular communication to modify the physiology of the recipient cell. The impact of 
the transfer of miRNAs on the function of the recipient cell still needs to be addressed. 
This knowledge will give us a better understanding of how the IS works and of what are 
the consequences of this mode of communication. Detailed understanding of how EVs are 
exchanged between immune cells would permit therapeutic exploitation of these vesicles, 
which are promising vehicles for gene therapy in diseases of the immune system and in 
other scenarios. 
 
 
Figure 5.1 Proposed model for intercellular communication between T cell and APC 
According to our results, exosomes released by T cells after activation can be uptaken by the APC. 
However, only exosomes transferred during the immune synapsis are able to transfer functional 
miRNAs that will in turn modulate the gene expression of the recipient cells. Thus, there is a 
cualitative difference between non-synaptic uptake and immune synapse mediated uptake of 
exosomes bearing miRNAs.  
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5.2 microRNA profile of T cells is regulated during activation 
Different cell types of the immune system show specific expression of defined subsets of 
miRNAs. It has been described that microRNAs changes to very specific profiles after T 
cell activation and Th cell differentiation (Kuchen et al., 2010; Landgraf et al., 2007; 
Monticelli et al., 2005). Our data are in accordance with previous studies on miRNA 
profile changes on T cells after activation and add the finding of the specific changes that 
occur after cognate interaction not only with conventional DCs but with plasmacytoid 
DCs. Moreover, we were able to identify common targets for the miRNAs regulated after 
T cell activation and validate experimentally the relationship between one of the most 
upregulated miRNAs, miR-132-3p, and the common target pik3r1 that resulted to be 
regulated inversely to this miRNA.  
5.2.1 miRNAs changes in T cells are specific of the type of activation  
pDCs are a particular subset of DCs that produces large amounts of type I interferons in 
response to viruses. It is largely accepted that in immature cDCs antigen presentation 
promotes T cell tolerance while after maturation they acquire capacity to induce effector T 
cell responses. However for pDCs it is not simply their activation status what determines 
their ability to promote tolerance or immunity. Activated pDCs function depends more on 
the anatomical localization and cytokine milieu although the precise mechanisms are still 
not  well stablished (Guery and Hugues, 2013). Moreover, pDCs have been related to 
Tregs development as well as the generation of hyporesponsiveness of CD4 T cells (Kang 
et al., 2007; Loschko et al., 2011). It has been described that spleen pDCs induce minimal 
proliferation and no cytokine polarization in antigen specific transgenic T cells that do not 
further proliferate and acquire regulatory activity (Martin et al., 2002). Moreover, bone 
marrow derived pDCs showed a very limited immunogenic capacity although they could 
still induce T cell activation (Mittelbrunn et al., 2009). Accordingly, our data of in vitro co-
culture of mature pDCs with OT-II CD4 T cells, suggest that although the T cells are still 
activated at some extent, pDCs are not as efficient as cDCs or anti CD3 plus anti CD28 
antibodies in activating T cells, at least in terms of CD69 and CD25 expression. Indeed, the 
microRNA profile of the T cells after encounter with pDCs differed substantially from the 
one of T cells activated with cDCs. Unfortunately, validation by qPCR of those miRNAs 
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was not successful. This may be due to a combination of false positives on the arrays like 
the viral miRNA miR-801-v10.1 detected; the lack of good characterization of some rare 
new miRNAs that in turn implies bad qPCRs probes designs (miR-1224); and the low 
expression of these miRNAs in general. Due to these unexpected difficulties we decided 
to focus on the group of miRNAs regulated after the interaction with cDCs that is a well 
characterized immunogenic activation.  
5.2.2 miRNAs regulated after T cell activation have common targets 
Different studies have reported the miRNA profile of CD4 T cells after T cell activation 
with CD3 and CD28 antibodies assessed by different techniques from northenblot to 
microarrays (Bronevetsky et al., 2013; Grigoryev et al., 2011; Jindra et al., 2010; Monticelli 
et al., 2005) However, all these works have in common that T cell activation was 
polyclonal with antibodies that do not resemble a physiological immune interaction and 
thus, bona fide T cell activation. In our study, CD4 T cells from transgenic OT-II mice 
expressing TCR specific for the OVA peptide are cocultured with DCs in presence or 
absence of the peptide in order to analyze their microRNA profile in a more physiological 
scenario that better resemble what is happening in vivo. Differences between the results of 
previous studies and ours might come precisely because of the different approach. For 
example miR-214 was highly upregulated in mouse T cells after 24h of stimulation but we 
do not detect a differential expression of this miRNA (Jindra et al., 2010). Another source 
of difference may reside on different animal models although the degree of conservation 
of miRNAs through different organisms is high, it is not complete. That was nicely 
confirmed by Rossi and coworkers who analyzed previous published data showing that 
only 12 of the miRNAs found in human lymphocytes were expressed in mouse 
lymphocytes but only 6 share expression profiles in human and mouse lymphocytes 
(Rossi et al., 2011). Moreover, especially with microarray data, normalization is 
particularly important. Bronevetsky et al used tRNAs to normalize miRNA microarrays 
(Bronevetsky et al., 2013) but tRNAs are actually unrelated to miRNAs regarding to their 
biogenesis or their turnover. Therefore it is not the most suitable housekeeping gene in 
this case. We used VSN-invariant method (Huber et al., 2002), as this method normalizes 
data with the group of miRNAs that are the most stable among the whole group of 
samples. In our case around 100 miRNAs were considered as “invariants”.  Finally, when 
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we compared our miRNA microarrays data with data we obtained later by next 
generation sequencing from T cells polyclonally activated with anti CD3 and anti CD28, 
we found that in the later the list was indeed increased in number. This is likely due to a 
higher depth of this technique, the different type of activation or the different length of 
incubation time. At any rate, the 75% of miRNAs detected with microarrays to be 
upregulated in T cells after 20 h of the encounter with cDCs-OVA was represented in the 
group of miRNAs detected by deep sequencing to be upregulated after activation with 
anti CD3 and anti CD28 for 48h. No miRNAs were detected to be regulated in the 
opposite direction indicating that data are robust. Finally, the specific kinetics of the 
individual miRNAs must be different as we determined for seven miRNAs by qPCR.  
To establish a relationship between miRNAs and their possible mRNA targets, some 
authors directly compare mRNA expression levels to miRNA expression levels assuming 
that mRNA targets of miRNA will be decreased when the miRNA is upregulated and 
viceversa (Fu et al., 2012; Li et al., 2013). It is noteworthy to highlight that mRNAs are not 
always degraded when targeted by a miRNA so this comparative approach will not be 
detecting every potential interaction. Our choice was instead to analyze the miRNAs 
regulated in the same direction (i.e. upregulated or downregulated) as a whole and look 
for common targets by in silico prediction. By this approach we were not missing any 
potential interaction and the fact that we were able to validate the interaction between 
miR-132 and pik3r1 gene points out that the prediction method was appropriate. Further 
validation of other relationships between the targets on the list and the miRNAs might 
strengthen our analysis.  
5.2.3 miR-132-3p in immunity 
miR-132 shares both its primary transcript and seed sequence with miR-212 in mouse and 
human. However, although they are transcribed together, in some studies one of the two 
miRNAs was found to be more induced than the other. Actually, this was our case since 
we observed a clear upregulation of miR-132 after T cell activation while miR-212 
remained unchanged. Whether this is due to either different stability or a preferential 
processing of one of the miRNAs still needs to be elucidated.  
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miR-132 has been mainly described in the nervous system with only a few recent 
emerging examples in the immune system including the regulation of hematopoietic stem 
cell function (Mehta et al., 2015b). It has been described that miR-132-3p facilitates viral 
infection both in innate immune cells (Lagos et al., 2010) and CD4 T cells (Chiang et al., 
2013) and it  has been recently related to resistance to experimental autoimmune 
encephalomyelitis (EAE) since it induces cholinergic anti-inflammatory system by 
targeting Acetylcholinesterase after ayrl hydrocarbon receptor activation (Hanieh and 
Alzahrani, 2013; Shaked et al., 2009). Mice deficient in the miR132/212 cluster exhibited 
significantly higher resistance to develop EAE and lower Th1 and Th17 cells in draining 
lymph nodes (Nakahama et al., 2013). Overexpression of miR-132 in encephalitogenic 
CD4 T cells decreased cell proliferation (Hanieh and Alzahrani, 2013). Very recently, miR-
132/212 cluster has been implicated in B cell development (Mehta et al., 2015a). However 
none of these works studied the role of miR-132 in naïve CD4 T cell activation. Our data 
indicate that it is upregulated being functional on targeting genes. Loss of function 
experiments will provide insights with the specific function of miR-132 in the context of 
CD4 T cell activation. Altogether, taking into account the available information, we 
hypothesize that miR-132-3p role in T cell activation might be more a cooperative role 
together with the other miRNAs regulated in the process that in turn will finely tune the 
correct T cell activation and T helper cell differentiation.  
5.2.4 Involvement of Pik3r1 in T cell activation 
miR-132-3p was experimentally validated to target pik3r1 gene and in fact, we predicted 
that this mRNAs is targeted by 11 of the 12 miRNAs upregulated after T cell activation. 
Moreover, we detected a downregulation of the gene both at protein and mRNA level 
after different time points of T cell activation. Pik3r1 gene encodes p50a, p55a and p85a, 
regulatory subunits of Class IA phosphatidylinositol 3-kinases (PI3K) that catalyze the 
conversion of phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-
trisphosphate (PIP3) and act downstream of receptors such as TCR and CD28 in T cells.  
The major roles of the regulatory subunits of IA PI3K are to bind and stabilize p110, the 
catalytic subunit (Conley et al., 2012), inhibit p110 kinase activity (Burke et al., 2011), and 
recruit the PI3K complex to phosphotyrosine that in turn will relieve the inhibitory 
contact with the catalytic subunit. The existence of p85a subunit unbound to p110 is still 
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an open question. Hence, the specific loss of p85a (with the  other regulatory subunits 
intact like p50a) inhibited the activation of Akt under conditions promoting the 
differentiation of Th1, Th2 and Th17 cells but only Th17 differentiation was affected 
(Kurebayashi et al., 2012). Recently, it has been described that patients with mutations on 
PIK3R1 undergo lymphoproliferation and exhibit hyperactive PI3K signaling since the 
resulting mutant p85a is expressed in abnormal low levels in the patients (Lucas et al., 
2014). Taking these data into account we hypothesize that pik3r1 is downregulated by 
miRNAs after T cell activation enabling the increase on PI3K signaling. miRNAs gain and 
loss of function experiments where we could study PI3K signaling as well as pik3r1 levels 
would help us to prove our hypothesis.  
5.3 Post-transcriptional modification of miRNAs during T cell activation 
In the third section of this thesis we aimed to study of the regulation of miRNA by post-
transcriptional modifications, i.e. addition of extra nucleotides to the transcribed 
sequence. Our results demonstrate that additions of nucleotides to the 3’ end of the 
miRNAs are functional modifications that impact the stability and turnover of this small 
RNA species. Our data indicate that miRNA uridylation is tightly regulated during T cell 
activation. We further identify TUT4 as the main enzyme responsible for uridylation of 
mature miRNA, and show that the turnover of uridylated microRNAs in T cells differs 
between resting and activated conditions, indicating that this is likely an important 
mechanism controlling the fate and function of miRNAs during T cell activation. 
5.3.1 Uridylated mature miRNA in T cell activation  
The study of miRNA variants or isomiRs is relatively recent and has expanded thank to 
the development of new analyzing techniques like next generation sequencing.  
Originally, there were some concerns about that isomiRs might be simply sequencing 
artefacts. However, “spike in” synthetic RNA oligonucleotide experiments indicated that 
isomiR identification far exceeds error rates (Wyman et al., 2011). 
As mentioned before, uridylation of pre-miRNAs can impact their fate depending on the 
context since it can promote pre-miRNAs degradation (poly-uridylation in stem cells (Heo 
et al., 2009)) or facilitate their processing (mono-uridylation in somatic cells (Heo et al., 
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2012)).  For mature miRNAs the scenario varies also depending on the organism and the 
miRNA studied (Ibrahim et al., 2010; Zhao et al., 2012). The examples studied in mammals 
until now only describe that uridylation specifically reduces the function of miR-26a, miR-
126-5p and miR-379 (Jones et al., 2012; Jones et al., 2009) but this work does not address 
any changes in miRNAs turnover. Our data describe a set of miRNAs that appears 
uridylated in naïve CD4 T cells that specifically decrease after T cells activation. 
Moreover, we demonstrate that uridylation impacts the stability of mature miRNAs in the 
context of T cell activation.  
The 3’UTR of mRNAs are shortened upon T cell activation, which in turn implies an 
inhibition of the regulation of gene expression dependent on miRNA (Sandberg et al., 
2008). Additionally, upon T cell activation, a global downregulation of mature miRNAs 
has been reported using microarray techniques (Bronevetsky et al., 2013). Similar results 
were detected by deep sequencing in our data after normalization. Although miRNA 
uridylation does not alter the levels of canonical mature miRNAs, it is conceivable that 
these changes in post-transcriptional modifications target specificity as well as 
functionality as has been described previously for specific miRNAs (Jones et al., 2009). 
More importantly, according to our results, miRNA stability can be altered also by these 
modifications. This process points to the same direction of the described miRNAs global 
downregulation during T cell activation.  
Our data indicate that not all the miRNAs are uridylated and that the modification is 
restricted to a specific group. Moreover, this group is widely coinciding with the group 
identified as TUT4 targets. We have attempted to find common sequence motives for the 
group of uridylated miRNAs as we did in the past for miRNAs sorted into extracellular 
vesicles (Villarroya-Beltri et al., 2013). Unfortunately, in this case we did not find any 
specific motif represented in the sequence of this group of uridylated miRNAs. However, 
the restriction of the process to a specific group of miRNAs indicates that there must be a 
biological reason for their specific degradation in activated T cells. The contrasting 
degradation of uridylated miRNAs and maintenance of adenylated miRNAs may 
represent an additional mechanism for the cell to eliminate less stable miRNAs that are 
not important or even detrimental for the cell at this specific stage.  
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It is finally worth to mention that due to the strong biological changes that lymphocytes 
undergo during the process of activation, that makes this biological context a specially 
suitable scenario for the study of  miRNA tailing and  turnover regulation were these 
molecular processes acquire their biological relevance. 
5.3.2 Terminal Uridyl transferases in T cells 
We found that there is a paired downregulation of the two TUTases responsible of 
miRNA uridylation, TUT4 and TUT7, concomitant with the decrease in miRNA 
uridylation itself after T cell activation. This fact indicates that degradation of uridylated 
miRNA plays an important role during T cell activation. When TUT4 deficient 
lymphocytes were analysed, we found a clear decrease of uridylated miRNAs compared 
to wild type, Interestingly, adenylated miRNAs are increased in TUT4 deficient cells 
strongly suggesting that miRNA uridylation and adenylation are coordinated processes 
that can compensate each other in steady state. Taking advantage of TUT4 knock out 
mice, we have also been able to identify the miRNA species that are target of TUT4 
uridylation. As mentioned above, TUT4 targets represent a large proportion of the 
uridylated miRNAs that is downregulated upon T cell activation in wild type cells. These 
results suggest that TUT4 controls a specific set of modified miRNAs that will be 
specifically decreased  upon T cell activation. Moreover, we found that there is still a 
proportion of uridylated miRNAs in TUT4 deficient cells. This may reflect the activity of 
TUT7, which can uridylate miRNAs (Thornton et al., 2015) and is still present in the TUT4 
deficient cells. Gain-of-function experiments were technically unfeasible in our system 
due to the difficulty of transfecting naive T cells and transducing such a large plasmid 
with lentivirus, but might have provided interesting additional data.  
TUT4 has been described to be acting together with Lin28 in the processing pathway of 
pre-miRNAs in stem cells (Heo et al., 2009). In somatic cells TUT4, TUT7 or TUT2 were 
described to add only one nucleotide to a pre-miRNAs (Heo et al., 2012). In this case they 
are believe to act alone, however it has not been well explored yet whether in somatic cells 
(that include lymphocytes) TUT4 and TUT7 could be acting in concert with an unknown 
cofactor. Lin28 recognize a specific motif on let-7 precursors terminal loop guiding TUT4 
to oligouridylate this specific family of pre-miRNAs (Heo et al., 2009). Similarly, the 
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potential unidentified TUT4 cofactor in somatic cells could be conferring the specificity for 
its miRNA targets.  
Recently, additional piece of knowledge was obtained by N. Kim’s group where they 
described that mRNA can be uridylated by TUT4 and TUT7 after the shortening of the 
polyA tail of this mRNAs. This way, mRNAs are targeted for degradation. This work 
supports both the function of TUT4 and TUT7 independently of Lin28 or other cofactor 
and the role of uridylation as a molecular mark for RNA decay (Lim et al., 2014). 
Moreover, it might be worth to mention that TUT4 has been described to regulate cell 
cycle progression and proliferation independently of its uridyltransferase activity (Blahna 
et al., 2011). However, the authors of this work do not describe which is the biological 
activity that mediates this function and only characterize the involvement of the N-
terminal region of the protein. 
5.3.3 Alternative mechanisms for the reduction of uridylated miRNAs after T 
cell activation 
Aside degradation into the cell we explored alternative fate for uridylated miRNAs: their 
export to the extracellular medium shuttled by exosomes. As explained in the first section 
of this thesis,  we have described that the repertoire of miRNAs from exosomes secreted 
by T cell lymphocytes differs from their cellular counterpart (Mittelbrunn et al., 2011) and 
that a specific sequence motives determine the sorting of miRNAs inside exosomes 
(Villarroya-Beltri et al., 2013). Moreover, it has been recently stated that uridylated 
miRNAs are more represented in extracellular vesicles produced by B cell lymphoma cells 
(Koppers-Lalic et al., 2014). However, when we assessed the representation of the 
different isomiRs within mouse lymphoblasts and their extracellular vesicles we did not 
detect any 3’ NTA more represented inside extracellular vesicles compared to the 
producing cells (data not shown). This made us to rule out this hypothesis for our system. 
5.3.4 The missing 3’ exonuclease  
A key outstanding question about miRNA decay is the identity of the enzymes that 
catalyze the degradation of these small RNAs during T cell activation. The pathway of 
miRNA catabolism is not very well established yet. Several mammalian exoribonucleases  
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have been described that show certain substrate specificity (Ruegger and Grosshans, 
2012). XRN1 affects the decay of miR-378 and miR-382 (Bail et al., 2010), whereas several 
exome subunits degrade specific miRNAs. For example, PNPT1 (PNPaseold-35) degrades 
miR-221 and RRP41 degrades miR-382 (Bail et al., 2010; Das et al., 2010). Moreover, 
Dsi3L2 has been shown to degrade uridylated pre-miRNAs (Chang et al., 2013), while 
poly(A)-specific ribonuclease (PARN) catalyzes the trimming needed for the final 
maturation step of non-canonical pre-miRNAs (Yoda et al., 2013). Finally, exoribonuclease 
1 (Eri1), an enzyme essential for T lymphocyte development and immunity, has been 
reported to globally target small RNAs in mouse lymphocytes (Thomas et al., 2012). 
Further research will be needed to identify the specific exoribonucleases that mediate the 
specific degradation of uridylated miRNAs observed after T cell activation. Once 
 
Figure 5.2 Diagram of the proposed mechanism of miRNA -transcriptional regulation post
during T cell activation 
Naïve cells under steady state contain basal levels of uridylated miRNAs that are downregulated 
after T cell activation. This decrease is accompanied by the downregulation of uridyltransferases 
TUT4 and TUT7. Additionally we hypothesize that an still unidentified exonuclease might be 
expressed in activated T cells responsible for uridylated miRNAs degradation. 
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identified, we could knock down this exonouclease and study the functional impact of the 
aberrant maintenance of uridylated miRNAs during T cell activation.  
Altogether, data presented in this section indicate that NTA modifications and TUTases 
enzymes are tightly regulated during T cell activation. Figure 5.2 represents our 
hypothesized scenario for 3’NTA of miRNAs during T cell activation. Future studies 
defining the mechanisms and functional significance of miRNA 3’ NTAs will be 
important for understanding the post-transcriptional regulation of miRNA function and 
turnover, and could also inform strategies for therapeutic modulation of miRNA activity. 
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6 CONCLUSIONS 
1. Immune cells secrete exosomes that contain a specific and enriched miRNA 
repertoire that differs from the cell of origin. 
2. MVBs of the T cell translocate towards functional Immune Synapse 
3. T cell exosomes bearing microRNA are transferred during Immune Synapsis to the 
APC. This transfer is unidirectional and functional since acquired microRNAs 
regulate gene expression at the APC. 
4. miRNA repertoire of T cells is modified after cognate interactions with different 
subsets of DCs. miRNAs upregulated after T cell activation have several common 
target genes.  
5. pik3r1 gene is directly regulated by miR-132-3p.   
6. Terminal Uridyltransferases responsible for miRNAs 3’ uridylation, TUT4 and 
TUT7, are downregulated after T cell activation as well as uridylated miRNAs 
being other types of modifications as adenlylation unchanged.  
7. Uridylated microRNAs are degraded more rapidly as compared to its canonical 
counterpart after T cell activation  
8. TUT4 is essential to maintain miRNA uridylation in steady state. Uridylated 
miRNAs are reduced in TUT4 deficient CD4 T cells while adenylated miRNAs are 
increased.  
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7 CONCLUSIONES 
1. Las células inmunes secretan exosomas que contienen un repertorio enriquecido y 
específico de miARNs distinto del de la célula que los ha producido.  
2.  Los cuerpos multivesiculares del linfocito T se translocan hacia la sinapsis 
inmunológica functional  
3.  Los exosomas de las células T que contienen miRNAs se transfieren a la CPA 
durante la sinapsis inmunológica. Esta transferencia es unidireccional y funcional 
ya que los miARNs adquiridos por la CPA son capaces de regular la expresión 
génica en dicha célula receptora.  
4.  El repertorio de miARNs de los linfocitos T se ve modificado después de la 
interacción con distintos tipos de células dentríticas. Los miARNs que aumentan 
su expresión después de la activación de la célula T tienen dianas comunes.  
5.  El gen pik3r1  se regula directamente por el miARN miR-132-3p.   
6. Las uridiltransferasas terminales TUT4 and TUT7 responsables de la uridilación en 
3’ de los miARNs, disminuyen después de la activación del linfocito T. Lo mismo 
ocurre con los miARNs uridilados mientras que los miARNs con otros tipos de 
modificaciones como la adenilación no se modifican. 
7. Los miARNs uridilados se degradan más rápido comparado con su 
correspondiente miARN canónico específicamente después de la activación T.  
8. TUT4 es esencial para mantener el estado de uridilación  de los miARNs en 
estados basales. Los miARNs uriiylados están disminuidos en el los linfocitos CD4 
deficientes en TUT4 mientras que los miARNs adenilados están aumentados. 
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Annex Table 9.1 
Proteins identified in exosome extracts from T lymphoblasts 
Proteins detected in exosomes lysates with at least 2 peptides indentified are presented. 
Accession 
Number 
Protein name # Peptides 
P08575  Leukocyte common antigen 72 
P08133  Annexin A6 43 
P06239  Proto-oncogene tyrosine-protein kinase LCK 38 
P26038  Moesin 38 
Q9H4M9  EH domain-containing protein 1 38 
P14618  Pyruvate kinase isozymes M1/M2 37 
B0I1T2  Myosin-Ig 36 
P15311  Ezrin 32 
P62736  Actin, aortic smooth muscle 32 
Q00610  Clathrin heavy chain 1 27 
P20701  Integrin alpha-L 24 
P11142  Heat shock cognate 71 kDa protein 23 
Q13885  Tubulin beta-2A chain 23 
P00558  Phosphoglycerate kinase 1 22 
P05107  Integrin beta-2 22 
P07355  Annexin A2 22 
P30443  HLA class I histocompatibility antigen, A-1 alpha chain  22 
P46940  Ras GTPase-activating-like protein IQGAP1 22 
P13612  Integrin alpha-4 21 
P06733  Alpha-enolase 20 
P27487  Dipeptidyl peptidase 4 20 
P68104  Elongation factor 1-alpha 1 20 
Q14254  Flotillin-2 20 
Q14764  Major vault protein 20 
Q71U36  Tubulin alpha-1A chain 20 
O14745  Na(+)/H(+) exchange regulatory cofactor NHE-RF1 19 
O75955  Flotillin-1 19 
P04406  Glyceraldehyde-3-phosphate dehydrogenase 19 
P08195  4F2 cell-surface antigen heavy chain 19 
P13796  Plastin-2 19 
P62873  Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit 19 
P01892  HLA class I histocompatibility antigen, A-2 alpha chain  18 
P04899  Guanine nucleotide-binding protein G(i), alpha-2 subunit 18 
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P05362  Intercellular adhesion molecule 1 18 
O00299  Chloride intracellular channel protein 1 17 
P02786  Transferrin receptor protein 1 16 
P62834  Ras-related protein Rap-1A 16 
O14672  Disintegrin and metalloproteinase domain-containing prot 15 
P05023  Sodium/potassium-transporting ATPase subunit alpha-1 15 
P16284  Platelet endothelial cell adhesion molecule 15 
P31946  14-3-3 protein beta/alpha 15 
P84077  ADP-ribosylation factor 1 15 
Q13576  Ras GTPase-activating-like protein IQGAP2 15 
Q15758  Neutral amino acid transporter B(0) 15 
Q86UX7  Fermitin family homolog 3 15 
Q96BY6  Dedicator of cytokinesis protein 10 15 
P06729  T-cell surface antigen CE2 14 
P20963  T-cell surface glycoprotein CE3 zeta chain 14 
P52566  Rho GDP-dissociation inhibitor 2 14 
Q86YV0  RAS protein activator like-3 14 
P08758  Annexin A5 13 
P10114  Ras-related protein Rap-2a 13 
Q6UWD8  Transmembrane protein C16orf54 13 
Q9H4E7  Differentially expressed in FDCP 6 homolog 13 
Q9Y3P8  Signaling threshold-regulating transmembrane adapter 1 13 
P27105  Erythrocyte band 7 integral membrane protein 12 
P43007  Neutral amino acid transporter A 12 
P60709  Actin, cytoplasmic 1 12 
P61586  Transforming protein RhoA 12 
P62136  Serine/threonine-protein phosphatase PP1-alpha catalytic  12 
P63096  Guanine nucleotide-binding protein G(i), alpha-1 subunit 12 
Q9H223  EH domain-containing protein 4 12 
Q9Y490  Talin-1 12 
O95466  Formin-like protein 1 11 
P04075  Fructose-bisphosphate aldolase A 11 
P05556  Integrin beta-1 11 
P07766  T-cell surface glycoprotein CE3 epsilon chain 11 
P16070  CE44 antigen 11 
P26010  Integrin beta-7 11 
P50995  Annexin A11 11 
P62805  Histone H4 11 
P62937  Peptidyl-prolyl cis-trans isomerase A 11 
Q8WUM4  Programmed cell death 6-interacting protein 11 
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Q969P0  Immunoglobulin superfamily member 8 11 
Q99828  Calcium and integrin-binding protein 1 11 
Q9P265  Disco-interacting protein 2 homolog B 11 
P01023  Alpha-2-macroglobulin 10 
P04229  HLA class II histocompatibility antigen, DRB1-1 beta chain 10 
P07737  Profilin-1 10 
P08754  Guanine nucleotide-binding protein G(k) subunit alpha 10 
P09525  Annexin A4 10 
P09693  T-cell surface glycoprotein CE3 gamma chain 10 
P21333  Filamin-A 10 
P33778  Histone H2B type 1-B 10 
P50395  Rab GDP dissociation inhibitor beta 10 
P52907  F-actin-capping protein subunit alpha-1 10 
P84095  Rho-related GTP-binding protein RhoG 10 
Q8TDB8  Solute carrier family 2, facilitated glucose transporter 10 
P01903  HLA class II histocompatibility antigen, DR alpha chain  9 
P04083  Annexin A1 9 
P04234  T-cell surface glycoprotein CE3 delta chain 9 
P06127  T-cell surface glycoprotein CE5 9 
P07195  L-lactate dehydrogenase B chain 9 
P27701  CD82 antigen 9 
P31146  Coronin-1A 9 
P35579  Myosin-9 9 
P42356  Phosphatidylinositol 4-kinase alpha 9 
P61006  Ras-related protein Rab-8A 9 
P62330  ADP-ribosylation factor 6 9 
Q14761  Protein tyrosine phosphatase receptor type C-associated p 9 
Q7L576  Cytoplasmic FMR1-interacting protein 1 9 
Q9BXI6  TBC1 domain family member 10A 9 
O94804  Serine/threonine-protein kinase 10 8 
P01732  T-cell surface glycoprotein CD8 alpha chain 8 
P01889  HLA class I histocompatibility antigen, B-7 alpha chain  8 
P11215  Integrin alpha-M 8 
P18462  HLA class I histocompatibility antigen, A-25 alpha chain  8 
P21580  Tumor necrosis factor, alpha-induced protein 3 8 
P23528  Cofilin-1 8 
P28907  ADP-ribosyl cyclase 1 8 
P42224  Signal transducer and activator of transcription 1-alpha 8 
P51149  Ras-related protein Rab-7a 8 
P54709  Sodium/potassium-transporting ATPase subunit beta-3 8 
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P60174  Triosephosphate isomerase 8 
P60660  Myosin light polypeptide 6 8 
P60953  Cell division control protein 42 homolog 8 
P61158  Actin-related protein 3 8 
P62258  14-3-3 protein epsilon 8 
P63000  Ras-related C3 botulinum toxin substrate 1 8 
P63104  14-3-3 protein zeta/delta 8 
Q15286  Ras-related protein Rab-35 8 
Q8IWA5  Choline transporter-like protein 2 8 
Q96F07  Cytoplasmic FMR1-interacting protein 2 8 
Q9NWQ8  Phosphoprotein associated with glycosphingolipid-enriched 8 
O75083  WD repeat-containing protein 1 7 
O95819  Mitogen-activated protein kinase kinase kinase kinase 4  7 
P02768  Serum albumin 7 
P06744  Glucose-6-phosphate isomerase 7 
P08670  Vimentin 7 
P11233  Ras-related protein Ral-A 7 
P11836  B-lymphocyte antigen CE20 7 
P15153  Ras-related C3 botulinum toxin substrate 2 7 
P16150  Leukosialin 7 
P23381  Tryptophanyl-tRNA synthetase, cytoplasmic 7 
P54652  Heat shock-related 70 kDa protein 2 7 
P61160  Actin-related protein 2 7 
P62070  Ras-related protein R-Ras2 7 
Q5JWF2  Guanine nucleotide-binding protein G(s) subunit alpha is 7 
Q8IU68  Transmembrane channel-like protein 8 7 
Q8N5I2  Arrestin domain-containing protein 1 7 
O00161  Synaptosomal-associated protein 23 6 
O00560  Syntenin-1 6 
P01730  T-cell surface glycoprotein CE4 6 
P01909  HLA class II histocompatibility antigen, DQ alpha 1 chain 6 
P01918  HLA class II histocompatibility antigen, DQ(1) beta chain 6 
P04440  HLA class II histocompatibility antigen, DP beta 1 chain  6 
P09326  CE48 antigen 6 
P11166  Solute carrier family 2, facilitated glucose transporter  6 
P13761  HLA class II histocompatibility antigen, DRB1-7 beta chain 6 
P35613  Basigin 6 
P37802  Transgelin-2 6 
P48960  CD97 antigen 6 
P69905  Hemoglobin subunit alpha 6 
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P78371  T-complex protein 1 subunit beta 6 
Q14156  Protein EFR3 homolog A 6 
Q14242  P-selectin glycoprotein ligand 1 6 
Q9Y4F9  Protein FAM65B 6 
O15144  Actin-related protein 2/3 complex subunit 2 5 
P00338  L-lactate dehydrogenase A chain 5 
P01848  T-cell receptor alpha chain C region 5 
P01850  T-cell receptor beta chain C region 5 
P13639  Elongation factor 2 5 
P23634  Plasma membrane calcium-transporting ATPase 4 5 
P30203  T-cell differentiation antigen CD6 5 
P30447  HLA class I histocompatibility antigen, A-23 alpha chain  5 
P30461  HLA class I histocompatibility antigen, B-13 alpha chain  5 
P32942  Intercellular adhesion molecule 3 5 
P55160  Nck-associated protein 1-like 5 
P61224  Ras-related protein Rap-1b 5 
P61225  Ras-related protein Rap-2b 5 
P62491  Ras-related protein Rab-11A 5 
P62879  Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit 5 
Q06830  Peroxiredoxin-1 5 
Q13077  TNF receptor-associated factor 1 5 
Q14344  Guanine nucleotide-binding protein subunit alpha-13 5 
Q30134  HLA class II histocompatibility antigen, DRB1-8 beta chai 5 
Q58FF7  Putative heat shock protein HSP 90-beta-3 5 
Q7Z403  Transmembrane channel-like protein 6 5 
Q8NG11  Tetraspanin-14 5 
Q96QV6  Histone H2A type 1-A 5 
Q9NUQ9  Protein FAM49B 5 
P00734  Prothrombin 4 
P00738  Haptoglobin 4 
P01024  Complement C3 4 
P05090  Apolipoprotein D 4 
P07437  Tubulin beta chain 4 
P09211  Glutathione S-transferase P 4 
P12259  Coagulation factor V 4 
P12814  Alpha-actinin-1 4 
P13164  Interferon-induced transmembrane protein 1 4 
P14222  Perforin-1 4 
P15880  40S ribosomal protein S2 4 
P16403  Histone H1.2 4 
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P18669  Phosphoglycerate mutase 1 4 
P20073  Annexin A7 4 
P20702  Integrin alpha-X 4 
P22629 STRAV Streptavidin 4 
P30685  HLA class I histocompatibility antigen, B-35 alpha chain  4 
P31949  Protein S100-A11 4 
P32455  Interferon-induced guanylate-binding protein 1 4 
P50991  T-complex protein 1 subunit delta 4 
P59768  Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit 4 
P60033  CD81 antigen 4 
P60842  Eukaryotic initiation factor 4A-I 4 
P61073  C-X-C chemokine receptor type 4 4 
P62158  Calmodulin 4 
P62241  40S ribosomal protein S8 4 
P62249  40S ribosomal protein S16 4 
P62807  Histone H2B type 1-C/E/F/G/I 4 
P62988  Ubiquitin 4 
P68371  Tubulin beta-2C chain 4 
Q01518  Adenylyl cyclase-associated protein 1 4 
Q07020  60S ribosomal protein L18 4 
Q10589  Bone marrow stromal antigen 2 4 
Q12846  Syntaxin-4 4 
Q13291  Signaling lymphocytic activation molecule 4 
Q14699  Raftlin 4 
Q15025  TNFAIP3-interacting protein 1 4 
Q58FF8  Putative heat shock protein HSP 90-beta 2 4 
Q9BYT8  Neurolysin, mitochondrial 4 
Q9H3M7  Thioredoxin-interacting protein 4 
Q9H4B7  Tubulin beta-1 chain 4 
Q9HBH0  Rho-related GTP-binding protein RhoF 4 
O00159  Myosin-Ic 3 
O00231  26S proteasome non-ATPase regulatory subunit 11 3 
O43143  Putative pre-mRNA-splicing factor ATP-dependent RNA heli 3 
O75131  Copine-3 3 
O75340  Programmed cell death protein 6 3 
O75427 
 Leucine-rich repeat and calponin homology domain-
contain 
3 
P01008  Antithrombin-III 3 
P01112  GTPase HRas 3 
P02765  Alpha-2-HS-glycoprotein 3 
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P04233  HLA class II histocompatibility antigen gamma chain 3 
P04908  Histone H2A type 1-B/E 3 
P06241  Proto-oncogene tyrosine-protein kinase Fyn 3 
P07900  Heat shock protein HSP 90-alpha 3 
P08238  Heat shock protein HSP 90-beta 3 
P09972  Fructose-bisphosphate aldolase C 3 
P11049  Leukocyte antigen CE37 3 
P11171  Protein 4.1 3 
P11234  Ras-related protein Ral-B 3 
P16401  Histone H1.5 3 
P18124  60S ribosomal protein L7 3 
P19397  Leukocyte surface antigen CE53 3 
P19440  Gamma-glutamyltranspeptidase 1 3 
P20020  Plasma membrane calcium-transporting ATPase 1 3 
P20036  HLA class II histocompatibility antigen, DP alpha 1 chain 3 
P20039  HLA class II histocompatibility antigen, DRB1-11 beta chain 3 
P21980  Protein-glutamine gamma-glutamyltransferase 2 3 
P22749  Granulysin 3 
P27348  14-3-3 protein theta 3 
P29350  Tyrosine-protein phosphatase non-receptor type 6 3 
P29965  CE40 ligand 3 
P30460  HLA class I histocompatibility antigen, B-8 alpha chain  3 
P30481  HLA class I histocompatibility antigen, B-44 alpha chain  3 
P30740  Leukocyte elastase inhibitor 3 
P36578  60S ribosomal protein L4 3 
P39023  60S ribosomal protein L3 3 
P41240  Tyrosine-protein kinase CSK 3 
P46776  60S ribosomal protein L27a 3 
P46781  40S ribosomal protein S9 3 
P50914  60S ribosomal protein L14 3 
P52333  Tyrosine-protein kinase JAK3 3 
P57075  Ubiquitin-associated and SH3 domain-containing protein A 3 
P61769  Beta-2-microglobulin 3 
P62847  40S ribosomal protein S24 3 
P78527  DNA-dependent protein kinase catalytic subunit 3 
P80723  Brain acid soluble protein 1 3 
P81605  Dermcidin 3 
Q04917  14-3-3 protein eta 3 
Q08431  Lactadherin 3 
Q15833  Syntaxin-binding protein 2 3 
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Q58FG0  Putative heat shock protein HSP 90-alpha A5 3 
Q86X29  Lipolysis-stimulated lipoprotein receptor 3 
Q92930  Ras-related protein Rab-8B 3 
Q96TA1  Niban-like protein 1 3 
Q9C0H2  Protein tweety homolog 3 3 
Q9H2G2  STE20-like serine/threonine-protein kinase 3 
Q9H4G4  Golgi-associated plant pathogenesis-related protein 1 3 
Q9H665  Transmembrane protein 149 3 
Q9NR48  Probable histone-lysine N-methyltransferase ASH1L 3 
Q9NRY6  Phospholipid scramblase 3 3 
Q9NZA1  Chloride intracellular channel protein 5 3 
Q9P289  Serine/threonine-protein kinase MST4 3 
Q9UI08  Ena/VASP-like protein 3 
O15162  Phospholipid scramblase 1 2 
O15260  Surfeit locus protein 4 2 
O43491  Band 4.1-like protein 2 2 
O43561  Linker for activation of T-cells family member 1 2 
O60361  Putative nucleoside diphosphate kinase 2 
O60488  Long-chain-fatty-acid--CoA ligase 4 2 
O60880  SH2 domain-containing protein 1A 2 
O75044  SLIT-ROBO Rho GTPase-activating protein 2 2 
O75531  Barrier-to-autointegration factor 2 
P00491  Purine nucleoside phosphorylase 2 
P00739  Haptoglobin-related protein 2 
P01111  GTPase NRas 2 
P01906  HLA class II histocompatibility antigen, DQ alpha 2 chain 2 
P01911  HLA class II histocompatibility antigen, DRB1-15 beta chain 2 
P01919 
 HLA class II histocompatibility antigen, DQ(W1.1) beta 
chain 
2 
P02771  Alpha-fetoprotein 2 
P02788  Lactotransferrin 2 
P02792  Ferritin light chain 2 
P04080  Cystatin-B 2 
P05109  Protein S100-A8 2 
P05164  Myeloperoxidase 2 
P05534  HLA class I histocompatibility antigen, A-24 alpha chain  2 
P05537  HLA class II histocompatibility antigen, DQ(W3) beta chain 2 
P05543  Thyroxine-binding globulin 2 
P06396  Gelsolin 2 
P06702  Protein S100-A9 2 
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P08648  Integrin alpha-5 2 
P08697  Alpha-2-antiplasmin 2 
P08962  CD63 antigen 2 
P09382  Galectin-1 2 
P09543  2',3'-cyclic-nucleotide 3'-phosphodiesterase 2 
P10599  Thioredoxin 2 
P11021  78 kDa glucose-regulated protein 2 
P13987  CE59 glycoprotein 2 
P14649  Myosin light chain 6B 2 
P15144  Aminopeptidase N 2 
P18433  Receptor-type tyrosine-protein phosphatase alpha 2 
P19971  Thymidine phosphorylase 2 
P20333  Tumor necrosis factor receptor superfamily member 1B 2 
P20339  Ras-related protein Rab-5A 2 
P23284  Peptidyl-prolyl cis-trans isomerase B 2 
P25311  Zinc-alpha-2-glycoprotein 2 
P25445  Tumor necrosis factor receptor superfamily member 6 2 
P25787  Proteasome subunit alpha type-2 2 
P29966  Myristoylated alanine-rich C-kinase substrate 2 
P30153 
 Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory 
2 
P30462  HLA class I histocompatibility antigen, B-14 alpha chain  2 
P30501  HLA class I histocompatibility antigen, Cw-2 alpha chain  2 
P30626  Sorcin 2 
P31150  Rab GDP dissociation inhibitor alpha 2 
P32119  Peroxiredoxin-2 2 
P35241  Radixin 2 
P40121  Macrophage-capping protein 2 
P40227  T-complex protein 1 subunit zeta 2 
P43403  Tyrosine-protein kinase ZAP-70 2 
P46939  Utrophin 2 
P47756  F-actin-capping protein subunit beta 2 
P48643  T-complex protein 1 subunit epsilon 2 
P49327  Fatty acid synthase 2 
P50552  Vasodilator-stimulated phosphoprotein 2 
P51148  Ras-related protein Rab-5C 2 
P52565  Rho GDP-dissociation inhibitor 1 2 
P53985  Monocarboxylate transporter 1 2 
P53990  IST1 homolog 2 
P59998  Actin-related protein 2/3 complex subunit 4 2 
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P61020  Ras-related protein Rab-5B 2 
P61026  Ras-related protein Rab-10 2 
P61978  Heterogeneous nuclear ribonucleoprotein K 2 
P61981  14-3-3 protein gamma 2 
P62424  60S ribosomal protein L7a 2 
P68363  Tubulin alpha-1B chain 2 
P68871  Hemoglobin subunit beta 2 
Q02878  60S ribosomal protein L6 2 
Q06323  Proteasome activator complex subunit 1 2 
Q08722  Leukocyte surface antigen CE47 2 
Q13200  26S proteasome non-ATPase regulatory subunit 2 2 
Q13277  Syntaxin-3 2 
Q14019  Coactosin-like protein 2 
Q14160  Protein scribble homolog 2 
Q14847  LIM and SH3 domain protein 1 2 
Q15283  Ras GTPase-activating protein 2 2 
Q15762  CE226 antigen 2 
Q16695  Histone H3.1t 2 
Q53GL0  Pleckstrin homology domain-containing family O member 1  2 
Q58EX2  Protein sidekick-2 2 
Q6P2Q9  Pre-mRNA-processing-splicing factor 8 2 
Q71UI9  Histone H2A.V 2 
Q86VP6  Cullin-associated NEDD8-dissociated protein 1 2 
Q8N4C8  Misshapen-like kinase 1 2 
Q8NF50  Dedicator of cytokinesis protein 8 2 
Q8NHW5  60S acidic ribosomal protein P0-like 2 
Q8WV92  MIT domain-containing protein 1 2 
Q92542  Nicastrin 2 
Q92598  Heat shock protein 105 kDa 2 
Q95365  HLA class I histocompatibility antigen, B-38 alpha chain  2 
Q96A08  Histone H2B type 1-A 2 
Q96DU3  SLAM family member 6 2 
Q9BSJ8  Extended synaptotagmin-1 2 
Q9BYX7  Beta-actin-like protein 3 2 
Q9BZ29  Dedicator of cytokinesis protein 9 2 
Q9H400  Lck-interacting transmembrane adapter 1 2 
Q9UJT0  Tubulin epsilon chain 2 
Q9ULT0  Tetratricopeptide repeat protein 7A 2 
Q9Y265  RuvB-like 1 2 
Q9Y376  Calcium-binding protein 39 2 
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Q9Y3L5  Ras-related protein Rap-2c 2 
Q9Y6W5  Wiskott-Aldrich syndrome protein family member 2 2 
Q9Y6W8  Inducible T-cell costimulator 2 
 
 
Annex Table 9.2 
Microarray analysis of exosomal miRNAs vs the miRNAs of their respective donor cells. miRNAs 
differentially represented in exosomes compared with their respective parental cells are shown. In 
each file, the columns represent: ProbeID; logFC= log Fold Change; A: average expression of the 
miRNA across all samples; P-value from the moderated t-test; Adjpvalue from the moderated t-
test. 
 
SUMMARY     
DEG DCs Cells vs Ex J Cells vs Ex R Cells vs Ex Cells_J vs R J Ex vs R Cell 
Up 140 148 21 54 88 
Down 8 89 47 29 105 
 
 
DCs Cells vs Exosomes    
Probe logFC A pvalue adjpvalue 
hsa-miR-335 -12.0756 -0.95529 6.63E-10 2.97E-07 
hsa-miR-760 -4.36396 2.490711 0.002414 0.010181 
hsa-miR-630 -4.2164 7.597597 0.008613 0.027434 
hsa-miR-632 -3.61822 0.599001 0.002437 0.010181 
hsa-miR-654-5p -3.02642 3.7374 0.008465 0.027223 
hsa-miR-671-5p -2.96257 3.809781 0.012867 0.039667 
hcmv-miR-US4 -2.94002 2.537085 0.001953 0.00873 
kshv-miR-K12-3 -2.67215 7.030808 0.006267 0.021119 
hsa-miR-505 1.99294 3.278082 0.006284 0.021119 
hsa-miR-326 2.316675 0.911044 0.002123 0.009304 
hsa-miR-769-5p 2.369604 2.928335 0.006441 0.021169 
hsa-miR-199b-5p 2.369803 1.297736 0.003591 0.013838 
hsa-miR-502-5p 2.395754 1.218676 0.002381 0.010136 
hsa-miR-551b 2.443113 1.146242 0.005615 0.019609 
hsa-miR-92a 2.647713 7.888559 0.005029 0.017985 
hsa-miR-221* 2.666148 0.780369 0.006207 0.021119 
hsa-miR-223* 2.697283 -0.20081 0.011054 0.034554 
hsa-miR-892b 2.767039 3.400897 0.006488 0.021169 
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hsa-miR-186 2.804144 4.096928 0.005309 0.018836 
kshv-miR-K12-12 2.821377 0.498928 0.013499 0.041329 
hsa-miR-542-5p 2.870363 2.439135 0.013974 0.042493 
hsa-let-7i* 2.941409 0.37316 0.006353 0.021169 
hsa-miR-188-3p 2.949323 -1.11087 0.010288 0.032384 
hsa-miR-155 3.042164 6.39405 0.01241 0.038523 
hsa-miR-324-3p 3.050461 6.555508 0.008654 0.027434 
hsa-miR-340* 3.102608 2.002909 0.001542 0.007331 
hsa-miR-132* 3.282246 0.940431 0.000563 0.003267 
hsa-miR-148a 3.437728 5.479736 0.003689 0.014092 
hsa-miR-450a 3.505534 1.522633 0.00017 0.001621 
hsa-miR-361-3p 3.54784 2.411733 0.001173 0.0057 
hsa-miR-363 3.57258 3.132228 0.003887 0.014605 
hsa-miR-501-3p 3.659003 0.677307 0.016548 0.049978 
hsa-miR-25 3.722619 7.128739 0.000979 0.00503 
hsa-miR-195 3.739732 1.98425 0.000665 0.003762 
hsa-miR-132 3.766694 2.179877 0.00298 0.011789 
hsa-miR-500* 3.811061 2.523807 0.000663 0.003762 
hsa-miR-181b 3.823066 4.408795 0.00238 0.010136 
hsa-miR-22* 3.829635 0.556572 0.001013 0.005145 
hsa-miR-342-3p 3.997499 6.228904 0.005895 0.02027 
hsa-miR-128 3.997814 4.50142 0.002732 0.011308 
hsa-miR-221 4.040188 3.755918 0.000132 0.001552 
hsa-miR-342-5p 4.047348 2.278087 0.002927 0.011681 
hsa-miR-181a 4.048904 6.633956 0.002889 0.011681 
hsa-miR-18b 4.087797 4.354533 0.004956 0.017864 
hsa-miR-130b 4.090896 5.623911 0.001763 0.008101 
hsa-miR-193b 4.11264 4.68102 0.000222 0.001807 
hsa-miR-362-3p 4.139051 1.577961 8.65E-05 0.001248 
hsa-miR-886-3p 4.176504 2.104636 0.000284 0.002116 
hsa-miR-361-5p 4.231149 4.611954 0.000246 0.001931 
hsa-miR-30a 4.246496 1.314469 0.000521 0.003137 
hsa-miR-223 4.247999 6.524582 0.000203 0.001745 
hsa-miR-331-3p 4.289376 5.767948 0.00018 0.001675 
hsa-miR-564 4.296045 2.565284 0.003888 0.014605 
hsa-miR-425 4.333441 6.216363 0.001159 0.005693 
hsa-miR-100 4.336212 0.796681 0.002208 0.00958 
hsa-miR-125b 4.337546 2.884451 0.001598 0.007521 
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hsa-miR-502-3p 4.51077 1.453375 0.001774 0.008101 
hsa-miR-93 4.511776 6.651276 0.00026 0.002003 
hsa-let-7b 4.51446 6.372928 0.001482 0.007122 
hsa-miR-23b 4.522701 4.232274 7.08E-05 0.001173 
hsa-miR-181c 4.538496 1.041504 0.004436 0.016255 
hsa-miR-590-5p 4.542851 4.424362 0.000368 0.002456 
hsa-miR-330-3p 4.559807 1.68355 0.000196 0.001745 
hsa-miR-30c 4.625263 5.281099 8.18E-05 0.001219 
hsa-miR-378 4.629269 5.655411 0.000717 0.00391 
hsa-miR-345 4.649667 1.488388 0.005737 0.01988 
hsa-miR-139-3p 4.669857 -0.254 0.005567 0.019594 
hsa-miR-146a 4.71275 5.349883 0.00355 0.013799 
hsa-miR-18a 4.808042 5.439979 0.002801 0.011487 
hsa-miR-23a 4.814407 5.39411 0.000108 0.001354 
hsa-miR-28-3p 4.858821 0.514537 0.004886 0.017755 
hsa-miR-30b 4.864099 6.057354 9.40E-05 0.001273 
hsa-miR-32 4.917479 2.183182 0.000677 0.00378 
hsa-miR-301a 4.969014 4.364936 0.000913 0.004803 
hsa-miR-22 4.986587 5.994069 0.000235 0.001872 
hsa-miR-542-3p 5.00366 0.032834 0.004238 0.015786 
hsa-miR-34b* 5.018456 0.240663 0.000489 0.003038 
hsa-miR-103 5.063557 7.886716 0.0003 0.00217 
hsa-miR-17 5.068094 7.850754 0.000216 0.001807 
hsa-let-7c 5.082043 4.899644 0.00051 0.003123 
hsa-miR-16 5.123376 9.236763 0.000446 0.002892 
hsa-miR-20a 5.149536 8.596518 0.000153 0.001588 
hsa-miR-15b 5.15992 7.80479 0.000129 0.001552 
hsa-miR-27b 5.200296 4.645793 3.35E-05 0.000832 
hsa-miR-532-3p 5.209571 0.658134 9.04E-06 0.000422 
hsa-miR-107 5.249441 7.648953 0.000416 0.002737 
hsa-miR-140-3p 5.254607 4.521609 0.000271 0.002052 
hsa-let-7d 5.307949 6.646928 0.000168 0.001621 
hsa-miR-28-5p 5.39533 3.456186 0.000536 0.003152 
hsa-miR-152 5.397609 0.511274 0.003466 0.013592 
hsa-miR-222 5.403254 2.034864 0.001794 0.008101 
hsa-miR-24 5.407399 5.455675 6.17E-05 0.001103 
hsa-miR-26b 5.443177 5.99802 0.000146 0.001581 
hsa-miR-30e* 5.44797 3.212352 0.000201 0.001745 
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hsa-miR-532-5p 5.495909 1.678208 0.000331 0.002277 
hsa-miR-146b-5p 5.501737 2.814973 1.02E-05 0.000422 
hsa-miR-503 5.510063 -0.02112 0.000476 0.003 
hsa-miR-339-3p 5.510554 0.977504 0.000319 0.002237 
hsa-miR-424 5.541397 3.14083 0.000169 0.001621 
hsa-let-7e 5.560933 0.518388 0.002088 0.009242 
hsa-let-7a 5.581678 8.193576 0.000195 0.001745 
hsa-miR-26a 5.588987 6.114013 0.000222 0.001807 
hsa-miR-98 5.608458 4.161263 0.000156 0.001589 
hsa-miR-338-3p 5.636554 0.827574 9.11E-07 0.000136 
hsa-miR-500 5.644595 2.958047 2.74E-05 0.00072 
hsa-miR-33a 5.660906 2.52445 0.006488 0.021169 
hsa-miR-374b 5.666651 3.398956 0.000708 0.003905 
hsa-miR-99a 5.749345 2.224874 7.88E-05 0.001214 
hsa-miR-130a 5.77136 0.506265 0.004416 0.016255 
hsa-let-7i 5.773538 6.904096 9.20E-05 0.001273 
hsa-miR-19b 5.77444 8.995531 0.000526 0.003137 
hsa-miR-30e 5.786303 5.906367 0.000728 0.003921 
hsa-miR-19a 5.797445 7.72209 0.00032 0.002237 
hsa-miR-21 5.806479 10.42407 9.92E-05 0.001304 
hsa-miR-141 5.815741 1.303714 9.14E-06 0.000422 
hsa-miR-29a 5.872355 7.206803 1.64E-05 0.000489 
hsa-miR-362-5p 5.876292 0.840336 0.006545 0.021202 
hsa-miR-140-5p 5.903781 4.627514 1.59E-05 0.000489 
hsa-miR-34a 5.929041 2.422767 4.11E-05 0.000905 
hsa-let-7f 5.969023 8.488932 0.000109 0.001354 
hsa-miR-151-3p 5.971591 2.560655 1.39E-05 0.000479 
hsa-miR-454 6.022069 2.023527 0.000907 0.004803 
hsa-miR-29c 6.026364 7.039184 0.000143 0.001581 
hsa-miR-494 6.063026 6.488467 0.001107 0.005496 
hsa-miR-15a 6.081912 7.401147 6.72E-05 0.001155 
hsa-miR-142-5p 6.166791 6.631964 0.000469 0.002996 
hsa-miR-27a 6.170025 4.496759 4.25E-05 0.000905 
hsa-miR-374a 6.239875 4.185961 0.000354 0.002398 
hsa-miR-660 6.259716 2.08946 1.35E-06 0.000151 
hsa-miR-193a-3p 6.29447 1.559961 0.00014 0.001581 
hsa-miR-185 6.294521 3.543762 0.001794 0.008101 
hsa-let-7g 6.326692 7.436612 6.13E-05 0.001103 
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hsa-miR-652 6.361945 2.061111 5.77E-05 0.001103 
hsa-miR-151-5p 6.381351 3.967527 4.71E-06 0.000316 
hsa-miR-20b 6.442932 6.744308 1.33E-05 0.000479 
hsa-miR-744 6.58519 1.344977 0.002917 0.011681 
hsa-miR-29b 6.65758 7.15443 2.58E-05 0.00072 
ebv-miR-BART19-3p 6.724201 2.68927 0.000961 0.004997 
hsa-miR-106b 6.986247 7.155615 0.000149 0.001581 
hsa-miR-378* 7.057995 2.117641 2.00E-06 0.000179 
hsa-miR-324-5p 7.062603 4.037968 1.04E-05 0.000422 
hsa-miR-101 7.302425 4.280864 0.000301 0.00217 
hsa-miR-210 7.347209 6.236888 4.79E-05 0.000974 
hsa-miR-340 7.440852 0.979883 0.00105 0.005274 
hsa-miR-21* 7.575147 2.993364 4.95E-06 0.000316 
hsa-miR-17* 7.673531 3.830187 7.85E-05 0.001214 
hsa-miR-142-3p 7.77528 9.278608 3.54E-05 0.000832 
hsa-miR-148b 7.881156 2.971673 6.91E-07 0.000136 
 
J77  Cells vs Exosomes    
Probe logFC A pvalue adjpvalue 
hsa-miR-422a -6.715 2.179435 3.12E-05 0.000887 
hsa-miR-193a-5p -6.3524 1.586369 0.00088 0.003846 
hsa-miR-936 -6.34831 -0.09782 3.05E-05 0.000887 
hsa-miR-193b* -6.18078 1.850504 0.000833 0.003699 
hsa-miR-198 -5.83439 1.648131 0.000146 0.00152 
kshv-miR-K12-3 -5.65175 7.030808 1.27E-06 0.000285 
hsa-miR-451 -5.62282 4.004414 1.16E-06 0.000285 
hsa-miR-921 -5.54841 0.242427 0.009487 0.022088 
hsa-miR-654-5p -5.52022 3.7374 1.02E-05 0.000887 
hsv1-miR-H1 -5.44706 1.665387 0.002902 0.009332 
hsa-miR-510 -5.31121 -0.97687 0.000936 0.003878 
hsa-miR-483-5p -5.2542 4.840386 2.94E-05 0.000887 
hsa-miR-150* -5.00425 3.911789 0.001286 0.005044 
hsa-miR-452 -4.95942 -0.72503 0.024306 0.046629 
kshv-miR-K12-7 -4.93412 -0.97239 0.000302 0.002177 
hsa-miR-125b-1* -4.91826 0.987357 0.011424 0.025281 
hcmv-miR-US25-2-5p -4.91436 1.669543 0.007643 0.018568 
hsa-miR-373* -4.90393 -0.19265 4.20E-05 0.000887 
hsa-miR-149* -4.89735 0.431632 0.000503 0.002882 
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hsa-miR-200a* -4.86985 0.015043 0.000148 0.00152 
hsa-miR-513a-5p -4.80981 4.377892 0.000536 0.002886 
hsa-miR-575 -4.69112 7.827253 0.010111 0.022941 
hsa-miR-125a-3p -4.68497 5.0213 0.006589 0.016926 
hsa-miR-632 -4.68246 0.599001 4.56E-05 0.000887 
hsa-miR-1224-5p -4.60459 3.435022 0.000643 0.003201 
hsa-miR-490-5p -4.5977 0.099988 3.71E-05 0.000887 
hsa-miR-188-5p -4.56884 5.340045 0.000454 0.002635 
hcmv-miR-US4 -4.52692 2.537085 5.88E-06 0.000657 
hsa-miR-370 -4.51006 -0.16016 0.004572 0.012935 
hsa-miR-765 -4.50633 2.7042 0.000709 0.003335 
hsa-miR-1226* -4.43468 1.97751 0.000432 0.002538 
hsa-miR-610 -4.41785 1.635868 0.000291 0.002165 
hsa-miR-877 -4.35834 1.275374 0.00648 0.016744 
hsa-miR-424* -4.29388 1.055555 0.022776 0.044265 
hsa-miR-887 -4.26695 2.018044 3.79E-05 0.000887 
hsa-miR-584 -4.22102 2.201837 1.83E-05 0.000887 
hsa-miR-760 -4.2105 2.490711 0.000609 0.003131 
hsa-miR-601 -4.19247 2.468441 0.000343 0.002325 
hsa-miR-125b-2* -4.1664 1.64737 0.000193 0.001797 
hsa-miR-513b -4.16116 2.783108 0.000662 0.003215 
hsa-miR-662 -4.11234 1.737444 1.76E-05 0.000887 
hsa-miR-28-3p -4.07604 0.514537 0.003719 0.011309 
hsa-miR-518e* -4.04984 -0.51745 0.005424 0.014695 
hsa-miR-99b* -3.95424 0.815586 0.021807 0.042753 
hsa-miR-638 -3.86994 7.327502 0.003751 0.011329 
hsa-miR-671-5p -3.80161 3.809781 0.000526 0.002886 
hsa-miR-520e -3.79614 1.563527 0.000365 0.002417 
hiv1-miR-H1 -3.73346 1.944811 0.01152 0.025367 
hsa-miR-617 -3.71381 2.197965 0.002662 0.008681 
ebv-miR-BART19-3p -3.63361 2.68927 0.01338 0.028893 
hsa-miR-513c -3.63153 2.107752 0.000296 0.002165 
hsa-miR-10b* -3.62337 0.814464 0.018978 0.037872 
hsa-miR-135a* -3.61625 3.760621 0.006236 0.016397 
hsa-miR-1225-5p -3.61307 7.167043 0.005731 0.015249 
hsa-miR-498 -3.59555 0.968832 0.00063 0.003198 
hsa-miR-630 -3.56148 7.597597 0.006429 0.016708 
ebv-miR-BART14 -3.54465 0.22025 0.002663 0.008681 
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hsa-miR-200b* -3.45914 -0.89685 0.015848 0.032495 
hsa-miR-557 -3.4179 1.865727 0.025226 0.048188 
hsa-miR-520b -3.41197 1.73105 0.009982 0.022882 
hsa-miR-134 -3.39363 3.710506 0.015404 0.031878 
hsa-miR-453 -3.34113 -0.74515 0.00702 0.01752 
hsa-miR-518c* -3.3333 0.851379 0.006668 0.017033 
ebv-miR-BART7 -3.32684 0.742811 0.001303 0.005066 
hsa-miR-491-5p -3.22655 -0.50783 0.005329 0.014614 
hsa-miR-382 -3.18177 0.340161 0.007013 0.01752 
hsa-miR-583 -3.15857 0.711317 0.007094 0.01752 
hsa-miR-339-3p -3.1552 0.977504 0.004192 0.012248 
hsa-miR-874 -3.09928 4.698323 0.011357 0.025257 
hsa-miR-516b -2.93605 -0.63473 0.021161 0.041853 
hsa-miR-518f -2.93233 -0.30978 0.008215 0.019637 
hsa-miR-622 -2.87693 1.614827 0.004448 0.012779 
kshv-miR-K12-8 -2.84093 -0.29682 0.013107 0.02844 
hsa-miR-513a-3p -2.8323 0.780434 0.008369 0.0199 
hcmv-miR-UL36 -2.77984 0.320012 0.007068 0.01752 
hsa-miR-141* -2.67343 -0.79115 0.00508 0.014016 
hsa-miR-492 -2.65829 0.457549 0.007766 0.018763 
hsa-miR-129-5p -2.58269 -0.11327 0.010559 0.023718 
hsa-miR-30c-2* -2.56741 0.321023 0.002161 0.007545 
hsa-miR-486-5p -2.49626 1.749489 0.004809 0.013351 
hsa-miR-631 -2.46885 1.865422 0.003972 0.01179 
hsa-miR-184 -2.38128 0.20812 0.015306 0.031821 
hsa-miR-145 -2.26583 0.960143 0.016825 0.034341 
hsa-miR-769-3p -2.15956 1.088625 0.009031 0.021359 
hsa-miR-628-5p -2.15472 1.069156 0.014778 0.031158 
hsa-miR-10b -1.85925 0.51196 0.003138 0.009949 
ebv-miR-BHRF1-1 -1.75942 2.97448 0.018517 0.037117 
hsa-miR-518d-3p -1.7254 0.079174 0.019962 0.039657 
hsa-let-7d* -1.33814 1.82913 0.015195 0.03174 
hsa-miR-505 1.485509 3.278082 0.009931 0.022882 
hsa-miR-197 1.659617 5.203971 0.009392 0.021981 
hsa-miR-93* 1.667247 0.672559 0.007946 0.019096 
hsa-miR-502-5p 1.745284 1.218676 0.004673 0.013073 
hsa-miR-548d-5p 1.748357 1.145468 0.02275 0.044265 
hsa-miR-548c-5p 1.776163 1.382284 0.026223 0.049669 
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hsa-miR-199b-5p 1.785141 1.297736 0.005524 0.014875 
hsa-miR-221* 1.794714 0.780369 0.01714 0.034826 
hsa-miR-770-5p 1.794742 3.077351 0.023943 0.046131 
hsa-miR-484 1.808492 3.818109 0.001349 0.005198 
hsa-miR-151-3p 1.841954 2.560655 0.021369 0.042079 
hsa-miR-186 1.922338 4.096928 0.013644 0.029321 
hsa-miR-744* 1.946595 1.917892 0.015768 0.032482 
hsa-miR-361-3p 2.008106 2.411733 0.011953 0.026063 
hsa-miR-22 2.042326 5.994069 0.023102 0.044703 
hsa-miR-92a 2.083366 7.888559 0.005799 0.015339 
hsa-miR-23a 2.086582 5.39411 0.010916 0.024398 
hsa-miR-449a 2.09259 0.810515 0.010404 0.023487 
hsa-miR-548a-5p 2.100562 0.428327 0.017947 0.036136 
hsa-miR-192 2.205406 3.142452 0.003307 0.010336 
hsa-miR-450a 2.207824 1.522633 0.001286 0.005044 
hsa-miR-148a* 2.266968 -0.79829 0.014911 0.031292 
hsa-miR-624* 2.270253 0.807887 0.006798 0.017264 
hsa-miR-324-3p 2.391106 6.555508 0.010082 0.022941 
hsa-miR-378 2.39641 5.655411 0.013806 0.029527 
hsa-miR-146b-5p 2.519216 2.814973 0.001545 0.005754 
hsa-miR-219-5p 2.532555 2.050207 0.000836 0.003699 
hsa-miR-221 2.577099 3.755918 0.000937 0.003878 
hsa-miR-16-2* 2.59845 2.100713 0.000579 0.003043 
hsa-miR-340* 2.606594 2.002909 0.001114 0.004446 
hsa-miR-29c* 2.621287 2.767852 0.003062 0.009777 
hsa-miR-195 2.636029 1.98425 0.001836 0.006618 
hsa-miR-25 2.650268 7.128739 0.002428 0.008221 
hsa-miR-550* 2.655955 1.665154 0.000368 0.002417 
hsa-miR-15b* 2.702458 1.203659 0.001039 0.004185 
hsa-miR-23b 2.704576 4.232274 0.000915 0.003862 
hsa-miR-15a* 2.745492 1.058576 0.000142 0.00152 
hsa-miR-24 2.767254 5.455675 0.002601 0.008613 
hsa-miR-193b 2.789989 4.68102 0.000916 0.003862 
hsa-miR-660 2.806678 2.08946 0.000402 0.002538 
hsa-miR-181d 2.808829 2.529472 0.006989 0.01752 
hsa-miR-194 2.82154 1.459043 0.009807 0.022714 
hsa-miR-188-3p 2.82359 -1.11087 0.003489 0.010755 
hsa-miR-128 2.835244 4.50142 0.006274 0.0164 
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hsa-miR-150 2.835626 2.916366 0.004341 0.012602 
hsa-miR-132 2.844915 2.179877 0.004555 0.012935 
hsa-miR-342-3p 2.861857 6.228904 0.011776 0.025803 
hsa-miR-106a* 2.868669 0.350731 0.001451 0.005497 
hsa-miR-196a 2.878518 1.814899 0.001013 0.004118 
hsa-miR-532-5p 2.892581 1.678208 0.007341 0.01793 
hsa-miR-103 2.917134 7.886716 0.00384 0.01152 
hsa-miR-27b 2.97002 4.645793 0.000709 0.003335 
hsa-miR-130b 2.973298 5.623911 0.003601 0.011025 
hsa-miR-769-5p 2.984919 2.928335 0.000225 0.001861 
hsa-miR-625 3.009816 3.063671 0.00333 0.010336 
hsa-miR-222 3.0175 2.034864 0.017418 0.035231 
hsa-miR-361-5p 3.035242 4.611954 0.000645 0.003201 
hsa-miR-152 3.047342 0.511274 0.026205 0.049669 
hsa-miR-378* 3.093929 2.117641 0.000652 0.003201 
hsa-miR-181b 3.122786 4.408795 0.00214 0.007532 
hsa-miR-425 3.225857 6.216363 0.002065 0.007327 
hsa-miR-140-3p 3.235695 4.521609 0.002237 0.007692 
hsa-miR-27a 3.239678 4.496759 0.001633 0.006034 
hsa-let-7a 3.256363 8.193576 0.00251 0.008437 
hsa-miR-193a-3p 3.290883 1.559961 0.004108 0.012082 
hsa-miR-148b 3.300032 2.971673 0.000426 0.002538 
hsa-miR-200c 3.341582 0.940946 0.014212 0.030251 
hsa-miR-331-3p 3.358338 5.767948 0.000229 0.001861 
hsa-miR-138-2* 3.418646 0.455684 0.014614 0.03096 
hsa-miR-151-5p 3.44851 3.967527 0.000221 0.001861 
hsa-miR-33b 3.48818 -0.47633 0.00468 0.013073 
hsa-miR-181a 3.524479 6.633956 0.001649 0.006042 
hsa-miR-532-3p 3.562321 0.658134 4.55E-05 0.000887 
hsa-miR-30c 3.577445 5.281099 0.000118 0.00152 
hsa-miR-29a 3.588112 7.206803 0.000219 0.001861 
hsa-miR-141 3.594151 1.303714 0.000118 0.00152 
hsa-miR-140-5p 3.626306 4.627514 0.000204 0.001805 
hsa-miR-210 3.645846 6.236888 0.00268 0.008681 
hsa-miR-301b 3.646298 2.355695 0.005414 0.014695 
hsa-miR-362-3p 3.658112 1.577961 3.56E-05 0.000887 
hsa-miR-21 3.673982 10.42407 0.000781 0.003561 
hsa-miR-183 3.694076 0.456838 0.009295 0.021869 
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hsa-miR-148a 3.696211 5.479736 0.000415 0.002538 
hsa-miR-181c 3.712684 1.041504 0.003983 0.01179 
hsa-miR-7-1* 3.727289 2.961363 9.90E-05 0.00152 
hsa-miR-30e* 3.735669 3.212352 0.000768 0.003541 
hsa-miR-30e 3.800534 5.906367 0.003269 0.010292 
hsa-miR-26a 3.807022 6.114013 0.000886 0.003846 
hsa-miR-652 3.820726 2.061111 0.000745 0.003469 
hsa-miR-30d* 3.832491 0.469122 0.000101 0.00152 
hsa-miR-363 3.855702 3.132228 0.00043 0.002538 
hsa-miR-107 3.893979 7.648953 0.000808 0.003646 
hsa-miR-93 3.911997 6.651276 0.000134 0.00152 
hsa-miR-182 3.976464 -0.51534 0.00015 0.00152 
hsa-miR-30b 3.992347 6.057354 7.83E-05 0.001399 
hsa-miR-574-3p 4.002783 3.407865 0.000206 0.001805 
hsa-miR-191 4.008188 0.402267 2.95E-05 0.000887 
hsa-miR-181a* 4.032505 3.458474 0.000376 0.002437 
hsa-miR-503 4.038662 -0.02112 0.001007 0.004118 
hsa-miR-16 4.043719 9.236763 0.000524 0.002886 
hsa-miR-20b 4.099877 6.744308 0.000127 0.00152 
hsa-miR-424 4.143597 3.14083 0.000321 0.002279 
hsa-miR-17 4.149988 7.850754 0.000185 0.001797 
hsa-let-7i 4.152481 6.904096 0.000252 0.001934 
hsa-miR-20a 4.17425 8.596518 0.000143 0.00152 
hsa-miR-590-5p 4.203424 4.424362 0.000108 0.00152 
hsa-miR-26b 4.227011 5.99802 0.000201 0.001805 
hsa-miR-454 4.246079 2.023527 0.002426 0.008221 
hsa-miR-19b-1* 4.248059 1.633824 0.000129 0.00152 
hsa-miR-28-5p 4.275852 3.456186 0.000607 0.003131 
hsa-miR-20a* 4.281869 2.511058 0.000328 0.002288 
hsa-miR-301a 4.289713 4.364936 0.00052 0.002886 
hsa-let-7d 4.364109 6.646928 0.000139 0.00152 
hsa-miR-185 4.440188 3.543762 0.00446 0.012779 
hsa-miR-98 4.455491 4.161263 0.000175 0.001743 
hsa-miR-9* 4.469793 3.224868 0.007202 0.017689 
hsa-miR-542-3p 4.48736 0.032834 0.002009 0.007184 
hsa-miR-106b 4.531011 7.155615 0.000912 0.003862 
hsa-miR-29c 4.573217 7.039184 0.000241 0.001889 
hsa-miR-15b 4.577173 7.80479 5.24E-05 0.000976 
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hsa-miR-18b 4.588286 4.354533 0.000422 0.002538 
hsa-miR-324-5p 4.602037 4.037968 8.14E-05 0.0014 
hsa-miR-19b 4.619041 8.995531 0.000553 0.002942 
hsa-miR-7 4.665231 4.889295 0.00142 0.005423 
hsa-let-7g 4.706648 7.436612 0.000127 0.00152 
hsa-miR-374b 4.719566 3.398956 0.000536 0.002886 
hsa-miR-9 4.724144 2.372944 3.29E-06 0.00049 
hsa-miR-15a 4.733328 7.401147 9.17E-05 0.001518 
hsa-let-7f 4.790065 8.488932 0.000112 0.00152 
hsa-miR-19a 4.790195 7.72209 0.000255 0.001934 
hsa-miR-744 4.79439 1.344977 0.005649 0.015121 
hsa-miR-101 4.823534 4.280864 0.001467 0.00551 
hsa-miR-431* 4.91777 0.776972 0.000238 0.001889 
hsa-miR-18a 4.973288 5.439979 0.000409 0.002538 
hsa-miR-21* 5.062058 2.993364 3.24E-05 0.000887 
hsa-miR-96 5.094901 2.095749 2.30E-05 0.000887 
hsa-miR-142-5p 5.157389 6.631964 0.00034 0.002325 
ebv-miR-BART12 5.23419 3.375875 0.002235 0.007692 
hsa-miR-374a 5.387318 4.185961 0.000193 0.001797 
hsa-miR-362-5p 5.447151 0.840336 0.00258 0.008608 
hsa-miR-29b 5.500428 7.15443 1.99E-05 0.000887 
hsa-miR-340 5.607931 0.979883 0.00172 0.00625 
hsa-miR-17* 5.764045 3.830187 0.000147 0.00152 
hsa-miR-32 5.800386 2.183182 2.15E-05 0.000887 
hsa-miR-142-3p 6.134129 9.278608 4.28E-05 0.000887 
hsa-miR-153 6.172829 -1.22659 3.16E-05 0.000887 
hsa-miR-33a 6.241604 2.52445 0.000693 0.003333 
 
 
Raji Cells vs Exosomes    
Probe logFC A pvalue adjpvalue 
hsa-miR-451 -7.46927 4.004414 4.78E-08 2.14E-05 
hsa-miR-575 -6.58693 7.827253 0.001028 0.014611 
hsa-miR-125b-1* -6.48942 0.987357 0.001925 0.021057 
hsa-miR-198 -6.12724 1.648131 9.36E-05 0.00499 
hsa-miR-125a-3p -5.72874 5.0213 0.001694 0.019927 
hsa-miR-658 -5.01178 1.359686 0.005389 0.039489 
hsa-miR-27a -5.00499 4.496759 3.94E-05 0.00352 
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hsa-miR-936 -4.86763 -0.09782 0.000346 0.011895 
hsa-miR-654-5p -4.85215 3.7374 3.69E-05 0.00352 
hsa-miR-126 -4.82742 2.733188 3.69E-05 0.00352 
hsa-miR-513a-5p -4.47072 4.377892 0.000961 0.014318 
hsa-miR-149* -4.46787 0.431632 0.001046 0.014611 
hsa-miR-10b* -4.34616 0.814464 0.006873 0.045854 
hsa-miR-760 -4.32058 2.490711 0.000494 0.012257 
hsa-miR-422a -4.25136 2.179435 0.00161 0.019927 
hsa-miR-483-5p -4.24282 4.840386 0.000214 0.008701 
hsa-miR-518c* -4.06732 0.851379 0.001745 0.020005 
hsa-miR-513b -3.99957 2.783108 0.000906 0.013965 
hsa-miR-122 -3.85855 0.04668 0.000759 0.013965 
hsa-miR-610 -3.85027 1.635868 0.000901 0.013965 
hsa-miR-632 -3.82026 0.599001 0.00029 0.01082 
hsa-miR-513a-3p -3.81307 0.780434 0.001107 0.015001 
hsa-miR-141* -3.7537 -0.79115 0.000413 0.012257 
hsa-miR-492 -3.75195 0.457549 0.000693 0.013965 
hsa-miR-1225-5p -3.69434 7.167043 0.004976 0.037363 
kshv-miR-K12-3 -3.64391 7.030808 0.000106 0.00499 
hsa-miR-184 -3.38111 0.20812 0.001667 0.019927 
hcmv-miR-US4 -3.35232 2.537085 0.000112 0.00499 
hsa-miR-373* -3.33226 -0.19265 0.001192 0.015676 
hsa-miR-200a* -3.32871 0.015043 0.003054 0.027862 
hsa-miR-23a -3.29621 5.39411 0.000445 0.012257 
hsa-miR-498 -3.26805 0.968832 0.001328 0.016956 
hsa-miR-513c -3.23952 2.107752 0.00076 0.013965 
hsa-miR-30c-2* -3.08061 0.321023 0.000533 0.012545 
hsa-miR-502-3p -3.0742 1.453375 0.005509 0.039716 
hsa-miR-150 -3.06376 2.916366 0.00257 0.025345 
hsa-miR-500* -3.0016 2.523807 0.000787 0.013965 
hsa-miR-671-5p -3.00104 3.809781 0.003119 0.027885 
hsa-miR-584 -2.96508 2.201837 0.000467 0.012257 
hsa-miR-939 -2.94603 6.200593 0.006347 0.043649 
hsa-miR-542-5p -2.93123 2.439135 0.003274 0.02814 
hsa-miR-181c* -2.87241 0.687299 0.00413 0.033563 
hsa-miR-223 -2.56602 6.524582 0.002026 0.021057 
hsa-miR-662 -2.27539 1.737444 0.002797 0.026046 
hsa-miR-199b-5p -2.07536 1.297736 0.001992 0.021057 
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hsa-miR-10b -1.95659 0.51196 0.002197 0.022322 
hsa-miR-338-3p -1.84395 0.827574 0.003339 0.028164 
hsa-miR-885-5p 1.712088 1.928617 0.00478 0.037245 
hsa-miR-769-5p 1.912402 2.928335 0.006327 0.043649 
hsa-miR-219-5p 2.173338 2.050207 0.002608 0.025345 
hsa-miR-378* 2.225296 2.117641 0.00677 0.045851 
hsa-miR-197 2.36303 5.203971 0.000835 0.013965 
hsa-miR-590-5p 2.573758 4.424362 0.005015 0.037363 
hsa-miR-191 2.738933 0.402267 0.000861 0.013965 
ebv-miR-BART11-5p 2.771278 -1.02908 0.003634 0.030078 
hsa-miR-9 2.870101 2.372944 0.00039 0.012257 
hsa-miR-324-5p 2.923193 4.037968 0.003218 0.02814 
ebv-miR-BART19-5p 3.174379 -1.09169 0.004833 0.037245 
hsa-miR-29b 3.229791 7.15443 0.001998 0.021057 
hsa-miR-193a-3p 3.278232 1.559961 0.004214 0.033636 
hsa-miR-17* 3.576346 3.830187 0.005743 0.040749 
ebv-miR-BHRF1-2* 3.581587 0.52684 0.000104 0.00499 
hsa-miR-142-3p 3.728955 9.278608 0.002726 0.025929 
hsa-miR-32 3.958077 2.183182 0.000675 0.013965 
hsa-miR-744* 4.145577 1.917892 5.66E-05 0.004218 
hsa-miR-431* 4.309403 0.776972 0.000717 0.013965 
hsa-miR-574-3p 4.854247 3.407865 3.45E-05 0.00352 
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Annex Table 9.3. Targets of TUT4.  
(A) Mono-uridylated (nont_3p_U) and oligo-uridylated (nont_3p_oligoU) miRNAs that are 
significantly less abundant in TUT4-deficient CD4 T cells. Species that are identified both for 
mono- or oligo-uridylation appear in bold. (B) miRNAs significantly less abundant in both the 
mono- and oligo-uridylated form in TUT4-deficient CD4 T cells.  
 
A: Complete list of TUT4 targets  
ID log2 Fold Change Adjusted p value 
mmu-let-7c-2-5p_nont_3p_U -1.167309726 0.02574908 
mmu-let-7f-2-5p_nont_3p_U -1.781355148 0.00021568 
mmu-let-7g-5p_nont_3p_U -1.7925212 1.83E-06 
mmu-let-7i-5p_nont_3p_U -0.657803428 3.39E-10 
mmu-mir-101b-3p_nont_3p_U -0.731672466 3.49E-11 
mmu-mir-106a-5p_nont_3p_U -1.521703894 0.00966257 
mmu-mir-106b-5p_nont_3p_U -1.36618412 0.03823983 
mmu-mir-130b-3p_nont_3p_U -0.757508609 0.00027401 
mmu-mir-132-3p_nont_3p_U -0.914747694 0.00186816 
mmu-mir-140-3p_nont_3p_U -1.06746012 3.68E-49 
mmu-mir-140-3p_nont_3p_oligoU -1.497566549 1.54E-05 
mmu-mir-140-5p_nont_3p_U -1.323650233 0.03457858 
mmu-mir-142-3p_nont_3p_U -1.162625018 8.25E-38 
mmu-mir-142-5p_nont_3p_U -1.119266718 8.07E-14 
mmu-mir-142-5p_nont_3p_oligoU -1.087649295 1.06E-06 
mmu-mir-146a-5p_nont_3p_U -0.575549883 0.03457858 
mmu-mir-146a-5p_nont_3p_oligoU -1.135284176 0.00021568 
mmu-mir-148b-3p_nont_3p_oligoU -0.580199386 8.66E-05 
mmu-mir-150-5p_nont_3p_U -0.823708066 0.00024956 
mmu-mir-150-5p_nont_3p_oligoU -0.893117924 0.02977229 
mmu-mir-155-5p_nont_3p_U -1.38292442 1.83E-07 
mmu-mir-15a-5p_nont_3p_U -0.950540696 0.00134439 
mmu-mir-15b-3p_nont_3p_U -1.228413995 0.02928478 
mmu-mir-17-3p_nont_3p_U -1.241786 0.01677079 
mmu-mir-17-5p_nont_3p_U -1.315542467 0.01670394 
mmu-mir-181a-2-5p_nont_3p_U -0.858754426 2.30E-41 
mmu-mir-181a-2-5p_nont_3p_oligoU -1.172783199 9.61E-09 
mmu-mir-192-5p_nont_3p_oligoU -1.025718311 0.00167943 
mmu-mir-19a-3p_nont_3p_U -1.083384538 0.01310334 
mmu-mir-19b-2-3p_nont_3p_U -1.229718913 2.41E-14 
mmu-mir-203-3p_nont_3p_U -1.191205403 4.78E-05 
mmu-mir-211-5p_nont_3p_U -1.253870647 0.02616096 
mmu-mir-21a-5p_nont_3p_U -0.810856854 0.01264793 
mmu-mir-25-3p_nont_3p_U -0.737184914 8.09E-19 
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mmu-mir-25-3p_nont_3p_oligoU -1.70606826 9.38E-07 
mmu-mir-26a-2-5p_nont_3p_U -0.939689388 2.36E-12 
mmu-mir-26a-2-5p_nont_3p_oligoU -1.696846625 1.58E-20 
mmu-mir-26b-5p_nont_3p_U -1.032433347 1.66E-21 
mmu-mir-26b-5p_nont_3p_oligoU -1.850375815 1.23E-06 
mmu-mir-27b-3p_nont_3p_oligoU -1.160756428 7.65E-13 
mmu-mir-28a-5p_nont_3p_U -1.867289555 0.0015607 
mmu-mir-29a-3p_nont_3p_U -0.833912905 3.35E-10 
mmu-mir-30a-5p_nont_3p_U -1.156514422 0.01370107 
mmu-mir-30c-1-5p_nont_3p_U -1.552391836 1.77E-11 
mmu-mir-30d-5p_nont_3p_U -1.168617517 3.57E-12 
mmu-mir-30d-5p_nont_3p_oligoU -1.851773274 0.00012624 
mmu-mir-30e-5p_nont_3p_U -0.840940373 5.17E-12 
mmu-mir-30e-5p_nont_3p_oligoU -2.356737519 0.00017378 
mmu-mir-322-5p_nont_3p_U -1.185099797 1.83E-06 
mmu-mir-378a-3p_nont_3p_oligoU -0.759430267 0.00835518 
mmu-mir-378c-5p_nont_3p_U -1.083600463 1.04E-07 
mmu-mir-421-3p_nont_3p_U -1.016570589 1.58E-06 
mmu-mir-425-5p_nont_3p_U -1.238368606 3.98E-08 
mmu-mir-92a-1-3p_nont_3p_U -0.881862797 2.50E-15 
mmu-mir-92a-1-3p_nont_3p_oligoU -1.436571358 3.72E-27 
mmu-mir-92a-2-3p_nont_3p_U -0.723421579 2.32E-07 
mmu-mir-92a-2-3p_nont_3p_oligoU -1.14678676 2.32E-09 
mmu-mir-93-5p_nont_3p_U -1.046286403 1.71E-12 
mmu-mir-93-5p_nont_3p_oligoU -1.858286979 3.79E-09 
mmu-mir-98-5p_nont_3p_U -1.168208826 0.01642043 
 
B: Short list of TUT4 targets 
mmu-mir-140-3p 
mmu-mir-142-5p 
mmu-mir-146a-5p 
mmu-mir-150-5p 
mmu-mir-181a-2-5p 
mmu-mir-25-3p 
mmu-mir-26a-2-5p 
mmu-mir-26b-5p 
mmu-mir-30d-5p 
mmu-mir-30e-5p 
mmu-mir-92a-1-3p 
mmu-mir-92a-2-3p 
mmu-mir-93-5p 
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Annex Table 9.4. TUT4 targets are downregulated after T cell activation. 
miRNAs whose abundance in the oligo-uridylated form is reduced after T cell activation; species 
that were also identified as TUT4 targets in TUT4-deficient mice are shown in bold italics. 
 
miR Log2 FC adj p value 
mmu-mir-150-5p -6.497 5.18E-12 
mmu-mir-150-3p -6.02 4.09E-10 
mmu-mir-181a-2-5p -5.749 6.71E-09 
mmu-mir-142-5p -5.38 1.31E-07 
mmu-mir-140-3p -5.361 1.11E-07 
mmu-mir-191-5p -5.032 1.08E-06 
mmu-mir-328-3p -4.993 1.39E-06 
mmu-mir-423-3p -4.711 8.05E-06 
mmu-let-7i-5p  -4.174 1.06E-09 
mmu-mir-151-3p  -3.62 6.85E-10 
mmu-mir-92b-3p  -3.598 1.69E-06 
mmu-mir-25-3p  -3.177 5.62E-14 
mmu-mir-26a-2-5p  -3.113 1.49E-24 
mmu-mir-146a-5p  -3.09 2.30E-06 
mmu-mir-92a-1-3p  -2.955 1.58E-34 
mmu-mir-378a-3p  -2.687 1.67E-16 
mmu-mir-27b-3p  -2.583 9.74E-05 
mmu-mir-93-5p  -2.542 0.00804452 
mmu-mir-92a-2-3p  -2.048 8.78E-20 
mmu-mir-30e-3p  -1.984 0.00304615 
mmu-mir-103-2-3p  -1.46 3.68E-08 
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